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Abstract
Systematic review and economic modelling of the clinical
effectiveness and cost-effectiveness of art therapy among
people with non-psychotic mental health disorders
Lesley Uttley,1* Alison Scope,1 Matt Stevenson,1 Andrew Rawdin,1
Elizabeth Taylor Buck,1 Anthea Sutton,1 John Stevens,1
Eva Kaltenthaler,1 Kim Dent-Brown2 and Chris Wood3
1School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK
2Department of Psychology, University of Hull, Hull, UK
3Sheffield Health and Social Care NHS Foundation Trust, Netherthorpe House, Sheffield, UK
*Corresponding author l.uttley@sheffield.ac.uk
Background: Mental health problems account for almost half of all ill health in people under 65 years.
The majority are non-psychotic (e.g. depression, anxiety and phobias). For some people, art therapy may
provide more profound and long-lasting healing than more standard forms of treatment, perhaps because
it can provide an alternative means of expression and release from trauma. As yet, no formal evaluation of
art therapy for non-psychotic mental health disorders has been conducted.
Aim: This review aimed to evaluate evidence for the clinical effectiveness and cost-effectiveness of art
therapy for non-psychotic mental health disorders.
Methods: Comprehensive literature searches for studies examining art therapy in populations with
non-psychotic mental health disorders were performed in major health-related and social science
bibliographic databases including MEDLINE, EMBASE, The Cochrane Library, Cumulative Index to Nursing
and Allied Health Literature (CINAHL), PsycINFO, Allied and Complementary Medicine Database (AMED)
and Applied Social Sciences Index and Abstracts (ASSIA) from inception up to May 2013. A quantitative
systematic review of clinical effectiveness, a qualitative review to explore the acceptability, relative benefits
and potential harms, and a cost–utility analysis of studies evaluating cost-effectiveness of art therapy
were conducted.
Results: In the quantitative review, 15 randomised controlled trials (RCTs) were included (n= 777).
Meta-analysis was not possible because of clinical heterogeneity and insufficient comparable data on
outcome measures across studies. A narrative synthesis reports that art therapy was associated with
significant positive changes relative to the control group in mental health symptoms in 10 out of the
15 studies. The control groups varied between studies but included wait-list/no treatment, attention
placebo controls and psychological therapy comparators. Four studies reported improvement from baseline
but no significant difference between groups. One study reported that outcomes were more favourable in
the control group. The quality of included RCTs was generally low. In the qualitative review, 12 cohort
studies were included (n= 188 service users; n= 16 service providers). Themes relating to benefits of art
therapy for service users included the relationship with the therapist, personal achievement and distraction.
Areas of potential harms were related to the activation of emotions that were then unresolved, lack of
skill of the art therapist and sudden termination of art therapy. The quality of included qualitative studies
was generally low to moderate. In the cost-effectiveness review, a de novo model was constructed and
populated with data identified from the clinical review. Scenario analyses were conducted allowing
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comparisons of group art therapy with wait-list control, group art therapy with group verbal therapy, and
individual art therapy versus control. Art therapy appeared cost-effective compared with wait-list control
with high certainty, although generalisability to the target population was unclear. Verbal therapy
appeared more cost-effective than art therapy but there was considerable uncertainty and a sizeable
probability that art therapy was more clinically effective. The cost-effectiveness of individual art therapy
was uncertain and dependent on assumptions regarding clinical benefit and duration of benefit.
Conclusions: From the limited available evidence, art therapy was associated with positive effects when
compared with a control in a number of studies in patients with different clinical profiles, and it was
reported to be an acceptable treatment and was associated with a number of benefits. Art therapy
appeared to be cost-effective compared with wait-list but further studies are needed to confirm this
finding as well as evidence to inform future cost-effective analyses of art therapy versus other treatments.
Study registration: The study is registered as PROSPERO CRD42013003957.
Funding: The National Institute for Health Research Health Technology Assessment programme.
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Plain English summary
We evaluated evidence for the clinical effectiveness and cost-effectiveness of art therapy fornon-psychotic mental health disorders. The majority of mental health problems are non-psychotic
(e.g. depression, anxiety and phobias). For some people, art therapy may be a more acceptable alternative
form of psychological therapy than more standard forms of treatment, such as talking therapies.
The evidence is current to May 2013. Fifteen clinical trials (777 patients) assessed the effectiveness of art
therapy. Art therapy was associated with positive changes to mental health symptoms compared with a
control group in 10 out of the 15 studies. The control groups varied between trials. Four trials found some
improvement but no difference between art therapy and the control group. One trial reported that
outcomes were more favourable in the control group.
Twelve studies (188 service users and 16 service providers) assessed the acceptability and the potential
benefits or harms of art therapy. Reported benefits of art therapy from service users included increased
understanding of self and expression of feelings. Some areas of potential harm were also identified.
The quality of all included studies was low to moderate.
A review to identify publications assessing the cost-effectiveness of art therapy was undertaken. One
relevant case study, of a single patient, was identified. A new analysis was, therefore, conducted using
data from three trials identified in the clinical review which found that art therapy is plausibly cost-effective
compared with wait-list control. There were limitations with the evidence used to conduct this analysis so
further investigation is needed before any final conclusions can be made.
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Scientific summary
Background
Mental health problems account for almost half of all ill health in people under 65 years. The majority of
these mental health problems are non-psychotic. These include anxiety disorders such as phobias and
obsessive–compulsive disorder, mood disorders such as depression and major depressive disorder, and
other problems such as eating disorders and personality disorders. Despite the high prevalence of these
disorders in mental ill health, only one-quarter of people with mental health problems are in treatment.
Currently the National Institute for Health and Care Excellence (NICE) recommends cognitive–behavioural
therapy (CBT) for most non-psychotic mental disorders and recommends arts therapies only for
schizophrenia. However, for some people, art therapies may provide an approach to psychological therapy
with which they find it easier to engage. For example, for those who find it difficult to express themselves
in verbal language alone, as required by more standard forms of treatment for mental health problems,
such as talking therapies, arts therapies can provide an alternative means of expression to help service
users understand, make sense of and cope with their distress. There is a small body of evidence to support
the claim that art therapy is effective in treating a variety of symptoms and disorders in patients of
different ages. However, to date a full systematic review of the clinical effectiveness and cost-effectiveness
of art therapy for non-psychotic mental disorders has not been undertaken. This project aimed to
systematically review the current evidence for art therapy for people with non-psychotic mental disorders.
Research questions
1. What is the evidence that art therapy is clinically effective in people with non-psychotic mental
health disorders?
2. What are the user and service provider perspectives on the acceptability and relative benefits and
potential harms of art therapy for people with non-psychotic mental disorders?
3. What is the evidence that art therapy is cost-effective in people with non-psychotic mental
health disorders?
Search methods
A systematic literature search was developed for studies examining art therapy in populations with
non-psychotic mental health disorders. Comprehensive searches were conducted in major health-related
and social science bibliographic databases including MEDLINE, EMBASE, The Cochrane Library, Cumulative
Index to Nursing and Allied Health Literature (CINAHL), PsycINFO, Allied and Complementary Medicine
Database (AMED) and Applied Social Sciences Index and Abstracts (ASSIA) from inception up to May 2013.
Search terms relating to art therapy were combined with methodological search filters to identify reviews,
randomised controlled trials (RCTs), economic evaluations, qualitative research and any other study types.
No date or language restrictions were applied. Additional searches were conducted via a number of
websites and electronic resources to identify grey literature. Hand-searching of key art therapy journals
was also conducted. A quantitative systematic review of the clinical effectiveness of art therapy was
undertaken, as well as a qualitative review to explore the acceptability, relative benefits and potential
harms of art therapy. In addition, a cost–utility analysis of studies evaluating cost-effectiveness of art
therapy was conducted.
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Inclusion criteria
Population: non-psychotic clinical samples.
Intervention: art therapy as might be delivered in the NHS.
Comparators: any including treatment as usual, wait-list, attention placebo or other psychological therapy.
Outcomes: treatment effectiveness as determined by changes in mental health rating scales; related clinical
or quality of life outcomes; qualitative data on the acceptability, relative benefits and potential harms of art
therapy; economic data on the costs or cost-effectiveness of art therapy.
Studies: quantitative review – RCTs. Qualitative review – case series, interviews and observational studies.
Studies in all settings were included, although community was the main setting of interest.
Exclusion criteria
Population: people with psychosis; healthy samples.
Intervention: other ‘arts therapies’, including drama, music and dance. Play therapy.
Comparators: none.
Outcomes: outcomes focused on interpretation of the art work itself, not the participant.
Studies: quantitative review – any evidence from non-randomised controlled studies. Qualitative
review – single case studies.
Data collection and analysis
For the quantitative and qualitative reviews, two review authors sifted titles and abstracts for identification
of relevant studies, assessed trial quality and extracted data independently for all studies. In the event of a
disagreement, a third reviewer was consulted. Studies were included regardless of study quality.
Results of the quantitative review
Of the 10,270 records retrieved, 15 RCTs were included in the review (n= 777). Study populations
included adults and children with depression, cancer, HIV/AIDS, sickle cell disease, post-traumatic stress
disorder, dementia and asthma. Owing to the scarcity of data in each condition as well as heterogeneity of
clinical profiles and outcomes measures, meta-analysis was not possible. A narrative synthesis reports that
art therapy was associated with significant positive changes in mental health symptoms relative to the
control group in 10 out of the 15 studies examined. Relevant mental health symptoms targeted in
the studies included depression, anxiety, mood, trauma, distress, quality of life, coping, cognition and
self-esteem. Comparators were treatment as usual, CBT, psychodynamic psychotherapy, regular programme
activities, simple calculations, art and craft activities, guided garden walking, educational support and
viewing a video tape. Four studies reported improvement from baseline but no significant difference
between groups. One study reported that outcomes were more favourable in the control group.
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The quality of the included RCTs was generally low. The risk assessment of bias highlighted that, although
all studies were reported to be RCTs, few studies reported how patients were randomised and in the
majority of studies there were several instances of high risk of bias. Areas of potential confounding
frequently associated with the studies included attrition, concomitant treatment and treatment fidelity and
subsequently the internal validity of the included studies is threatened. Owing to the low quality of the
15 RCTs, the results included in the quantitative review should be interpreted with caution.
Results of the qualitative review
In total, 12 cohort studies of art therapy were included in the qualitative review, providing data from
188 service users and 16 service providers. Major themes relating to the benefits of art therapy for service
users included the importance of the relationship with the therapist, increased understanding of self,
distraction from own illness, personal achievement, self-expression, relaxation, empowerment and
expression of feelings. Potential harms related to the activation of emotions that were then unresolved,
lack of skill of the art therapist and sudden termination of art therapy. Service providers reported benefits
such as the promotion of communication, anger management and expression of emotions and highlighted
the importance of art therapists and other health professionals working together; if they did not, this was
a barrier to service users’ participation in art therapy.
The quality of included qualitative studies was generally low to moderate. Each finding could potentially be
graded as being of high, moderate or low certainty. For the evidence from patients, there were a total of
38 findings: 20 were assessed as being of moderate certainty and 18 were assessed to be of low certainty.
For the evidence from service providers, as only two studies contributed to the evidence, there were a total
of 25 findings: 19 were assessed as being of moderate certainty and six were assessed to be of low
certainty. No findings were assessed as being of high certainty.
Results of the cost-effectiveness review
The systematic review of cost-effectiveness data for art therapy identified one relevant case study. For this
reason, a de novo model was constructed and populated with data from three RCTs identified in the
clinical review from which preference-based utility data could be estimated. Given heterogeneous
interventions, scenario analyses were conducted. These allowed comparisons of group art therapy with
wait-list control; group art therapy with group verbal therapy; and individual art therapy versus control.
None of the art therapy interventions was similar to that employed in England and Wales and thus
generalisations could not be made with any confidence. However, based on the interventions within
the RCTs group and assuming a willingness to pay £20,000 per quality-adjusted life-year gained, art
therapy appeared more cost-effective than wait-list control with high certainty; verbal therapy appeared
more cost-effective than art therapy but there was considerable uncertainty and a sizeable probability
(20%) that art therapy was more clinically effective. The cost-effectiveness of individual art therapy was
uncertain and dependent on assumptions made regarding clinical benefit and duration of benefit. An
exploratory analysis was undertaken to estimate the utility gain required for art therapy as used in England
and Wales to be cost-effective. This threshold level was below the gain seen in the RCT of art therapy
against wait-list control, despite the short duration of art therapy in this study.
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Conclusions
From the limited available evidence the following conclusions can be made from this review.
l Art therapy appears to have statistically significant positive effects compared with control in a number
of studies in patients with different clinical profiles.
l Art therapy was reported to be an acceptable treatment and was associated with a number of benefits.
A small numbers of patients reported varying reasons for not wanting to take part and, therefore,
art therapy may not be a preferred treatment option for everyone.
l Art therapy appears to be cost-effective versus wait-list, but confirmatory studies are needed to confirm
this finding, as well as evidence to inform future cost-effective analyses of art therapy versus
other treatments.
Recommendations
Recommendations for future research are suggested which include more multiarm controlled trials,
pre-specified populations, random selection and allocation of participants, allocation concealment, use of
user-validated outcomes and ensuring appropriate long-term follow-up of treatment response.
Study registration
The study is registered as PROSPERO CRD42013003957.
Funding
The National Institute for Health Research Health Technology Assessment programme.
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Chapter 1 Introduction
Background to the underlying health problem
Definition and prevalence of non-psychotic mental disorders
Among people under 65 years, nearly half of all ill health is mental illness, which accounts for 38%
of all morbidity in the UK burden of disease.1 Mental ill health is the largest single cause of disability in
our society.2 Mental disorders can be broadly categorised as either psychotic or non-psychotic, with
non-psychotic disorders accounting for most (94%) mental health morbidity in adults.1,3 Non-psychotic
mental disorders include anxiety disorders such as phobias and obsessive–compulsive disorder, mood
disorders such as depression and major depressive disorder, and other conditions such as eating disorders
and personality disorders. Depression alone accounts for the greatest burden of disease among all mental
health problems.4,5 In addition, nearly one-third of all people with long-term physical conditions have
a comorbid mental health problem such as depression or anxiety disorders, indicating an interaction
between physical and mental illness.6–8 Figures for mental illness quoted in the London School of
Economics and Political Science report do not include dementia and alcohol and substance misuse, which
are also important issues in their own right, and account for part of the outlay in mental health services in
the UK NHS.1
Costs to the NHS
Mental health receives a 13% share of the NHS expenditure despite mental health accounting for 23% in
the burden of disease.1 The largest part of this expenditure is on psychotic disorders, but these disorders
account for less than 6% of people suffering with mental illness. One-quarter of all those with mental
health problems are in treatment, compared with the vast majority of those with physical illnesses.1
Research indicates that the costs of psychological therapy are low compared with general care
admissions,9,10 and recovery rates are high.11 Unlike most long-term physical conditions, much mental
illness is curable.11 For depression and anxiety the number needed to treat is estimated to be under 3.1
Moreover, the same research used data from relevant National Institute for Health and Care Excellence
(NICE) guidance compiled by the National Collaborating Centre for Mental Health and posits that ‘more
expenditure on the most common mental disorders would almost certainly cost the NHS nothing’ because
‘when people with physical symptoms receive psychological therapy, the average improvement in physical
symptoms is so great that the resulting savings on NHS physical care outweigh the cost of the
psychological therapy’.1
The NHS is under increasing pressure to provide cost-effective treatments to service users in a timely
manner. The UK government initiative for Improving Access to Psychological Therapies (IAPT) for
depression and anxiety disorders within the NHS offers evidence-based psychological therapies that are
recommended by NICE. However, IAPT is facing increasing criticism that it is too limited to handle the
mental health problems of people with long-term physical conditions or medically unexplained symptoms.1
Recent evidence also suggests that only one-quarter of people with a mental illness receive treatment for it
and that mental health is seriously undervalued, under-recognised and underfunded in the NHS.1 It may be
that more mental health treatment options are needed, which vary according to the type and severity of
mental disorder, rather than a one-size-fits-all approach across professions. In addition, recent evidence
suggests that psychological treatment may be a preferred treatment option over pharmacological
treatment for many who are undergoing treatment for a psychiatric disorder.12,13 Moreover, patient
preference for treatment may impact on adherence and treatment outcome.14,15 Therefore, evaluation of
forms of psychological therapy other than cognitive–behavioural therapy (CBT) need to be conducted in
addition to the evaluation of specific pathways within those psychological therapies, in order to create a
strategic framework of pathways for managing the burden of mental health morbidity.
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Evaluation of psychological therapies such as art therapy is therefore critical in order to inform future
recommendations for its use. There is a small body of evidence to support the claim that art therapy is
effective in treating a variety of symptoms and disorders in patients of different ages.16 However, to date a
full systematic review of the clinical effectiveness and cost-effectiveness of art therapy for non-psychotic
mental disorders has not been undertaken. This project aimed to evaluate the current evidence for art
therapy for people with non-psychotic mental disorders in order to inform researchers and commissioners
about the value of future use of art therapy in the NHS.
Art therapy
Description of intervention
The intervention of interest is art therapy as might be delivered in the NHS. Art therapy involves using
painting, clay work and other creative visual art-making (including creative digital media) as a form
of non-verbal expression, in conjunction with other modes of communication within a therapeutic
relationship in an appropriate therapeutic setting. Art therapy is a specific branch of treatment under the
umbrella term ‘arts therapies’ used by the Health and Care Professions Council (HCPC) which includes
drama therapy and music therapy. Dance movement therapy is also described as one of the arts therapies
but is not yet regulated. For the purpose of this technology assessment these other forms of arts therapies,
which do not centre on the creation of a sustainable physical piece of visual art, are excluded.
Despite art therapy being an established and practised form of psychological therapy for decades, only
more recently have researchers in the field of art therapy addressed the need to integrate art therapy into
a model of evidence-based practice. Therefore, an abundance of literature exists consisting of single case
studies or theoretical concepts in art therapy. Proponents of art therapy17–19 and of the arts therapies20,21
only relatively recently have come to realise that randomised controlled studies of art therapy are needed
in order to create a pluralistic body of evidence. As a consequence there has been limited formal synthesis
of evidence16,22 for the clinical effectiveness and cost-effectiveness of art therapy in order to assess its
relevance as a treatment for the most common mental disorders in the NHS.
Current use of art therapy in NHS
Currently, CBT is the most widely recommended psychological therapy for most mental health problems.
However, NICE has identified that the arts therapies (including art therapy) may have specific benefits
for people with psychosis and schizophrenia and, therefore, recommends art therapy to be considered
for these patients, above counselling and supportive psychological therapy.23 There are a number of
non-psychotic mental health problems that are typified by service users’ reluctance or inability to
communicate their feelings verbally. Art therapy is currently being used in the NHS for many non-psychotic
mental disorders. For example, arts therapies are included in the autistic spectrum disorder (ASD) Strategic
Plan for Wales20 as an accessible and appropriate form of psychotherapy for those with ASD. For these and
other service users, it may be that art therapy is a more appropriate treatment than standard talking
therapies, but the evidence base for the use and acceptability of art therapy in non-psychotic mental
disorders has yet to be formally evaluated. There are clinical guidelines by art therapists for working with
elderly people,24 working with prisoners,25 working with children, adolescents and families,26 and working
with people with a diagnosis of personality disorder,27 indicating movement in the profession towards
more specific systematic practice and research. There are currently no national guidelines in the UK
specifically for the use of art therapy for non-psychotic mental disorders.
Art therapy is a widely used psychological therapy which has HCPC approval, higher education Quality
Assurance Agency for Higher Education subject benchmarks and a professional organisation for its
practitioners – the British Association of Art Therapists (BAAT). While testimonials and case studies
occupied much of the evidence for art therapy in the past, there has been less focus on producing rigorous
randomised controlled trials (RCTs) of art therapy. The purpose of this review is to assess systematically the
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evidence that is relevant to whether or not art therapy is effective, how it may be clinically effective and
whether or not it is cost-effective in people with non-psychotic mental health disorders.
The results of the 2014 BAAT Workforce Survey represented one-third of members from the professional
association; with 70 responses from Scotland and 567 responses from England, Wales and Northern
Ireland. The survey results suggested that:
l In England, Wales and Northern Ireland, the NHS employs around half of art therapists who responded.
Other large employers are third-sector organisations (charities, voluntary and independent organisations),
educational institutions, private practices and local authorities.
l Over half of art therapists who responded use generic skills in their work, such as assessments and
key working, possibly reflecting a change towards delivering other services in addition to providing
art therapy.
l The majority of client groups served are adults, children and young people. Elderly people and families
account for smaller proportions.
l The range of mental health difficulties dealt with by art therapists who responded includes complex
trauma and abuse, learning disabilities, alcohol and substance use, forensic mental health, criminal
justice, elderly people and palliative care.
There are likely to be regional variations in the availability and practice of art therapy in the UK not
captured by this survey.
There is no definitive criterion for who is routinely referred for art therapy, and at what point in their care
pathway.28 The only standardised guidelines for its use are in relation to schizophrenia.29 However, discernible
clusters of people undergo art therapy according to published literature, including people who have been
abused and traumatised, who are on the autistic spectrum, who have addictions, dementia, eating disorders
or learning difficulties, who are offenders, who are in palliative care, who have depression or personality
disorders or who were displaced as a result of political violence. Therefore, adults are referred from a broad
range of diagnostic categories, but they tend not to be referred on the basis of diagnosis alone. They may be
referred on the basis of behavioural problems, including problems with engaging with services or problems
with putting distress into words, for which talking therapies would not be the preferred option. Other
clinicians making referrals to art therapy are often looking to widen the range of treatment options for people
who, in addition to having complex, severe and enduring mental health problems, face emotional and
socioeconomic deprivation. As seen in the use of art therapy for service users in palliative care, people facing
the emotional consequences of serious physical health may also be referred.
Defining the use of art therapy for children and adolescents is also problematic. This is because children’s
problems tend to be grouped as ‘emotional’ or ‘behavioural’ in the absence of diagnosed disorders.30
Published outcome data are scarcer for children and adolescents, with more qualitative descriptions of art
therapy occurring in the literature. However, BAAT reports that, in November 2010, of the approximately
1800 full members of BAAT, 878 described themselves as working with children, young people and/or
families. Seemingly, therefore, art therapy is currently being widely practised with children and young
people and should be duly considered in this review.
The art therapist’s role in the mental health service pathway
In service contexts where art therapists are working more briefly with service users, they may also refer on
to other services. This is particularly important for clients who have long-term conditions, as it leaves the
way open for clients to return for more art therapy at a later stage. Accordingly, art therapists have a
professional responsibility to consider carefully referrals that they receive and that they make. Figure 1
indicates the mental health service pathway open to art therapists who are working in a multiagency
context. This diagram is adapted from a presentation at the BAAT annual general meeting in 2010,31 in
which a two-way bridge was highlighted as a potentially important relationship for art therapists who are
working, clinically, with service users for relatively short periods of time.
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Adapting the research to the research question
The protocol for this research project was designed by the research team in consultation with a project
steering group consisting of external health professionals and service users (see Appendix 1). The steering
group was made up of consultant psychiatrists with experience of referring to art therapy and service users
who had been referred to art therapy. The purpose of the steering group was to ensure that the research
team’s proposed research design was open to the views of stakeholders. In addition, the protocol was also
publicly available online and the project was registered on the PROSPERO database of systematic reviews
(registration no. CRD4201300395732).
One of the major challenges in delivering the research lay in tailoring the research methodology to fit with
the research question. The research question can be regarded as non-standard in that it centres on the
intervention rather than the population. This health technology assessment can therefore be regarded as
an evidence portfolio for art therapy. The population under review is patients with non-psychotic mental
disorders. Psychosis is not a precise mental health condition but is a symptom that can feature in several
mental health disorders; for example, conditions such as bipolar disorder and depression can occur with or
without psychotic symptoms. Conversely, schizophrenia is perhaps one of the few mental health conditions
that is characterised by psychosis, along with delusional disorder, acute and transient psychotic disorder,
schizoaffective disorder, non-organic psychotic disorder and organic psychotic disorder. These are,
therefore, some of the few mental health conditions that can be regarded as falling outside the population
for this research.
Art therapy as a clinical intervention: definition
Although art therapy is a HCPC-approved form of psychological therapy in the UK, there is currently a lack
of a clear single definition of art therapy. The BAAT describes art therapy as a form of psychological
therapy that uses the art-making process as its primary mode of communication and can therefore be
particularly helpful to people who find it hard to express their thoughts and feelings verbally. Clients who
are referred to an art therapist do not need to have previous experience or skill in art, and the overall aim
of its practitioners is to enable the client to explore and express their feelings in a safe and facilitating
environment. Art therapy can be regarded as a three-way process between the client, the therapist and
the image or artefact.33
The concept of art therapy may sometimes be confused with creative arts movements or strategies
designed to improve well-being through art (often called ‘arts in health’ approaches) which, although
potentially beneficial, are not specific formal therapeutic interventions to target mental health conditions in
individual service users. In order to distinguish the psychotherapeutic use of art therapy as is under
REFERRAL
Admission
Art therapy
Other
treatment
Bridge
Community
services,
arts and well-being
programmes,
schools,
etc.
Inform Clinical focus Innovate Partnership
TREATMENT SOCIAL INCLUSION
FIGURE 1 Mental health service pathway for art therapists working in a multiagency context.
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investigation in this research question, a criterion to define art therapy as a form of psychological therapy
has been formulated. This pragmatic definition was developed as a screening tool and a guide for
assessing papers for inclusion into the systematic review. It is not intended to be an exhaustive definition
and needed to be sufficiently flexible to include practices in the UK and abroad.
Definition of art therapy in this review:
l The procedure includes establishing therapeutic boundaries appropriate for art therapy interventions
(such as clarity about the start and finish of therapy and the frequency and length of sessions).
l The intervention takes places in the presence of a therapist with whom there is an appropriate
therapeutic relationship.
l The intervention includes the therapeutic use of art materials.
l The description of art therapy is appropriate to the cultural and service context.
Art therapy as a complex intervention
Non-pharmacological treatments such as psychotherapies are often considered to be complex
interventions. The key features of complex interventions have been described (Craig et al. 200834) as:
l having a number of interacting components
l having a number and difficulty of behaviours required by those delivering or receiving the intervention
l having a number of groups or organisational levels targeted by the intervention
l having a number and variability of outcomes
l requiring a degree of flexibility or tailoring of the intervention permitted (non-standardisation/reproducibility).
Art therapy can be regarded as a complex intervention according to each of these features for the
following reasons:
l Art therapy may often be used in service users with complex clinical presentations who may or may not
have responded to several other treatments in mental health services. It is frequently delivered as part
of a wider package of treatment and sometimes as a last resort when other treatments have failed.
l Art therapy is not delivered for any one specific health condition or symptom. It is used in a variety of
patient populations. In addition, art therapy is not alone in lacking a clear single definition; psychological
therapy more generally is open to heterogeneity through its delivery by different individuals.
l Art therapy is frequently used in service users with comorbid physical long-term conditions which
may actually be their primary health diagnosis. There is no set clinical pathway for who should receive
art therapy and at what stage of treatment. Therefore, it is difficult to define or exhaustively list
comparators for art therapy.
l There is currently no standard outcome measure for defining ‘successful’ treatment through art therapy
in clinical practice.
l Art therapists do not offer a set package but tend to tailor the course of treatment, as well as each
individual session, to the client.
Thus, confidence in building a coherent network of evidence for a mixed treatment comparison that would
contain all possible comparators, comparable study designs and homogeneous participants was low. The
use of substantial resources to construct a comparison with potentially low internal validity, in terms of
the relative dearth of relevant art therapy evidence, was not deemed appropriate.
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Non-psychotic mental health population: definition
The population under consideration is people undergoing treatment for mental health symptoms that do
not include psychosis. However, one of the complexities of this population is that not everyone who is
being treated for mental health symptoms has a mental health diagnosis. The target population can be
described as:
(a) Mainstream mental health clinical samples with or without formal diagnoses.
The primary health diagnosis for many people who are service users in mental health may be for a
long-term physical health condition or illness that impacts on their mental health. A second group who are
also relevant to the research question can be defined as the study population:
b(i) Reversible or fluctuating physical conditions where the treatment goals of art therapy include
reduction of mental health symptoms (such as depression, anxiety or trauma) as demonstrated by the
outcome measures used.
In addition, service users may be in receipt of mental health services for conditions where the primary goal
of treatment cannot be considered solely as ‘recovery’ from symptoms, but may be to cope with the
symptoms of chronic conditions such as dementia. Therefore, a third group which can also be regarded as
relevant to the research question can be defined as the study population:
b(ii) Irreversible AND/OR deteriorating physical conditions for which mental health outcomes (such as
reduction in depression, anxiety or trauma symptoms) were explicitly targeted and measured.
The use of a more flexible definition for the population, while unconventional in the majority of health
technology assessments, is employed here in order to ensure that, while adhering to the research question,
the review is also providing a complete picture of the literature relevant to the research question.
Positive outcomes and ‘success’ in mental health treatment
In the field of mental health there is a movement to accept the term ‘recovery’ rather than ‘cure’. This is
because recovery can be seen as an ongoing experience which may not be comparable to end points
in pharmacological trials. The term ‘recovery’ accommodates the concept that the journey of transitioning
from a negative mental health state may be non-linear and may include setbacks as well as progress.21,35
Essential elements of the recovery approach are reported to be those that facilitate the rebuilding of a
meaningful life despite the continuing presence of mental health problems.36
In addition, the measurement of recovery from a mental health disorder requires the use of a user-validated
outcome measure.37,38 In this sense, the majority of service users would need to agree that the measure
makes sense and evaluates human factors that are important to them. Crucially, the outcome measure
selected to evaluate treatment needs to be valid, reliable and sensitive to change over time. Mental health
disorders can be chronic, recurring and multistage, and it is important that formal evaluation of mental
health states is able to capture these complexities.
Time points for measuring recovery should also receive consideration. Individual differences may account
for some variation in response to treatment but programmes of psychological treatment themselves vary
in duration and frequency. Interventions may or may not be tailored to the individual service user
according to service provision. Measurement of patient response to treatment using long-term follow-up,
as well as within the time period of the intervention, are essential to determine sustained benefit of
psychological interventions.
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Research questions addressed in this review
1. What is the evidence that art therapy is clinically effective in people with non-psychotic mental
health disorders?
2. What are the user and service provider perspectives on the acceptability and relative benefits and
potential harms of art therapy for people with non-psychotic mental disorders?
3. What is the evidence that art therapy is cost-effective in people with non-psychotic mental
health disorders?
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Chapter 2 Clinical effectiveness of art therapy:
quantitative systematic review
This chapter aims to provide an overview of the evidence examining the clinical effectiveness of arttherapy in people with non-psychotic mental health disorders.
Literature search methods
Bibliographic database searching
Comprehensive literature searches were used to inform the quantitative, qualitative and cost-effectiveness
reviews. A search strategy was developed to identify reviews, RCTs, economic evaluations, qualitative
research and all other study types relating to art therapy. Methodological search filters were applied where
appropriate. No other search limitations were used and all databases were searched from inception
to present. Searches were conducted from May to July 2013. The full search strategies can be found
in Appendix 2.
To ensure that the full breadth of literature for the non-psychotic population was included, it was
pragmatic to search for all art therapy studies and then subsequently exclude studies manually
(through the sifting process) that were conducted in people with a psychotic disorder or a disorder in
which symptoms of psychosis were reported. It is therefore possible for the reviewer to view all potentially
relevant records available and manually exclude studies of samples with psychotic disorders. This method
of searching through the literature is in contrast to an approach that uses a search strategy listing all
possible mental health disorders that are considered to be ‘non-psychotic’ in the search terms. The latter
method may not retrieve all relevant studies from populations that are not indexed under the named
mental health disorders.
In addition to the range of conditions covered by the population, the evidence from the studies being
generated was frequently not a clear-cut diagnosed ‘mental health disorder’ and the populations retrieved
were not the clinical populations of common mental health problems that were first anticipated. At this
point in the study identification process it would have been easy to exclude any study that did not include
patients with a clinically diagnosed mental health disorder. If this approach had been taken, there would
have been three studies in the quantitative review. Instead a pragmatic approach was taken by identifying,
including and describing the populations that art therapy is being studied in, with reference to targeting
mental health symptoms (see Chapter 1, Non-psychotic mental health population: definition).
Databases searched
l MEDLINE and MEDLINE In-Process & Other Non-Indexed citations (OvidSP).
l EMBASE (OvidSP).
l Cochrane Database of Systematic Reviews (The Cochrane Library).
l Cochrane Central Register of Controlled Trials (The Cochrane Library).
l Database of Abstracts of Review of Effects (The Cochrane Library).
l NHS Economic Evaluation Database (The Cochrane Library).
l Health Technology Assessment Database (The Cochrane Library).
l Science Citation Index (Web of Science via Web of Knowledge).
l Social Sciences Citation Index (Web of Science via Web of Knowledge).
l CINAHL: Cumulative Index to Nursing and Allied Health Literature (EBSCOhost).
l PsycINFO (OvidSP).
l AMED: Allied and Complementary Medicine Database (OvidSP).
l ASSIA: Applied Social Sciences Index and Abstracts (ProQuest).
DOI: 10.3310/hta19180 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 18
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Uttley et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
9
Sensitive keyword strategies using free-text and, where available, thesaurus terms using Boolean operators
and database-specific syntax were developed to search the electronic databases. Date limits or language
restrictions were not used on any database. All resources were searched from inception to May 2013.
Grey literature searching
A number of sources were searched to identify any relevant grey literature. Relevant grey literature or
unpublished evidence would include reports and dissertations that report sufficient details of the methods
and results of the study to permit quality assessment. Conference proceedings without a corresponding
final report (published or unpublished) would not qualify for inclusion, as they are unlikely to contain
sufficient information to permit quality assessment and can often be different to results published in the
final report.39,40
Sources searched
l NHS Evidence (Guidelines): www.evidence.nhs.uk/.
l The BAAT: www.baat.org/index.html.
l UK Clinical Research Network Portfolio Database: public.ukcrn.org.uk/Search/Portfolio.aspx.
l National Research Register Archive: www.nihr.ac.uk/Pages/NRRArchive.aspx.
l Current Controlled Trials: www.controlled-trials.com/.
l OpenGrey: www.opengrey.eu/.
l Google Scholar: scholar.google.co.uk/.
l Mind: www.mind.org.uk/.
l International Art Therapy Organisation: www.internationalarttherapy.org/.
l National Coalition of Arts Therapies Associations: www.nccata.org/.
Additional search methods
A hand search of the International Journal of Art Therapy (formerly Inscape) was conducted. The additional
search methods of reference list checking and citation searching of the included studies were utilised.
Other complementary search methods were considered such as pearl growing; however, because the
search method employed was considered to be very inclusive, such additional methods were unlikely to
generate additional relevant records.
Review methods
Screening and eligibility
The operational sifting criteria (eligibility criteria) were defined and verified by two reviewers (LU and AS).
Titles and abstracts of all records generated from the searches were scrutinised by one assessor and
checked by a second assessor to identify studies for possible inclusion into the quantitative review. All
studies identified for inclusion at abstract stage were obtained in full text for more detailed appraisal.
Non-English studies were translated and included if relevant. For conference abstracts or clinical trial
records without study data, authors were contacted via e-mail; however, no additional data were retrieved
by contacting study authors. There was no exclusion on the basis of quality. If closer assessment of studies
at full text indicated that eligible studies were not RCTs, then the studies were excluded. Agreement on
inclusion, for 20% of the total search results (n= 2015), was calculated at title/abstract sift demonstrating
0.93 agreement using the kappa statistic. If there was uncertainty regarding the inclusion of a study, the
reviewers sought the opinion of the team members with the relevant clinical, methodological or subject
expertise to guide the decision.
Accumulation of results
All references were accumulated in a database using Reference Manager Version 12 (Thomson Reuters,
Philadelphia, PA, USA), enabling studies to be retrieved in categories by keyword searches and duplicates
to be removed.
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Study appraisal
Two reviewers (LU and AS) performed data extraction independently for all included papers and
discrepancies were resolved by discussion between reviewers. When necessary, authors of the studies were
contacted for further information. Data were input into a data extraction template using Microsoft Excel
(Microsoft Corporation, Redmond, WA, USA), which was designed for the purpose of this review and
verified by two reviewers. Information related to study population, sample size, intervention, comparators,
potential biases in the conduct of the trial, outcomes including adverse events, follow-up and methods of
statistical analysis was abstracted from the published papers directly into the electronic data
extraction spreadsheet.
The evidence generated from the comprehensive searches highlighted that the majority of research in art
therapy is conducted by or with art therapists. This indicates potential researcher allegiance towards the
intervention in that art therapists are likely to have a vested interest in the output of the study. For this
reason it was deemed important to focus on the highest quality evidence available from the study
literature. Trials that were non-randomised (i.e. in which the researcher was able to select and allocate
participants to treatment arms) were considered to be too low in methodological rigour to be included in
this review. The consequence of including data from non-randomised studies into the review is that the
resulting data are biased and therefore not robust or sufficient to inform and contribute to the evidence
base.41,42 The inclusion and exclusion criteria for the quantitative review are shown in Figure 2.
Included Excluded
P
Population
Non-psychotic clinical samples 
(see Introduction, Adapting the 
research to the research, Art 
therapy as a complex intervention)
People with psychosis
Healthy samples 
I
Intervention
Art therapy as might be delivered 
in the NHS (see Introduction, 
Adapting the research to the 
research, Art therapy as a clinical 
intervention: definition) 
Other arts therapies including
drama, music, and dance
Play therapy 
C
Comparator
Any including: treatment as usual; 
waiting list; attention placebo; or
other psychological therapy 
None
O
Outcomes
Primary: treatment effectiveness;
response as determined by 
changes in mental health rating 
scales
Secondary: related clinical 
or quality-of-life outcomes
Outcomes focused on interpretation
of the art work itself, not the
participant 
S
Studies
RCTs Any level III–143 evidence including
non-randomised controlled studies 
FIGURE 2 Eligibility criteria for the quantitative review.
Setting
Studies could be conducted in any setting, including primary, secondary, community based or inpatient.
Sessions
Study selection was not limited by the number of sessions, and studies that provided the intervention in a
single session were included.
Timing of outcome assessment
Post-treatment outcomes and outcomes at reported follow-up points were extracted and summarised
when reported.
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Quality assessment strategy
Quality assessment of included RCTs was performed for all studies independently by two reviewers using
quality assessment criteria adapted from the Cochrane risk of bias,44 Centre for Reviews and Dissemination
(CRD) guidance45 and Critical Appraisal Skills Programme (CASP)46 checklists to develop a modified tool for
the purpose of this review. The modified tool was developed to incorporate relevant elements across
several tools to allow comprehensive and relevant quality assessment for the included trials. Judgements
and corresponding reasons for judgements for each quality criterion for all studies were stated explicitly
and recorded. Risk of bias was assessed to be low, high or unclear. Where insufficient details were
reported to make a judgement, risk of bias was stated to be unclear and authors were not contacted for
further details. Discrepancies in judgements were resolved by discussion between the two reviewers.
Results of the quantitative review
The total number of published articles yielded from electronic database searches after duplicates were
removed was 10,073 (see Figure 3). An additional 197 records were identified from supplementary
searches, resulting in a total of 10,270 records for screening. Of these, 10,221 records were excluded at
title/abstract screening. Common reasons for exclusion from the review can be seen in Table 1. A full list of
the studies excluded from the quantitative review at full text stage (with reasons for exclusion) can be
found in Appendix 3.
The grey literature searches yielded very few potentially relevant records that were not generated by the
electronic searches. One record appeared highly relevant to the research question and related to a clinical
trial record of and RCT of art therapy in personality disorder (CREATe) for which the status was ‘ongoing’.
However, e-mail contact with the primary investigator of this trial confirmed that the trial had been
terminated because of poor recruitment.
Included studies: quantitative review
Fifteen RCTs were identified for inclusion into the review which were reported in 18 sources (see Table 2).
For clarity in this comparison, where a study with multiple sources is discussed only one of the sources has
been noted.
Ten out of the 15 included studies were conducted in the USA, while only one study was conducted in the
UK (see Tables 2 and 3). Eleven of the studies were conducted in adults (who are the primary focus of this
review) and four were conducted in children. All trials had small final sample sizes with the number
of participants reported to be included in each study ranging between 18 and 111. The mean sample size
was 52.
Three studies are of patients from the target population of people with non-psychotic mental disorders.47–49
Of these three studies, only one was conducted in adults.47
In the remaining 12 studies, the study population comprised individuals without a formal mental health
diagnosis.49–59,61,62 The populations in these studies are, therefore, mainly people with long-term medical
conditions which are not reported to be accompanied by a mental health diagnosis; however, outcomes
targeted in these studies were mental health symptoms.
The total number of patients in the included studies is 777. Nine studies compared art therapy with an
active control group and six studies compared art therapy with a wait-list control or treatment as usual.
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Additional records identified
through other sources
(n = 197)
• Hand search, n = 143
• Grey literature search, n = 54
Records screened
(n = 10,270)
Records excluded at title/abstract
(n = 10,221)
Full-text articles
assessed for eligibility
(n = 49)
 
Full-text articles excluded,
with reasons
(n = 31) 
• Psychotic disorder, n = 4
• No randomisation, n = 7
• No control group, n = 4
• No study data, n = 5
• No corresponding reference to
   citation, n = 2
• Arts therapy, n = 2
• Not a RCT, n = 5
• Not art therapy, n = 2
Studies included in
quantitative synthesis
(n = 18 references;
15 studies)
Records identified through
database searching after
removing duplicates
(n = 10,073)
FIGURE 3 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram of studies
included in the quantitative review.
TABLE 1 Common reasons for exclusion from the review
Common reasons for
exclusion Examples
Not art therapy Arts-based initiatives not adhering to art therapy definition (see Art therapy as a clinical
intervention: definition), antiretroviral therapy
Not a RCT Before-and-after study, no control group, no randomisation
Psychotic disorder Patients with schizophrenia or psychosis
Arts therapies Combination of therapies without individual results for art therapy
No study data Abstract without data and no response from author contact, studies which focused on the
artwork itself and did not measure health outcomes
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TABLE 2 Description of 15 included RCTs
Study author and year Journal/publication Country n Patients
Target population
Chapman et al. 200149 Art therapy USA 85a Children with PTSD
Lyshak-Stelzer et al. 200748 Art therapy USA 29 Adolescents with PTSD
Thyme et al. 200747 Psychoanalytic Psychotherapy Sweden 39 Depressed female adults
Study population
Beebe et al. 201058 Journal of Allergy and Clinical
Immunology
USA 22 Children with asthma
Broome et al. 200150 Journal of National Black Nurses’
Association
USA 97a Children (n= 65) and
adolescents (n= 32) with sickle
cell disease
Gussak 200759 International Journal of Offender
Therapy and Comparative
Criminology
USA 44a Incarcerated males
Hattori et al. 201151 Geriatrics and Gerontology
International
Japan 39 Patients with Alzheimer’s disease
Kim 201352 The Arts in Psychotherapy Korea 50 Non-clinical older adults (no
formal mental health diagnosis)
McCaffrey et al. 201153 Research in Gerontological Nursing USA 39 Older adults
Monti and Peterson 200460 Psychiatric Times USA 111a Women with cancer
Monti et al. 200661 Psycho-Oncology
Monti et al. 201254 Stress and Health USA 18 Women with breast cancer (no
clinical mental health problem)
Puig et al. 200655 The Arts in Psychotherapy USA 39 Women with breast cancer
Rao et al. 200956 AIDS Care USA 79a Adults with HIV/AIDS
Rusted et al. 200657 Group Analysis UK 45a Patients with dementia
Thyme et al. 200962 Palliative and Supportive Care Sweden 41 Women with breast cancer
Svensk et al. 200963 European Journal of Cancer Care
Oster et al. 200664 Palliative and Supportive Care
PTSD, post-traumatic stress disorder.
a Number reported is different in final sample results (see Attrition).
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Two studies were reported to be conducted in an inpatient setting48,49 and one study was conducted in
prison.59 The majority of studies were conducted in community/outpatient setting, although the precise
setting for conducting the intervention was not reported in six studies.50,52,54–56,61
Brief descriptions of the art therapy interventions are provided in Tables 4 and 5.
Study duration ranged between the 15 studies from 1 session to 40 sessions, with a mean number of nine
sessions (see Tables 4 and 5). Most studies with an active control group were of ‘group’ art therapy. One
study which was a ‘brief’ intervention consisting of one individual session per participant.56 Two studies did
not state explicitly if sessions were in a group or individual.47,53 Three studies with no active control were
group art therapy58,59,61 and three studies were individual art therapy.49,55,62
The symptoms or outcome domains under investigation and associated outcome measures are reported in
Table 6.
TABLE 3 Comparators across the 15 included studies
Study type Comparator Study Control group description
Non-active
control
Treatment as
usual
Chapman et al. 200149 Standard hospital careb
Gussak 200759 No treatment
Thyme et al. 2009;62 Svensk et al. 2009;63
Oster et al. 200664
No art therapy
Wait-list Beebe et al. 201058 Crossover not reported
Monti and Peterson 2004;60
Monti et al. 200661
Control offered crossover at 9 weeks
Puig et al. 200655 Control offered crossover at 4 weeks
Active control Attention
placebo
aBroome et al. 200150 Fun activities
Hattori et al. 201151 Simple calculations
Kim 201352 Regular programme activities
Lyshak-Stelzer et al. 200748 Arts and craft activities
McCaffrey et al. 201153 Guided garden walking
Monti et al. 201254 Educational support group
Rao et al. 200956 Video tape on use of art therapy
Rusted et al. 200657 Activity group
Psychological
therapy
aBroome et al. 200150 CBT relation for pain
Thyme et al. 200947 Verbal dynamic psychotherapy
a Two control groups.
b Reported that hospital care was defined as the normal and usual course of paediatric care including Child Life services,
art therapy, social work and psychiatric consultations.
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TABLE 4 Description of intervention and control in studies with active control
Study
Age (years),
range (mean)
Duration and
type Art therapy description Control description
Broome et al.
200150
6–18 (child, 9.2;
adolescent, 15.3)
4 weeks; group Opportunity to express feelings
about pain and develop social
skills through interactions with
others using art as a focal point
CBT relaxation for pain;
or attention control (fun
activities e.g. picnic, museum)
for children group only
Hattori et al.
201151
73–83 (74) 12 weeks; group
(approximately
n= 5) session
Primary task to colour abstract
patterns, which are unclear
before colouring. Encouraged
to draw familiar objects based
on memories or favourite
seasons
Simple calculations (additions
and multiplications of one- or
two-digit numbers). No preset
target; patients completed as
many as they could in session
Kim 201352 69–87 (78) 4 weeks; group Introductory 10–15 minutes
‘unfreezing’ phase, followed by
35–40 minutes for individual
art-making, 15–20 minutes for
group discussion
Regular programme activities
such as reading books,
playing board games and
watching television
Lyshak-Stelzer
et al. 200748
13–17 (15) 16 weeks; group
(approximately
n= 2 to 5)
session
Completion of 13> collages or
drawings to express a ‘life
story’ narrative. Encouraged
but not required to discuss
dreams, memories and feelings
related to their trauma
‘Treatment as usual’ – arts
and craft making activity
group
McCaffrey et al.
201153
65–NR (74) 6 weeks; NR Drawing self-portraits;
presented to group; create new
drawings; display and discuss
(art therapy was reported as
the control)
The two intervention groups
were individual (n= 13) or
guided (n= 13) garden
walking in the Morikami
Museum and Japanese
Gardens in Delray Beach
Monti et al.
201254
52–77 (54) 8 weeks; group Mindfulness-based art therapy.
Art-making paired with
meditation and ways of
expressing emotional
information in a personally
meaningful manner
Educational support group:
control given equal time and
provided with support and
resources to maximise quality
of life including expert
speakers on topics and time
for sharing and supportive
exchanges
Rao et al.
200956
18–NR (42) Brief (1 session);
individual
Art therapist learns about
patient and then offers art
materials and assures patient
they can use them in any way.
Therapist helped participant
process the meaning of the
work and then discussed
thoughts and feelings elicited
Viewed a video tape on the
uses of art therapy
Rusted et al.
200657
67–92 (82) 40 weeks; group
(approximately
n= 6)
Group-interactive
psychodynamic approach
Activity groups: a selection of
recreational activities from
different centres in the locality
Thyme et al.
200947
19–35 (34) 10 weeks; NR Psychodynamic art therapy.
Painting and reflective dialogue
between the participant and
the therapist
Verbal psychodynamic
psychotherapy
NR, no response.
CLINICAL EFFECTIVENESS OF ART THERAPY: QUANTITATIVE SYSTEMATIC REVIEW
NIHR Journals Library www.journalslibrary.nihr.ac.uk
16
TABLE 5 Description of intervention in studies with non-active control
Study
Age (years),
range (mean)
Duration
and type Art therapy description
Beebe et al.
201058
7–14 (NR) 7 weeks;
group
Included an opening activity; discussion of the weekly topic and art
intervention; art-making; opportunity for the parents to share their
feelings related to the art they created; and the closing activity
Chapman et al.
200149
7–17 (10.7) NR;
individual
Chapman Art Therapy Treatment Intervention including drawing;
verbal narrative and encouragement to express trauma-specific fears
Gussak 200759 21–59 (NR) 8 weeks;
group
Asked to draw person picking an apple from a tree and other similar
art therapy tasks
Monti and
Peterson 200460
Monti et al.
200661
26–82 (54) 8 weeks;
group
Mindfulness-based art therapy multimodal programme including
a standardised mindfulness-based stress reduction curriculum;
art therapy tasks and supportive group therapy
Puig et al.
200655
18-NR (51) 4 weeks;
individual
Semistructured creative experiences using art creation. Creative
freedom encouraged in order to facilitate and explore emotional
expression, spirituality and psychological well-being state
Thyme et al.
200962
Svensk et al.
200963
Oster et al.
200664
37–69 (median:
59 and 55)
5 weeks;
individual
Art-making with an art therapist including reflection and expression
using verbal and non-verbal methods. Aimed at triggering a chain
of feelings and thoughts an important object for communication.
Basic idea was to use the participant’s picture as the new mode of
expression, followed by a reflective dialogue
NR, not reported.
TABLE 6 Outcome domains under investigation in the 15 included RCTs
Study author
and year
Outcome domains
investigated Outcome measures Time points
Adults
Gussak 200759 Depression BDI-II Exact time point post
test NR
Hattori et al.
201151
Mood; vitality; behavioural
impairment; QoL; ADL;
cognitive function
MMSE, WMS-R, GDS; Apathy Scale
(Japanese version) SF-8 – Physical and
Mental components; Barthel Index;
DBD; Zarit Caregiver Burden Interview
12 weeks
Kim et al. 201352 Positive/negative affect;
state-trait anxiety; self-esteem
PANAS; STAI; RSES NR: assume 4 weeks
McCaffrey et al.
201153
Depression GDS 6 weeks
Monti 200660,61 Symptoms of distress including
depression, anxiety and quality
of life
SCL-90-R, GSI; SF-36 8 and 16 weeks
Monti et al.
201254
Correlation of CBF on fMRI
with experimental condition
fMRI; CBF; correlation with anxiety
using SCL-90-R
Within 2 weeks of end
of 8-week programme
Puig et al. 200655 Mood symptoms including
depression and anxiety
POMS; EACS 4 weeks
Rao et al. 200956 Physical symptoms including
pain etc.; anxiety
ESAS; STAI Immediately following
session
continued
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Data synthesis
Heterogeneity of the included studies
The study populations are heterogeneous (Figure 4), highlighting the wide application of art therapy in this
small number of included RCTs but also demonstrating the difficulty in obtaining a pooled estimate of
treatment effect. In this respect the clinical profile of patients can be regarded as a potential treatment
effect modifier.
The control groups across the included studies are heterogeneous (Figure 5); therefore, there may be
different estimates of treatment effects depending on what art therapy is compared against. Creating a
network meta-analysis, which would incorporate all relevant evidence for all the comparators, for all
non-psychotic mental health disorders, would be beyond the remit for this research project.
TABLE 6 Outcome domains under investigation in the 15 included RCTs (continued )
Study author
and year
Outcome domains
investigated Outcome measures Time points
Rusted et al.
200657
Depression; mood; sociability
and physical involvement
CSDD; MOSES; MMSE; RBMIT; TEA;
Benton Fluency Task
10, 20 and 40 weeks
during trial then 44-week
and 56-week follow-up
Thyme et al.
200747
Stress reactions after a range of
traumatic events; mental health
symptoms; depression
IES; SCL-90; BDI; HRSD 10 weeks and 3 month
follow-up
Thyme et al.
2009;62
Svensk et al.
2009;63 Oster
et al. 200664
Depression; anxiety; somatic
and general symptoms; QoL
Coping methods
SASB; GSI; SCL-90; WHOQOL-BREF;
EORTC QoL Questionnaire-BR23; CRI
2 and 6 months
Children and adolescents
Beebe et al.
201058
QoL; behavioural and
emotional adaptation
PedsQL; Asthma module Beck Youth
Inventories – Second Edition
7 weeks and 6 months
Broome et al.
200150
Coping and health care
utilisation
SCSI; A-COPE; ER visits; clinic visits;
hospital admissions
4 weeks and 12 months
Chapman et al.
200149
PTSD symptoms Children’s PTSD-I 1 week, 1 month and
6 months after discharge
Lyshak-Stelzer
et al. 200748
PTSD symptoms University of California, Los Angeles
PTSD Reaction Index for DSM-IV Child
Version; Milieu behavioural measures,
e.g. use of restraints
NR: reports (n) for 2 years.
Study is ongoing in a
further 15 patients
A-COPE, Adolescent Coping Orientation for Problem Experiences; ADL, activities of daily living; BDI, Beck Depression
Inventory; CBF, cerebral blood flow; CRI, Coping Resources Inventory; CSDD, Cornell Scale for Depression in Dementia;
DBD, Dementia Behaviour Disturbance Scale; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders – Fourth
Edition; EACS, Emotional Approach Coping Scale; EORTC, European Organization for Research and Treatment of Cancer;
ER, emergency room; ESAS, Edmonton Symptom Assessment Scale; fMRI, functional magnetic imaging; GDS, Geriatric
Depression Scale; GSI, Global Severity Index; HRSD, Hamilton Rating Scale of Depression; IES, Impact of Event Scale;
MMSE, Mini Mental State Examination Score; MOSES, The Multi Observational Scale for the Elderly; NR, not reported;
PANAS, Positive and Negative Affect Schedule; PedsQL, Pediatric Quality of Life; POMS, Profile of Mood States;
PTSD, post-traumatic stress disorder; PTSD-I, Post Traumatic Stress Disorder Index; QoL, quality of life; RBMIT, The Rivermead
Behavioural Memory Test; RSES, Rosenberg Self-Esteem Scale; SASB, Structural Analysis of Social Behavior;
SCL-90; Symptom-Checklist-90; SCL-90-R, Symptom-Checklist-90-Revised; SCSI, Schoolagers Coping Strategies Inventory;
SF-8, Short Form questionnaire-18 items; SF-36, Short Form questionnaire-36 items; STAI, State–Trait Anxiety Inventory;
TEA, Tests of Everyday Attention; WHO, World Health Organization; WHO-BREF, WHO Quality of Life instrument – Swedish
version; WMS-R, Wechler Memory Scale revised.
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In addition, despite common mental health symptoms being investigated across the included RCTs, the
majority of studies were using different measurement scales to assess these outcomes (Table 7). Therefore,
as there are insufficient comparable data on outcome measure across studies, it is not possible to perform
a formal pooled analysis.
Potential treatment effect modifiers in the included studies
As well as the patient’s clinical profile, several other treatment effect modifiers can be identified from the
included studies.
Experience/qualification of the art therapist
Twelve of the 15 included studies stated that the art therapy was delivered by one or more art therapists.
One study was reported in three sources to use a ‘trained’ art therapist.62–64 One study reported the art
therapist as ‘licensed’.56 Two studies reported using a ‘qualified’ art therapist.48,57 Two studies reported
using a ‘certified’ art therapist.50,53 One study was reported in two sources as using a ‘registered’ art
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(females)
Post-traumatic
stress
disorder
(children and
adolescents)
Dementia/
Alzheimer’s
Cancer Older adults
(non-clinical)
Sickle cell
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Incarcerated
(males)
Asthma
(children)HIV/AIDS
PATIENTS
n = 1
n = 2
n = 2
n = 2
n = 4
n = 1
n = 1
n = 1
n = 1
FIGURE 4 Patient clinical profiles in the 15 included RCTs.
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FIGURE 5 Comparator arms in the 15 included RCTs.
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TABLE 7 Instruments used in the 15 included RCTs
Outcome measure n studies Study names
SCL-90-R 4 Monti and Peterson 2004;60 Monti et al. 200661
Monti et al. 201254
Thyme et al. 200747
Thyme et al. 200962
GDS 2 Hattori et al. 201151
McCaffrey et al. 53
GSI 2 Monti and Peterson 2004;60 Monti et al. 2006;61
aThyme et al. 200962
STAI 2 Rao et al. 201156
Kim 201352
A-COPE 1 Broome et al. 200150
Apathy Scale (Japanese version) 1 Hattori et al. 201151
Barthel Index 1 Hattori et al. 201151
BDI 1 Thyme et al. 200747
BDI-II 1 Gussak 200759
Beck Youth Inventories – Second Edition 1 Beebe et al. 201058
Benton Fluency Task 1 Rusted et al. 200657
Children’s PTSD-I 1 Chapman et al. 200149
CRI 1 aOster et al. 200664
CSDD 1 Rusted et al. 200657
DBD 1 Hattori et al. 201151
ESAS 1 Rao et al. 200956
EORTC QoL Questionnaire-BR23 1 aSvensk et al. 200963
ER visits; clinic visits; hospital admissions 1 Broome et al. 50
HRSD 1 Thyme et al. 200747
IES 1 Thyme et al. 200747
Medical Outcomes Study SF-36 1 Monti and Peterson 2004;60 Monti et al. 200661
MMSE 1 Hattori et al. 201151
MOSES 1 Rusted et al. 200657
PedsQL Asthma module 1 Beebe et al. 201058
PANAS 1 Kim 201352
POMS 1 Puig et al. 200655
RBMIT 1 Rusted et al. 200657
RSES 1 Kim 201352
SCSI 1 Broome et al. 200150
SF-8 – Physical (PCS-8) and Mental (MCS-8) 1 Hattori et al. 201151
SASB 1 aThyme et al. 200962
TEA 1 Rusted et al. 200657
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therapist.60,61 One study reported using ‘experienced art psychotherapists’.47 Four studies simply stated
‘art therapist’ without reference to accreditation.49,52,58,59 One study stated that the sessions were run by
one artist and two speech therapists.51 One study stated that the sessions were run by two mental health
counsellors.55 One study did not state whether or not an art therapist was involved.54 While there was
considerable variability in the reporting of the accreditation of the therapist, most studies were conducted
by a person who was considered to be qualified as an art therapist.
Individual versus group art therapy
The majority of RCTs are of group art therapy with only 4 of the 15 RCTs examining individual
art therapy.49,55,56,62
Age
Eleven RCTs are of adults and four RCTs are of children or adolescents.48,49,50,58
Gender
Five RCTs involved only women,47,54,55,61,62 and one RCT only men.59 In the remaining nine RCTs the subjects
were of mixed gender.
Pre-existing physical condition
In nine studies patients had pre-existing physical conditions.50,51,54–58,61,62 The remaining six studies involved
people who were depressed,47,59 people with post-traumatic stress disorder (PTSD)48,49 or older people.52,53
Other
Other potential treatment effect modifiers which are not fully explored in the included RCTs include
duration of disease (mental or physical), underlying reason for mental health disorder and patient
preference for art therapy.
Owing to the degree of clinical heterogeneity across the studies and the lack of comparable data on
outcome measures, meta-analysis was not appropriate. Therefore, the synthesis of data is limited to a
narrative review to analyse the robustness of the data, which includes trial summaries as well as tabulation
of results.
TABLE 7 Instruments used in the 15 included RCTs (continued )
Outcome measure n studies Study names
University of California, Los Angeles PTSD
Reaction Index for DSM-IV Child Version
1 Lyshak-Stelzer et al. 200748
WMS-R 1 Hattori et al. 201151
WHOQOL-BREF 1 aSvensk et al. 200963
A-COPE, Adolescent Coping Orientation for Problem Experiences; BDI, Beck Depression Inventory; BDI-II, Beck Depression
Inventory-Short Form; CRI, Coping Resources Inventory; CSDD, Cornell Scale for Depression in Dementia; DBD, Dementia
Behaviour Disturbance Scale; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders – Fourth Edition;
EORTC, European Organization for Research and Treatment of Cancer; ER, emergency room; ESAS, Edmonton Symptom
Assessment Scale; GDS, Geriatric Depression Scale; GSI, Global Severity Index; HRSD, Hamilton Rating Scale of Depression;
IES, Impact of Event Scale; MMSE, Mini Mental State Examination Score; MOSES, The Multi Observational Scale for the
Elderly; PANAS, Positive and Negative Affect Schedule; PedsQL, Pediatric Quality of Life; POMS, Profile of Mood States;
PTSD, post-traumatic stress disorder; PTSD-I, Post Traumatic Stress Disorder Index; QoL, quality of life; RBMIT, The
Rivermead Behavioural Memory Test; RSES, Rosenberg Self-Esteem Scale; SASB, Structural Analysis of Social Behavior;
SCL-90-R, Symptom Checklist-90-Revised; SF-36, Short Form questionnaire-36 items; STAI, State–Trait Anxiety Inventory;
TEA, Tests of Everyday Attention; WHO, World Health Organization; WHOQOL-BREF, WHO Quality of Life instrument –
Swedish version; WMS-R, Wechler Memory Scale revised.
a Three references relating to one study.
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Study summaries
This section provides short overviews of each study with reference to statistically significant differences
between groups that were reported in each of the studies.
Beebe et al. 201058
This was a RCT in children (n= 22) with asthma of art therapy versus wait-list control. Sessions lasting
60 minutes were provided once a week for seven weeks. Outcomes were measured at baseline,
immediately following completion of therapy and 6 months after the final session. Targeted variables were
quality of life (QoL) and behavioural and emotional adaptation. Outcome measurement tools were the
Paediatric QoL asthma module and Beck Youth Inventories. Pre- and post-test scores were compared
between groups using analysis of variance (ANOVA) and Dunnett’s test. Compared with baseline scores,
the intervention group showed a significant reduction in 4 out of 10 QoL items at 7 weeks and in 2 out of
10 QoL items at 6 months. Significant improvement relative to the control group was found in two out
of five items of the Beck Youth Inventory at 7 weeks and in one out of five items at 6 months.
Broome et al. 200150
This was a three-arm RCT in children and adolescents (n= 97) with sickle cell disease of art therapy versus
CBT (relaxation for pain) or attention control (fun activities). Group sessions were provided over 4 weeks.
Outcomes were measured at baseline and at 4 weeks and 12 months. The targeted variable was coping
and the authors hypothesised that coping strategies would increase after attending a self-care intervention.
Outcome measures were the Schoolagers’ Coping Strategies Inventory and Adolescent Coping Orientation
for Problem Experiences scores and numbers of emergency room visits, clinic visits and hospital admissions.
The number of coping strategies used was analysed at three time points using Pearson’s correlations,
independent t-tests and ANOVA. Coping strategies increased in children and adolescents in all three
groups, but data regarding the difference between the intervention and control groups were not reported.
Chapman et al. 200149
This RCT of brief art therapy versus treatment as usual was carried out in children (n= 85) hospitalised with
PTSD. A 1-hour individual session was provided but the number of sessions was not reported. Outcomes
were measured at baseline and at 1 week, 1 month, and 6 and 12 months (in children who were still
symptomatic). The targeted symptom was PTSD. The outcome measurement tool was Children’s Post
Traumatic Stress Disorder Index (PTSD-I). The method of statistical analysis was not described. No
significant differences were found between groups, but a non-significant trend towards greater reduction
in PTSD-I scores was observed in the intervention group relative to the control group.
Gussak 200759
This was a RCT in incarcerated adult males (n= 44) of art therapy versus no treatment. Eight weekly group
sessions were provided. Outcomes were measured pre- and post-test (exact time points not reported). The
targeted symptom was depression. The outcome measure was the Beck Depression Inventory-Short Form
(BDI-II). The change in BDI-II scores from pre-test to post test was calculated and differences between
groups analysed using independent-samples t-tests. Depression was significantly lower in the intervention
group than in the control group post test.
Hattori et al. 201151
This was a RCT in Alzheimer disease (n= 39) of art therapy versus a ‘simple calculation’ control group.
Twelve 45-minute weekly sessions were provided (individual/group not reported). Outcomes were
measured at baseline and at 12 weeks. Targeted variables were mood, vitality, behavioural impairment,
QoL, activities of daily living and cognitive function. Outcome measures were the Mini Mental State
Examination Score (MMSE), the Wechsler Memory Scale revised; the Geriatric Depression Scale (GDS);
the Apathy Scale (Japanese version); Short Form questionnaire-8 items (SF-8) – Physical (PCS-8) and
Mental (MCS-8) components; the Barthel Index; the Dementia Behaviour Disturbance Scale; and the Zarit
Caregiver Burden Interview. Outcomes were measured at baseline and 12 weeks. The percentage of
responders who showed a 10% or greater improvement relative to baseline score before the intervention
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was compared between groups using a chi-squared test. A significant improvement in the intervention
group was seen in MCS-8 subscale of the SF-8 and the Apathy Scale. The control group showed a
significant improvement in MMSE relative to the intervention group. No significant differences between
groups in other items were reported.
Kim 201352
This RCT in older adults (n= 50) compared art therapy with regular programme activities. Between 8 and
12 sessions lasting 60–75 minutes were provided over 4 weeks. Targeted variables were positive/negative
affect, state–trait anxiety and self-esteem. Outcomes were measured using the Positive & Negative Affect
Schedule, the State–Trait Anxiety Inventory (STAI) and the Rosenberg Self-Esteem Scale. Time points for
measurement were not reported (assumed 4 weeks). Independent group t-tests were performed to
compare pre- and post-test scores between groups. Significant improvements in the intervention were
seen in all three outcomes compared with the control group.
Lyshak-Stelzer et al. 200748
This RCT in adolescents (n= 29) with PTSD compared art therapy with arts and crafts activities. Sixteen
weekly group sessions were provided. The targeted symptom was PTSD. Outcome measurement tools
were the University of California, Los Angeles (UCLA) PTSD Reaction Index (Diagnostic and Statistical
Manual of Mental Disorders – Fourth Edition, Child Version) (primary measure) and milieu behavioural
measures (e.g. use of restraints). Measurement time points were not reported, but data at two years were
provided. Pre- and post-test scores were compared between groups using repeated-measures ANOVA. The
intervention was significantly better than control at reducing PTSD symptoms, according to the UCLA PTSD
Reaction Index.
McCaffrey et al. 201153
This was a RCT in older adults (n= 39) of art therapy versus garden walking (individual and group). Twelve
60-minute sessions (group/individual not reported) were provided over 6 weeks. The targeted symptom
was depression. The outcome measurement tool was the GDS. Pre- and post-test scores were compared
between groups using repeated-measures ANOVA. Measurement was at baseline and 6 weeks. Depression
significantly improved from baseline in all three groups with no significant differences between groups.
Monti and Peterson 2004;60 Monti et al. 200661
This RCT in women with cancer (n= 111) compared mindfulness-based art therapy with wait-list control.
The trial was sized to have 80% power to detect a standardised effect size of 0.62. Eight 150-minute
group sessions were provided over 8 weeks. Targeted variables were distress, depression, anxiety and
QoL. Outcome measurement tools were the Symptom Checklist-90-Revised (SCL-90-R), the Global Severity
Index (GSI) and the Short Form questionnaire-36 items (SF-36). Measurement was at baseline and at
8 weeks and 16 weeks. Pre-and post-test measures were compared between groups using mixed-effects
repeated-measures ANOVA. A significant decrease in symptoms of distress and highly significant
improvements in some areas of the QoL scale were observed in the intervention group compared with the
control group.
Monti et al. 201254
This RCT of women with breast cancer (n= 18) compared mindfulness-based art therapy with educational
support (control group). Eight 150-minute weekly group sessions were provided. The targeted symptom
was anxiety but the authors were interested in whether or not cerebral blood flow (CBF) correlated with
experimental condition. The primary outcome measurement was functional magnetic resonance imaging
(fMRI) CBF and the correlation with anxiety using SCL-90-R. Measurement was at baseline and within
2 weeks of the end of the 8-week programme. The method of statistical analysis was not described
and the effectiveness of the intervention was not the primary outcome. Anxiety was reduced in the
intervention group but not in the control group. CBF on fMRI changed in certain brain areas in the art
therapy group only. It should be noted that patients with a confirmed diagnosis of a psychiatric disorder
were excluded from this study.
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Puig et al. 200655
This was a RCT in women with breast cancer (n= 39) of art therapy versus delayed treatment. Four
60-minute weekly sessions were provided. Targeted symptoms were anger, confusion, depression, fatigue,
anxiety, activity and coping. The outcomes, the Profile of Mood States and the Emotional Approach
Coping Scale (EACS) scores, were measured before and 2 weeks after the intervention. Pre- and post-test
scores were compared between groups using ANOVA. The intervention group showed significant
improvements in the anger, confusion, depression and anxiety mood states but fatigue and activity were
not significantly different between the groups. In the intervention group, EACS coping scores increased,
but were not significantly different from those in the delayed treatment control group.
Rao et al. 200956
In this RCT in adults with HIV/AIDS (n= 79), the intervention group received brief art therapy while the
controls watched a video tape on the uses of art therapy. Only one 60-minute session of individual art
therapy was provided. Targeted symptoms were anxiety and physical symptoms, including pain. The
outcome measures used were Edmonton Symptom Assessment Scale (ESAS) scores (primary outcome) and
STAI scores. Pre-and post-test scores were compared between groups using analysis of covariance
(ANCOVA) and adjusted for age, gender and ethnicity. Measurements were recorded before and
immediately after the intervention or control session. The intervention group experienced significant
improvements in physical symptoms (ESAS) compared with the control group, but anxiety was not
significantly different between the groups.
Rusted et al. 200657
In this RCT in adults with dementia (n= 45), art therapy was compared with an activity group control.
Forty 60-minute weekly group sessions were provided. Targeted symptoms were depression, mood,
sociability and physical involvement. Outcome measures were the Cornell Scale for Depression in Dementia
the Multi Observational Scale for the Elderly, MMSE, The Rivermead Behavioural Memory Test, Tests of
Everyday Attention and the Benton Fluency Task. Measurements were recorded at baseline, 10 weeks,
20 weeks, 40 weeks and at follow-up at 44 and 56 weeks. Pre- and post-test scores were compared
between groups using ANOVA with time of assessment as repeated measures. At 40 weeks, the
intervention group was significantly more depressed than the control group, but this effect was reduced
at follow-up. However, groups were not comparable at baseline, as the art therapy group were more
depressed at the beginning of the study than the control group.
Thyme et al. 200747
This was a RCT in depressed female adults (n= 39) of psychodynamic art therapy versus verbal dynamic
psychotherapy. Ten 60-minute weekly sessions (individual/group not reported) were provided. Targeted
symptoms were stress reactions after a range of traumatic events, mental health symptoms and
depression. Outcome measurements were Impact of Event Scale, Symptom-Checklist-90 (SCL-90),
Beck Depression Inventory (BDI) and Hamilton Rating Scale of Depression scores. Measurements were
recorded at baseline, at 10 weeks and at a 3-month follow-up. All patients improved from baseline
on all scales (p< 0.001). There were no significant differences between groups so art therapy was not
significantly different to the comparator at either time point.
Thyme et al. 2009;62 Svensk et al. 2009;63 Oster et al. 200664
This RCT in women with breast cancer (n= 41) compared art therapy with treatment as usual as a
control. Five 60-minute weekly individual session were provided. Targeted symptoms were depression,
anxiety, somatic, general symptoms, QoL and coping methods. Outcome measure tools were the
Structural Analysis of Social Behavior, the GSI, the SCL-90, the World Health Organization (WHO) QoL
instrument – Swedish version, the European Organization for Research and Treatment of Cancer (EORTC)
QoL Questionnaire-BR23 and the Coping Resources Inventory (CRI). Measurements were recorded at
baseline and at 2 months and 6 months. The intervention significantly improved depressive, anxiety,
somatic and general symptoms compared with the control. Pre- and post-test scores were compared
between groups using t-tests, ANOVA and linear regression. On the WHOQoL, scores on the overall,
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general health and environmental domains at 6 months were significantly higher in the intervention group
than in the control group. There were no significant differences between groups on the EORTC. In the
intervention group, the score on only the ‘social’ dimension of the CRI was increased relative to the
control group.
Results
Findings of the included studies
The directions of statistically significant results from the 15 included RCTs are summarised in Table 8.
As can be seen in Table 8, in 14 of the 15 included studies there were improvements from baseline in
some outcomes in the art therapy groups. However, both the intervention and the control groups
improved from baseline in four studies, with no significant difference between the groups.47,49,50,53 The
control groups across these four studies were verbal psychodynamic psychotherapy,47 treatment as usual,49
CBT50 and garden walking,53 and verbal psychodynamic psychotherapy, respectively.
In eight studies, art therapy was significantly better than the control group for some but not all outcome
measures. Table 9 shows the results according to the mean change from baseline between groups in these
eight studies.
In one study,52 all outcomes were significantly better in the art therapy intervention group than in the
control group. Table 10 shows the results from the Kim52 study.
TABLE 8 Summary of the direction of findings from the 15 included studies
Direction of significant findings n Studies
Significant positive effects in all outcome
measurements investigated in the art therapy
group compared with the control group
1 Kim 201352
Significant positive effects in some, but not all,
outcome measurements investigated in the art
therapy group compared with the control group
9 Beebe et al. 201058
Gussak 200759
aHattori et al. 201151
Lyshak-Stelzer et al. 200748
Monti and Peterson 2004;60 Monti et al. 200661
Monti et al. 201254
Puig et al. 200655
Rao et al. 200956
Thyme et al. 2009;62 Svensk et al. 2009;63 Oster et al. 200664
Improvement from baseline but no significant
difference between groups
4 Broome et al. 200150
Chapman et al. 200149
McCaffrey et al. 201153
Thyme et al. 200747
Art therapy worse than comparator at baseline and
follow-up
1 Rusted et al. 200657
a In addition, a significant positive effect for control group on one outcome measurement.
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TABLE 9 Nine included studies with statistically significant findings in the art therapy group in some but not all
outcome measures
Study and control
description Outcome measures Mean CFB and ps
Beebe et al. 201058
Wait-list
PedsQL Asthma module Intervention positive reduction in 4 out of 10 QoL items at 7 weeks
Between-group means at 7 weeks:
QoL – parent total (6.167 vs. –13.091), p= 0.025; QoL – child total
(9.727 vs. –13.364), p= 0.0123; QoL – parent worry (47.917 vs.
–13.182), p= 0.0144; QoL – child worry (54.545 vs. –45.909),
p= 0.0142
Intervention positive reduction in 2 out of 10 at 6 months
Between-group means at 6 months:
QoL – Parent worry (58.333 vs. –40.909), p= 0.024;
QoL – child worry (79.545 vs. –25.000), p= 0.0279
Beck Youth Inventories –
Second Edition
Intervention significant reduction in 2 out of 5 items at 7 weeks
compared with control
Beck – Anxiety (–15.6 vs. 5.3), p= 0.0388, Beck – Self-concept
(12.091 vs. –3.545), p= 0.0222
Intervention significant reduction 1/5 at 6 months:
Beck – Anxiety (–14 vs. 0.545), p= 0.03
No significant differences for depression component of Beck youth
inventory at 7 weeks (p= 0.21) or 6 months (p= 0.29)
Baseline means NR
Gussak 200759
Treatment as usual
BDI-II Statistically significantly greater decrease in intervention compared
with control: BDI Intervention mean CFB (–7.81) vs. control (+ 1.0),
p< 0.05
Hattori et al. 201151
Simple calculations
SF-8 – PCS-8 and MCS-8 Intervention significant improvement from baseline in MCS-8
subscale of SF-8 components: percentage of patients showing a
≥10% improvement was compared between groups by chi-squared
test. MCS-8 (p= 0.038; odds ratio 5.54)
Apathy Scale
(Japanese version)
Statistically significant improvement from baseline (p= 0.0014) in
Apathy Scale but not significantly different to control: CFB
Intervention (–3.2) vs. control (–1.1), p= 0.09
MMSE Control group significant improvement in MMSE compared with art
therapy intervention: CFB Intervention (–0.02) vs. control (+ 1.1),
p< 0.01
WMS-R; GDS; Barthel
Index; DBD; Zarit
Caregiver Burden
Interview
No significant differences in other items
Lyshak-Stelzer et al.
200748
Arts and craft
University of California,
Los Angeles PTSD
Reaction Index (DSM-IV
Child Version)
Intervention significantly better at reducing trauma symptoms than
control: CFB intervention (–20.8) vs. control (–2.5) p< 0.01
Milieu behavioural measures
(e.g. use of restraints)
No significant differences for behavioural milieu
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TABLE 9 Nine included studies with statistically significant findings in the art therapy group in some but not all
outcome measures (continued )
Study and control
description Outcome measures Mean CFB and ps
Monti and Peterson
2004;60 Monti et al.
200661
Wait-list
GSI Intervention significantly decreased symptoms of distress and
resulted in highly significant improvements in some QoL areas
compared with control: intervention (–0.20) vs. control (–0.04),
p< 0.001
SCL-90-R Anxiety, intervention (–0.26) vs. control (–0.10), p= 0.02;
depression, intervention (–0.27) vs. control (–0.08), p= 0.01
Medical Outcomes Study
SF-36
SF-36: general health intervention (7.97) vs. control (–0.59),
p= 0.008; mental health intervention (13.05) vs. control (2.16),
p< 0.001
Monti et al. 201254
Educational support
group
SCL-90-R Anxiety reduced in intervention but not control group: SCL-90-R
decrease in intervention (p= 0.03) but not in control (p= 0.09)
fMRI CBF and correlation
with anxiety using CBF
fMRI changed in certain brain areas in art therapy group only.
No changes in control group
Puig et al. 200655
Wait-list
POMS ANCOVA showed intervention had significantly decreased
symptoms of:
l anger–hostility: F(1,36)= 7.31, p< 0.05
l confusion–bewilderment: F(1,36)= 6.42, p < 0.05
l depression–anxiety: F(1,36)= 9.23, p< 0.05
l tension–anxiety: F(1,36)= 9.23, p< 0.05
EACS No significant differences for coping
Rao et al. 200956
Video-tape on the
uses of art therapy
ESAS Intervention significantly better for physical symptoms (ESAS) than
control: adjusted ESAS total score (21.1 vs. 26.2), p < 0.05
STAI Not significantly different for anxiety
Thyme et al. 2009;62
Svensk et al. 2009;63
Oster et al. 200664
Treatment as usual
General Intervention significantly improved depressive, anxiety, somatic and
general symptoms compared with no significant improvements
in control
SCL-90 Depression, intervention (–0.37) vs. control (–0.15), p= 0.002;
anxiety, intervention (–0.26) vs. control (–0.09), p= 0.009
SASB Intervention (–0.14) vs. control (–0.03), p= 0.049
GSI Intervention (–0.16) vs. control (–0.05), p=0.005
WHOQOL-BREF Intervention significantly improved WHOQoL overall and on the
general health and environmental domains vs. control at 6 months
WHOQoL CFB: overall Intervention (+10) vs. control (–5.12),
p= 0.003; general health intervention (+ 13.75) vs. control (–4.52),
p= 0.024; environment intervention (–0.35) vs. control (–2.1),
p= 0.034
CRI Intervention significantly improved only the ‘social’ domain, out of
five possible domains, for coping resources compared with control
(p < 0.05 at 2 and 6 months)
EORTC QoL
Questionnaire-BR23
No significant differences between groups
CFB, change from baseline; PedsQL, Pediatric Quality of Life; POMS, Profile of Mood States; SCSI, Schoolagers Coping
Strategies Inventory.
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In one study57 of a sample of people with dementia, outcomes were worse for the art therapy group than
for the control group, which was an activity control group. An unusual pattern of results is presented,
including a significant increase in anxious/depressed mood (p< 0.01) at 40 weeks which was not present
at the 10- or 20-week time points and dissipated by 44 and 56 weeks. The authors discuss several reasons
for this result including the high level of attrition; the reliance on observer ratings in the frail and elderly
sample (and subsequent potential impact of observer bias); the increased depression as a response to the
sessions ending; and the possibility that art therapy was contraindicated in this sample.
Narrative subgroup analysis of studies by mental health outcome domains
Table 11 presents the results for effectiveness of art therapy across relevant mental health
outcome domains.
Depression
Among the nine studies examining depression,47,51,53,55,57–59,61,62 art therapy resulted in significant reduction
in depression in six studies.47,53,55,59,61,62 In four of these six studies,55,59,61,62 art therapy was significantly more
effective than the control. Data relating to significant differences are reported in Table 9.
Anxiety
Among the seven studies examining anxiety,52,54–56,58,61,62 art therapy resulted in significant reduction of
anxiety in six studies.52,54,55,58,61,62 In these six studies, art therapy was significantly more effective than the
control. Data relating to significant differences are reported in Tables 8 and 9.
Mood
Among the four studies examining mood or affect,51,52,55,57 art therapy resulted in significant positive
improvements to mood in three studies.51,52,55 In these three studies, art therapy was significantly more
effective than the control. Data relating to significant differences are reported in Tables 8 and 9.
Trauma
Among the three studies examining trauma,47–49 art therapy resulted in significant reduction of symptoms
of trauma in all studies. While trauma improved from baseline, there was no significant difference between
the art therapy and control groups in any of the three studies.
Distress
Among the three studies examining distress,47,61,62 art therapy resulted in significant reduction of distress in
all studies. In two studies,61,62 art therapy was significantly more effective than the control group. Data
relating to significant differences are reported in Table 9.
TABLE 10 One included study with statistically positive findings for all outcomes in the art therapy group
Study and control
description
Outcome
measures Results
Kim 201352
Regular programme
activities
General Significant improvements in all three outcomes in the intervention group
compared with control
PANAS CFB: intervention (19.88) vs. control (–5.64), p< 0.01
STAI CFB State: intervention (–13.17) vs. control (+3.08), p< 0.01
CFB Trait: intervention (–7.84) vs. control (+2.96), p< 0.01
RSES CFB: intervention (4.24) vs. control (–0.48), p< 0.01
CFB, change from baseline; PANAS, Positive and Negative Affect Schedule; RSES, Rosenberg Self-Esteem Scale.
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TABLE 11 Effectiveness of art therapy across mental health outcome domains
Symptom/variable
Art therapy significantly
better than control group
Improvement from baseline
but no difference between
groups
No improvement from
baseline/control group
better
Depression
(n= 9 studies)
Gussak59 aBeebe et al.58 Rusted et al.57
Monti and Peterson 2004;60
Monti et al. 200661
Hattori et al.51
Puig et al.55 McCaffrey53
Thyme et al. 200747 Thyme et al. 2009;62
Svensk et al. 2009;63
Oster et al. 200664
Anxiety
(n= 7 studies)
aBeebe et al.58 Rao et al.
56
Kim52
Monti and Peterson 2004;60
Monti et al. 200661
Monti et al. 201254
Puig et al.55
Thyme et al. 2009;62
Svensk et al. 2009;63
Oster et al. 200664
Mood
(n= 4 studies)
Hattori et al.;51 Kim 2013;52
Puig et al.55
Rusted et al.57
Trauma
(n= 3 studies)
aChapman et al. 2001;49
aLyshak-Stelzer et al.;48
Thyme et al. 200747
Distress
(n= 3 studies)
Monti and Peterson 2004;60
Monti et al. 200661
Thyme et al. 200747
Thyme et al. 2009;62
Svensk et al. 2009;63
Oster et al. 200664
Quality of life
(n= 4 studies)
aBeebe et al.58
Hattori et al.51
Monti and Peterson 2004;60
Monti et al. 200661
Thyme et al. 2009;62
Svensk et al. 2009;63
Oster et al. 200664
Coping
(n= 3 studies)
Thyme et al. 2009;62
Svensk et al. 2009;63
Oster et al. 200664
aBroome et al.;50 Puig et al.55
Cognition
(n= 1 study)
Hattori et al.51
Self-esteem
(n= 1 study)
Kim 201352
a Paediatric sample.
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Quality of life
In the four studies examining QoL,51,58,61,62 art therapy resulted in significant improvements to some but
not all components of the QoL measures in all studies. In all studies, art therapy was significantly more
effective than the control. Data relating to significant differences are reported in Table 9.
Coping
Among the three studies examining coping,50,55,62 art therapy resulted in significant improvements to
coping resources in all studies. In one study,62 art therapy was significantly more effective than the control.
In another study, there was no difference between groups.55 In the third study, significant differences
between the art therapy and control groups were not reported.50 Data relating to significant differences
are reported in Table 9.
Cognition
In the one study examining cognition,51 the control group (simple calculations) exhibited significant
improvements in cognitive function relative to the art therapy group. Data relating to significant
differences are reported in Table 9.
Self-esteem
In the one study examining self-esteem,52 art therapy resulted in significant improvements in self-esteem
relative to the control group. Data relating to significant differences are reported in Tables 9 and 10.
Adverse events
Adverse events were not reported in any of the included RCTs. However, three studies reported outcomes
that may be indirectly related to the safety of art therapy. The Lyshak-Stelzer et al.48 study reported no
significant differences between groups in the number of incidents, seclusions, restraints or ‘PRN [pro re
nata, as needed] orders’. The Broome et al.50 study reported a decrease in emergency room visits, clinic
visits and hospital admissions over time in both the art therapy and control groups. In addition, the Beebe
et al.58 study reported equal asthma exacerbation numbers in each group but these occurred after the trial
has finished.
The lack of adverse event data in the majority of included studies is not necessarily evidence that there
were no adverse events in the included trials. It may indicate only that adverse events were not recorded.
Potential harms and negative effects of art therapy are further explored in the qualitative review
(see Chapter 3).
Quality assessment: strength of the evidence
Table 12 illustrates the types of study designs and the number of studies included into the quantitative and
qualitative reviews.
Critical appraisal of the potential sources of bias in the included studies
Method of recruitment
Participants were typically convenience samples from existing clinical patient groups. Few details were
provided on the inclusion/exclusion criteria of the patients in the studies, as can be seen from Table 13.
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TABLE 12 Study designs and their inclusion into the review
Evidence Study design Quantitative review Qualitative review
Experimental RCT: active comparator n= 9 –
RCTs with no active comparator n= 6 –
Quasi-experimental (non-randomised studies) –
Single-arm studies –
Observational Cohort studies n= 12
Case–control studies –
Cross-sectional studies –
Before-and-after studies –
Case series –
Case studies
–, no relevant studies identified.
TABLE 13 Method of participant recruitment in the 15 included RCTs
Study Method recruitment Inclusion/exclusion criteria
Beebe et al. 201058 Recruited students from a particular school NR
Broome et al. 200150 Invited if eligible from two comprehensive
sickle cell centres
Criteria relating to vaso-occlusive episodes
Chapman et al.
200149
Screened for eligibility if admitted for injury Inclusion criteria: admitted to a level 1 trauma
centre for traumatic injuries; injury severe
enough to warrant hospital admission
> 24 hours. Exclusion criteria: admitted for
injuries resulting from burns, child abuse or
severe head injury; non-English speakers
Gussak 200759 Call for volunteers made on all units NR
Hattori et al. 201151 Hospital outpatients Inclusion criteria: 65–85 years; mild
impairment; MMSE score> 20; exhibiting
neurological signs of dementia on magnetic
resonance imaging or single-photon emission
computed tomography (SPECT); recent
memory impairment; < 6 months since
donepezil hydrochloride. Exclusion criteria:
MMSE score> 25; primary symptoms of speech
and executive function impairments
Kim 201352 All attendees at two day centres were assessed
for eligibility using the MMSE
Inclusion criteria: no previous experience of art
therapy; MMSE score > 25 out of 30 within
6 months prior to study
Lyshak-Stelzer et al.
200748
142 referred and then assessed for inclusion Inclusion criteria: age 13–18 years; able to
sustain school programme for 2 weeks running
and expected to stay in hospital for at least
16 weeks from date of parental consent.
Exclusion criteria: treatment court mandated
or contraindicated
continued
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Allocation bias: Method of randomisation
Table 14 shows the descriptions of randomisation from the included RCTs. Randomisation usually refers to
the random assignment of participants to two or more groups. Randomisation was not described in seven
studies.48–50,54,55,58,59 This information could simply be missing from the published journal paper and, if
benefit of the doubt were applied, it could be assumed that proper randomisation may have been done
but not reported. This would represent an unclear risk of bias. However, it could also be assumed that
proper randomisation did not take place and the method of selecting participants into the studies was
flawed. This would represent a high risk of bias. Therefore, there is an unclear/high risk that randomisation
was not adequately performed in these six studies.
TABLE 13 Method of participant recruitment in the 15 included RCTs (continued )
Study Method recruitment Inclusion/exclusion criteria
McCaffrey et al.
201153
Purposive sampling to enrol first 48 people
who volunteered and met inclusion criteria.
Fliers placed at local senior centres and an
information session held at the gardens
Inclusion criteria: age >65 years; self-diagnosed
of health-care provider diagnosed depression;
able to walk approximately 1 mile; could get to
the gardens twice per week for 6 weeks
Monti and Peterson
2004;60 Monti et al.
200661
Females recruited through the Jefferson
Cancer Network
Inclusion criteria: between 4 months and
2 years after diagnosis (original or recurrence).
Exclusion criteria: terminal cancer; diagnosis of
major mood disorder or psychotic disorder;
significant cognitive defects
Monti et al. 201254 Recruited through Thomas Jefferson University
as a supplement to a parent study RO1
CA111832
Inclusion: received breast cancer diagnosis
between 6 months and 3 years prior to
enrolment. Exclusion criteria: psychiatric
disorder; not expected to live for more than
6 months; diagnosis of thought disorder, mood
disorder or psychotic disorder; significant
cognitive defects; use of psychotropic
medication
Puig et al. 200655 Referred by private physician, hospital or the
American Cancer Society support network
Inclusion criteria: > 18 years; diagnosed with
stage I or stage II breast cancer within 12 months
prior to entering study
Rao et al. 200956 Recruitment fliers and advanced practice nurse
recruited over 6 months
Inclusion criteria: age > 18 years; cognitively
intact; able to participate for 1 hour; English
speaking
Rusted et al. 200657 Volunteers invited to participate Inclusion criteria: diagnosis of dementia;
attendance at day care or residential facility;
previous diagnosis by consultant
psychogeriatrician; confirmatory diagnosis from
medical records. Exclusion criterion: additional
psychiatric disorders
Thyme et al. 200747 Women who agreed to take part from a
psychiatric clinic
Inclusion criteria: diagnosed with dysthymic
disorder according to DSM-IV or had
depressive symptoms and difficulties. Exclusion
criterion: psychopharmacological treatment
Thyme et al. 2009;62
Svensk et al. 2009;63
Oster et al. 200664
Consecutive selection ‘convenience sample’:
143 answered written invitation to participate
for 6 months in a study related to the start of
radiotherapy
Exclusion criteria: pre-existing physical or
psychiatric illness; dementia or severe
psychiatric illness
DSM-IV, Diagnostic and Statistical Manual of Mental Disorders – Fourth Edition; NR, not reported.
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TABLE 14 Description of randomisation from the included RCTs
Study Method of randomisation as described in the paper
Beebe et al. 201058 NR
Broome et al. 200150 NR
Chapman et al. 200149 NR
Gussak 200759 NR
Hattori et al. 201151 Stratified by age (≤ 75 and ≥ 76 years), sex and MMSE score and then minimisation method
Kim 201352 Randomly assigned either to the intervention or to the control group based on programme
days first, and then assigning them to each group (intervention or control) alternately
Lyshak-Stelzer et al. 200748 NR
McCaffrey et al. 201153 Sealed envelope technique
Monti and Peterson 200460
Monti et al. 200661
Paired by age with one subject of each pair randomised to either intervention or control
Monti et al. 201254 NR
Puig et al. 200655 NR
Rao et al. 200956 Stratified randomisation
Rusted et al. 200657 Random allocation was based on participant ID numbers being drawn by chance
Thyme et al. 200747 A randomisation procedure was implemented between the collection of the self-rated data
and the first interview before therapy. The research leader administered the box with
50 pieces of paper, half of them were given one sign and the others were given a different
sign. An impartial individual performed the randomisation using this box. When the
impartial individual in charge had picked one piece of paper and the group assignment was
documented, the piece of paper was put back into the box
Thyme et al. 2009;62
Svensk et al. 2009;63
Oster et al.64
Computer generated and stratified according to receipt of chemotherapy to ensure equal
numbers treated with cytostatics between groups
NR, not reported.
Allocation bias: allocation concealment
In order to ensure that the sequence of treatment allocation was concealed, a robust method of allocation
to the study arms should be undertaken and documented. Allocation concealment was not reported in
any of the included studies. Lack of allocation concealment can destroy the purpose of randomisation,
as it can permit selective assignment to the study arms.
Appropriate randomisation for allocation to study arms includes undertaking ‘simple’ randomisation
(e.g. tossing a coin), which avoids introducing excessive stratification to prevent imbalanced groups, and
‘distance’ randomisation so that researchers are unable to influence allocation (e.g. a central randomisation
service which notes basic patient details and issues a treatment allocation). Several of the eight
randomisation methods described are likely to be open to allocation bias either because they did not use
distance randomisation or because the reports do not provide enough details about what measures were
taken to ensure that allocation was truly concealed to the investigators. For example, the Hattori et al.51
study describes stratification by three variables. Stratifying by more than one variable can be problematic,
and stratifying by more than two variables is not advisable.65 In addition, the Kim52 study does not
clearly describe how randomisation was undertaken. The sealed envelope technique employed in the
McCaffrey et al.53 study is intended to ensure that equal numbers receive the intervention and the control
but is vulnerable to subterfuge. Few of the included RCTs reported adequate details of methods of
randomisation and, consequently, these studies, as reported, had an unclear risk of allocation bias.
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Performance bias: blinding
Blinding of participants was not conducted in any of the included RCTs. Blinding of participants to their
experimental condition is understandably unfeasible in trials of psychological therapy as opposed to
pharmacological interventions. Therefore, while lack of blinding across the included trials means that the
trials are at risk of performance bias, the trials cannot be deemed to be of poor quality on this basis.
Performance bias: baseline comparability
Groups were reported to be comparable at baseline in 7 out of the 15 studies (Table 15).48,51–54,56,62
(Baseline comparability was unclear or not reported and therefore was unable to be assessed in
five studies.47,49,50,55,58) In three studies,57,59,61 patients in the art therapy group appeared to have more
severe illness at baseline. These differences could reflect a potential allocation bias resulting from
flawed randomisation procedures in the studies.
Performance bias: groups treated equally
As blinding was not possible, all studies are at risk of performance bias. In the case of the six
studies49,55,58,59,61,62 that had wait-list/treatment as usual controls rather than an active comparator group, it
can be argued that the groups were not treated equally, as the control groups were not given the time
and attention that an active control group would receive. Therefore, the risk of performance bias in the art
therapy group is higher in these six studies.
Reporting bias: selective outcome reporting
No studies appeared to have collected data on outcomes that were not reported in the results.
TABLE 15 Baseline comparability between intervention and control groups in the included 15 RCTs
Study Baseline comparability
Beebe et al. 201058 Unclear (NR and baseline demographics not provided)
Broome et al. 200150 Unclear (NR and baseline demographics not provided)
Chapman et al. 200149 Unclear (NR and baseline demographics not provided)
Gussak 200759 No. More were in receipt of medication in the art therapy group; different numbers
allocated to groups (27 versus 17); baseline BDI scores were not provided but were
reported to be ‘slightly higher’ in the art therapy group
Hattori et al. 201151 Yes
Kim 201352 Yes
Lyshak-Stelzer et al. 200748 Yes
McCaffrey et al. 201153 Yes
Monti and Peterson 2004;60
Monti et al. 200661
No. Levels of depression and anxiety at baseline were higher in the art therapy group
Monti et al. 201254 Yes
Rao et al. 200956 Yes
Rusted et al. 200657 No. Art therapy group had a significantly higher mean depression score (p< 0.01)
than the control group
Thyme et al. 200747 Unclear (NR and baseline demographics not provided)
Thyme et al. 2009;62
Svensk et al. 2009;63
Oster et al. 200664
Yes
NR, not reported.
CLINICAL EFFECTIVENESS OF ART THERAPY: QUANTITATIVE SYSTEMATIC REVIEW
NIHR Journals Library www.journalslibrary.nihr.ac.uk
34
Reporting bias: incomplete outcome data
In three studies,48,54,57 outcome data were incomplete, indicating a high risk of reporting bias. The reasons
for this were: data on 20% completers only (80% of participants withdrew or were excluded);48 actual
data not provided (only p-values reported);54 and group numbers not provided at any time point.57 In four
studies the risk of reporting bias was unclear because incomplete outcome data were reported.49,50,58,59
Detection bias
Blinding of clinical outcome assessment was reported to be conducted in only one study.58 Therefore,
14 out of the 15 included RCTs are at unclear to high risk of detection bias, as assessors may have
influenced the recording of clinical outcomes.
Researcher allegiance
In the Kim52 study there was only one author, and the two researchers are reported to be art therapists.
The author is also a senior art therapist. The Gussak 200759 study also has only one author, who is a
professor of art therapy. Trials that are published by one author are unlikely to have been conducted as
collaborative projects adhering to standards of good clinical practice. The risk of researcher allegiance in
these studies is, therefore, high.
The McCaffrey et al. 201153 study was funded by the owners of the gardens that were the basis of the
comparator. The gardens are profit-making, and participants who completed the study were given 1 year’s
free membership. The risk of researcher allegiance for the control group in this study, can, therefore, be
considered to be high.
As can be seen from Table 16, all studies were prone to many instances of unclear risk of bias. Some
studies were prone to several instances of high risk of bias. In the context of this review, with the
exception of blinding participants, all the risk of bias domains are important to be able to establish internal
validity of these trials. Currently the only domain that is at low risk of bias is selective outcome reporting.
Owing to the risks of bias highlighted by the critical appraisal of these studies, it can be concluded that the
included RCTs are generally of low quality.
Critical appraisal of other potential sources of confounding
Attrition
Withdrawals and exclusions are reported in Table 17.
As can be seen from Table 17, there were only four studies in which all participants completed the
trial.52,54,55,58 While several studies reported substantial numbers of dropouts, only one study reported to be
sized with reference to effect size.61 Considering that the sample sizes in the remaining 14 RCTs are small
and not sufficiently powered to account for attrition, these dropouts have a significant impact on the
reliability of these RCTs. For example, in the Rusted et al.57 study, attrition was 53.3%, meaning that the
final data are reported for 9 versus 12 people in the art therapy and activity control groups, respectively.
This small number of completers calls into question the reliability of this study’s results.
Only 5 of the 11 studies in which dropouts occurred reported the breakdown of withdrawal between
groups. Two studies50,59 do not report the reasons for withdrawal in the dropouts that occurred. In
addition, attrition was not handled appropriately in the included RCTs as imputation for missing data were
generally not reported or were reported to be not conducted except in one study.62 The risk of attrition
bias in the 11 studies where dropouts occurred is, therefore, unclear.
Concomitant treatment
Co-therapy or concomitant medication was not reported in eight trials.49–52,55–58 In a further two studies,53,61
participants were eligible to take part if in receipt of mental health treatment but the actual data for
concomitant therapy (overall or between groups) are not reported.
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TABLE 17 Withdrawals from the study across the included RCTs
Study Randomised
Completed,
% (n/N)
Between-group
withdrawals Reasons for withdrawal
Beebe et al. 201058 22 100% (22/22) N/A N/A
Broome et al. 200150 97 51% (49/97) ‘No significant
differences’
NR
Chapman et al. 200149 85 68% (58/85) NR No PTSD symptoms (n= 27)
Gussak 200759 44 66% (29/44) Art therapy
(n= 11)
NR
Control (n= 4)
Hattori et al. 201151 43 91% (39/43) Art therapy
(n= 2)
Owing to physical diseases (n= 4)
Control (n= 2)
Kim 201352 50 100% (50/50) N/A N/A
Lyshak-Stelzer et al.
200748
77 38% (29/77) NR Discharged prior to completion (n= 23)
Withdrew (n= 5)
Withdrawn by clinical team (n= 3)
Ongoing, no data yet (n= 15)
NR (n= 2)
McCaffrey et al. 201153 48 81% (39/48) Art therapy
(n= 3)
Surgery (n= 2)
Control (n= 6) Respiratory infection (n= 5)
Family issues (n= 2)
Monti and Peterson
2004;60 Monti et al.
200661
111 84% (93/111) NR ‘The majority of dropouts were due to
progression of illness and/or cancer
treatment complications’
Monti et al. 201254 18 100% (18/18) N/A N/A
Puig et al. 200655 39 100% (39/39) N/A N/A
Rao et al. 200956 79 96% (76/79) NR Drowsiness (n= 2)
Consulting with physician (n= 1)
Rusted et al. 200657 45 46% (21/45) NR Died (n= 10)
Moved away (n= 5)
Incomplete data (n= 9)
Thyme et al. 200747 43 91% (39/43) Art therapy
(n= 3)
Dropped out (n= 3)
Control (n= 1) Referred to long-time art therapy (n= 1)
Thyme et al. 2009;62
Svensk et al. 2009;63
Oster et al. 200664
55 75% (41/55) Art therapy
(n= 5)
Too much strain (n= 7)
Disease complication (n= 2)
Control (n= 8) Dissatisfaction with randomisation
outcome (n= 4)
Data incomplete and discarded (n= 1)
N/A, not applicable; NR, not reported.
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In the Gussak59 study, 93% (n= 25/27) of participants in the intervention group were taking medication
for a mental illness, compared with 27% (n=NR) in the control group. In the Thyme et al.47 study, it was
reported that psychopharmacological treatment was an exclusion criterion. It is subsequently stated that
‘in the [art therapy] group, one participant were [sic] prescribed antidepressants during therapy (n= 1) and
one between termination of therapy and the 3-month follow-up (n= 1), and in the [verbal therapy] group
three during therapy (n= 1) [sic] and two after (n= 2). Two participants in VT accepted Body Awareness as
an additional treatment during psychotherapy.’47
In the Thyme et al. 200962 study the usage of antidepressants was self-reported, and therefore this
information may be incomplete. In the Chapman et al.49 study, ‘treatment as usual’ hospital care was
defined as the normal and usual course of paediatric care including Child Life services, art therapy, and
social work and psychiatric consultations. While only the Monti et al. 201254 study reports that use of
psychotropic medication was an exclusion criterion, there is generally an unclear/high risk of confounding
as a result permitted additional treatment across the included studies.
Treatment fidelity
Sufficient measures to ensure treatment fidelity would include monitoring the therapy sessions through
audio or video tapes to allow independent checking. No such measures to ensure that the intervention
was being delivered consistently were reported in any of the studies. However, one study58 does provide
an appendix of the content of each session. In addition, one study61 provides the art therapy programme
details in the first of the two resulting publications.60 Most studies provided brief synopses of the
intervention programme and content of the sessions.48,50,52,54–56,62 However, some studies provided scant
details of what took place in the sessions.47,49,51,53,57,66 Moreover, Chapman et al.49 do not even state how
many sessions were provided. Therefore, the included RCTs have unclear risk of poor treatment fidelity.
The risk of bias assessment and the potential areas of confounding including attrition, concomitant
treatment and treatment fidelity illustrate that the included trials are generally of low quality and,
therefore, the results of the 15 RCTs that are included in the quantitative review should be interpreted
with caution. Three studies47,51,56 can be considered as being of slightly better quality because there are no
instances of high risk of bias (other than blinding, which is a common hurdle in trials of psychological
therapy) and at low risk of bias on at least four domains.
Discussion
Discussion of the quantitative review
The aim of the quantitative systematic review was to assess the evidence of clinical effectiveness of art
therapy compared with control for treating non-psychotic mental health disorders. The limited available
evidence showed that patients receiving art therapy had significant positive improvements in 14 out of
15 RCTs. In 10 of these studies, art therapy resulted in significantly more improved outcomes than the
control, while in four studies art therapy resulted in an improvement from baseline but the improvement in
the intervention group was not significantly greater than in the control group. In one study, outcomes
were better in the control group than in the art therapy group. Relevant mental health outcome domains
that were targeted in the included studies were depression, anxiety, mood, trauma, distress, QoL, coping,
cognition and self-esteem. Improvements were frequently reported in each of these symptoms except
for cognition.
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Limitations of the quantitative evidence
Despite every possible effort to identify all relevant trials, the number of studies that qualified for inclusion
was small. Despite a large number of records on art therapy yielded from the searches, very few studies
were RCTs, demonstrating a slow uptake of the evidence-based medicine model in this field. The study
samples are heterogeneous and few samples can be regarded strictly as the target population for this
review – people diagnosed with a mental health condition. The limited selection of mental health disorders
in the included study samples means that the external validity to the population with non-psychotic mental
health disorders is limited. In addition, the sample sizes are small, and as yet there are no large-scale RCTs
of art therapy in non-psychotic mental health disorders. The paucity of RCT evidence means that it is not
possible to make generalisations about specific disorders or population characteristics.
The risk assessment of bias highlighted that, although all studies were reported to be RCTs, few studies
reported how patients were randomised, and in the majority of studies there were several instances of
high risk of bias. Areas of potential confounding frequently associated with the studies included attrition,
concomitant treatment and treatment fidelity. Consequently, the internal validity of the included studies is
threatened. Owing to the low quality of the 15 RCTs, the results included in the quantitative review should
be interpreted with caution. As this systematic review did not search for and include direct evidence about
other interventions for non-psychotic mental health disorders, it has not been possible to identify indirect
evidence for the effect of art therapy in a mixed treatment comparison within the scope of this research.
Therefore, the effectiveness of art therapy compared with other commonly used treatments that have been
shown to be effective is unknown. In addition, the underlying mechanisms of action in art therapy remain
unclear from this evidence. The qualitative systematic review that is presented in the next chapters will
explore the factors that may contribute to the therapeutic action in art therapy.
Conclusions
From the limited number of studies identified, in patients with different clinical profiles, art therapy was
reported to have statistically significant positive effects compared with control in a number of studies.
The symptoms most relevant to the review question which were effectively targeted in these studies
were depression, anxiety, low mood, trauma, distress, poor QoL, inability to cope and low self-esteem.
The small evidence base, consisting of low-quality RCTs, indicated that art therapy was associated with
an improvement from baseline in all but one study and was a more effective treatment for at least one
outcome than the control groups in the majority of studies.
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Chapter 3 The acceptability and relative benefits
and potential harms of art therapy: qualitative
systematic review
This chapter aims to provide an overview of the evidence for service user and service providerperspectives on the acceptability, relative benefits and potential harms of art therapy for people with
non-psychotic mental health disorders.
Review methods
Bibliographic database searching
As the searches for the clinical effectiveness were comprehensive for art therapy literature, the same
database was used for both the quantitative and qualitative reviews (see Chapter 2, Literature
search methods).
Screening and eligibility
All abstracts, and then full papers, were read by two reviewers (AS and LU) who made independent
decisions regarding inclusion or exclusion, and consensus, where possible, was obtained by meeting to
compare decisions. In the event of disagreement, a third reviewer (EK) read the paper and made the
decision. Study types included were:
l qualitative research reporting the perspectives and attitudes of people with non-psychotic mental
health disorders who have received art therapy in order to examine issues of acceptability
l qualitative data embedded in trial reports or in accompanying process evaluations, to inform an
understanding of how issues of acceptability are likely to affect the clinical effectiveness of art therapy
l qualitative data either from separately conceived research or embedded within quantitative study
reports, reporting the acceptability of art therapy to health care practitioners.
The inclusion and exclusion criteria for the qualitative review are reported in Figure 6. Studies in all settings
were included, although the community was the main setting of interest.
Quality assessment strategy
Studies meeting the inclusion criteria were evaluated by two reviewers using the CerQual approach.
CerQual (certainty of the qualitative evidence67) aims to assess how much certainty can be placed in the
qualitative evidence for the review finding, or, in other words, how reliable the review finding is. This
approach relies on assessing both the methodological quality of the individual included studies and the
coherence of the review finding as defined by the extent to which a clear pattern across the individual
study data is identifiable.
To assess methodological quality individual studies were appraised using an abbreviated version of the
CASP quality assessment tool for qualitative studies.68
Two reviewers (AS and LU) independently applied the set of quality criteria to each included study. In the
event of a disagreement, a third reviewer (EK) was consulted. Studies were included in the review
regardless of study quality.
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Whereas study quality applies to each individual included study, ‘coherence’ relates to the review finding
which is subsequently developed through the synthesis of the individual studies. Therefore, the coherence
of each review finding was then assessed by looking at the extent to which a clear pattern across the data
was identified and was contributed by each individual study. This was assessed by looking to see if the
review finding was consistent across multiple contexts and if the review finding incorporated explanations
for any variation across individual studies. Coherence was further strengthened when the individual
studies contributing to the finding were drawn from a wide range of settings. Using the assessment of
methodological quality and assessment of coherence together, the certainty of each review finding was
rated as high, moderate or low.
Data extraction strategy
Data extraction from included qualitative studies was undertaken independently by AS using a data
extraction tool adapted and tailored for the precise purpose of the qualitative review. All data extractions
were checked by LU, with any discrepancies being discussed by both data extractors. Where data for included
studies were missing, reviewers attempted to contact the authors at their last known e-mail addresses.
For the purpose of data extraction, two principal approaches to decide what counts as qualitative
evidence have been proposed.69 In the first, only data from primary studies which are illustrated by a
direct quotation from the respondent are extracted, whereas in the second all qualitative data identified
in the primary studies and relevant to the review question are extracted. Given the anticipated paucity
of evidence, the latter, more inclusive, approach to data type was adopted, together with a selective
approach to extract data relevant to the specific research question. A framework for extraction was
developed which focused specifically on data relating to the review question, including how art therapy
helped (relative benefits); how art therapy was unhelpful (potential harms); neutral effects (neither
benefits or harms); barriers to participation [acceptability (a)]; and recommendations for service delivery
[acceptability (b)] from patients and health practitioners. Table 18 illustrates the data extraction elements.
Included Excluded
P
Population
Non-psychotic clinical samples 
(see Introduction, Adapting the 
research to the research, Art 
therapy as a complex intervention)
and health-care practioners
Psychosis or healthy samples
without mental health symptoms
I
Intervention
Art therapy as might be delivered 
in the NHS (see Introduction, 
Adapting the research to the 
research, Art therapy as a clinical 
intervention: definition) 
Art therapy combined with any
other therapy (creative therapy = art 
and music therapy) and ‘The Arts
in Health’ Movement 
C
Comparator
N/A N/A
O
Outcomes
Qualitative research data
(see below)
S
Studies
Case series, interviews and
observational studies
Single case studies
FIGURE 6 Eligibility criteria for the qualitative review.
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Data synthesis strategy
Qualitative meta-synthesis was undertaken to provide added value to the quantitative analysis by indicating
patient issues around the acceptability of art therapy as a treatment for non-psychotic mental health
disorders. Specifically, thematic synthesis was used to aggregate the findings.70 The framework developed
for data extraction was used to shape the synthesis of the findings.
Combining the quantitative and qualitative data
Methodological work to date has been unable to establish the superiority of conducting the qualitative
and quantitative synthesis in parallel or of conducting quantitative followed by qualitative, qualitative
followed by quantitative or some more iterative approach. Our choice of method of combining data was
determined by the needs of this particular review, in which the quantitative data were the main focus and
the qualitative data were used for their explanatory potential. We, therefore, employ methods similar to
those described by Noyes et al.71 to explore the effectiveness review in the light of supporting qualitative
research data.
Results of the qualitative review
Included studies: qualitative review
From the 10,270 citations identified from the initial searches (see Chapter 2), 290 were considered
following abstract sift and 42 papers were considered at full paper sift for the qualitative review. Figure 7
shows the flow chart of studies included in the qualitative review. The sifting process resulted in the
inclusion of 12 studies (13 sources) at full paper sift. All included full papers were published between 2002
and 2013 (although one study was an unpublished manuscript linked to a published abstract within this
time scale72). Two were theses,73,74 and one of these had an associated peer-reviewed paper75 which
reported the same study.
TABLE 18 Data extraction elements from the qualitative review
Elements of the
research question
Evidence from
patients/health
professionals
To inform intervention –
elements of the
intervention Service delivery
Relative benefits How art therapy helped What to do How to do it
Potential harms How art therapy was
unhelpful
What not to do How not to do it
Neither benefits nor
harms
Neutral effects of art
therapy
Contribute to understanding of
suitable potential patients
Specify suitable potential
patients
Acceptability (a) Barriers to participation Are the barriers real? Can they
be addressed?
Address barriers/specify any
unsuitable groups (if any)
Acceptability (b) Recommendations for
service delivery
Assess feasibility Direct recommendations to be
considered for incorporation into
the service
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Id
en
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n
Records screened by title
(n = 10,270)
Full-text articles assessed
for eligibility
(n = 42)
Full-text articles and abstracts 
excluded with reasons
(n = 29)
• Not art therapy, n = 9
• Did not contain qualitative
   data, n = 8
• Case study, n = 5
• Not relevant to attitudes of 
   art therapy, n = 3
• Abstract only available, n = 2
• Abstract superseded by full
   paper, n = 1
• Not available within the
   time scale, n = 1
Excluded by abstract
(n = 248)
Full-text articles and
abstracts (citations)
included in qualitative
synthesis
(n = 13 references relating
to 12 studies)In
cl
u
d
ed
Records identified through
database searching
(n = 10,073)
Additional records identified
through other sources
(n = 197)
• Hand search, n = 143
• Grey literature search, n = 54
Records screened by abstract 
(n = 290)
Excluded by title
(n = 9980)
FIGURE 7 Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flow chart of studies
included in the qualitative review.
Study respondents
Eleven studies assessed patients’ attitudes and two studies assessed health practitioner attitudes to the
intervention [general practitioners (GPs)= 1; art therapists= 1]. The studies contained qualitative data from
188 patients and 16 health practitioners. The primary diagnoses of the patient populations studied
included cancer (n= 6), depression/anxiety/stress (n= 3), PTSD (n= 1) and obesity (n= 1). The symptoms
being treated by art therapy included depression, stress, anxiety, psychological distress, low self-esteem,
fatigue and fear.
Six studies did not report the age of the participants. Where age range was reported,73,76–78 ages ranged
from 26 to 82 years. Five studies77,81–84 did not report the gender of the participants. In four studies,72,73,76,78
all participants were female, while one study79 included 69 men and 88 women and a final study80
included four women and one man.
Study setting
Three studies80–82 were conducted in the UK. One of these studies82 provided data from patients and the
other from GPs who referred patients to art therapy.81 Four studies73,74,78,83 were conducted in the USA,
with one of these studies73 also including participants from Canada. Three of these studies73,78,83 provided
data from patients and the final study74 provided data from art therapists. The remaining five studies were
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conducted in European countries, Sweden,76 Germany,77 France,72 Italy79 and Switzerland,84 and provided
data from patients.
In seven studies,72,74,76,77,79,82,84 the art therapy took place in secondary care; one study81 took place in
primary care and one study78 took place in a state correctional facility (USA). In another study73 participants
had taken part in art therapy in varied settings including secondary care and private sessions. The setting
was not reported in two studies.80,83
Intervention description
The reporting of the art therapy intervention was limited in a number of cases. One study81 did not report
any details of the intervention, and two studies73,80 reported on perceptions of patients who had taken part
in a variety of different interventions, although details of each were not reported. Of the remaining eight
studies assessing patient views of art therapy, in four studies77,82,83,84 the art therapy had been conducted in
a group, with group sizes ranging from four to nine participants, while three studies76,78,79 reported on
individual sessions; in one study,72 the format was not reported. In six studies72,76,79,82–4 it was reported that
the intervention had been delivered by an art therapist. This was reported to be a professional or qualified
art therapist in three of these studies72,79,82 and an art therapy psychotherapist in a further study.84 The
service provider was not reported in the remaining two studies.77,78 Sessions were 1 hour in length in three
studies72,78,79 and 2 hours in length in two studies;82,84 duration was not reported in three studies.76,77,83
The number of sessions delivered ranged from 1 to 22. Sessions were reported as occurring weekly in four
studies; the frequency was not reported in three studies. One study82 reported perceptions of patients who
had taken part in art therapy as part of a rolling programme. Table 19 shows the study characteristics of
qualitative studies with data from patients.
Table 20 shows the study characteristics of qualitative studies with data from service providers.
Quality of the included studies
Table 21 shows the methodological quality assessment of the included studies (adaptation of the critical
appraisal skills programme checklist for qualitative studies.
Our inclusion criteria specified that qualitative research or qualitative data within mixed methods studies
were acceptable for inclusion; however, only three studies could be described as qualitative research.74–76
Researcher reflexivity can be described as awareness of the researcher’s contribution to the construction of
meanings throughout the research process and an acknowledgement of the impossibility of remaining
‘outside of’ one’s subject matter while conducting research. Few studies made reference to researcher
reflexivity, and in those that did these descriptions were often brief. Most studies provided descriptions of the
context and aims of the study, recruitment methods and data collection methods, although these tended to
be brief. The study methods used were interview methods in most studies (n= 10) [semistructured interviews
(n= 7), in-depth interview (n= 1), interview (n= 2)]. One study used the focus group method, one used
patient diaries, one used field notes, and one used the transcription of a video-recorded group discussion
which had been used for a television programme. Only around half of the included studies provided an
adequate description of data analysis methods, and in only a few studies were in-depth, detailed and rich
data presented. It should be noted that this may have been, in part, a result of limitations imposed by
journals. Furthermore, the level of evidence that was included was extended to include data identified in
both the results section and the discussion and will include author comments and interpretation. If data were
limited only to participants, it was feared that important data would be missed.
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TABLE 20 Study characteristics of qualitative studies with data from service providers
Author, Year Country Population
n (contributing
qualitative evidence)
Study methods
(yielding qualitative data)
Turnbull et al.
200281
UK GPs on art therapy for anxiety,
depression and stress
4 Semistructured interview
Sharf 200474 USA Art therapists on art therapy for
substance abuse
12 Semistructured interview
TABLE 21 Methodological quality assessment of the included studies (adaptation of the critical appraisal skills
programme checklist for qualitative studies)
Question
Yes/somewhat
N= 12 studies, % (n)
1 Is the study qualitative research or does it provide qualitative data? 100 (12)
2 Is the study context and aims clearly described? 75 (9)
3 Is there evidence of researcher reflexivity? 42 (5)
4 Are the sampling methods clearly described and appropriate for the research question? 66 (8)
5 Are the methods of data collection clearly described and appropriate to the research question? 66 (8)
6 Is the method of analysis clearly described and appropriate to the research question? 58 (7)
7 Are the claims made supported by sufficient evidence (i.e. did the data provide sufficient
depth, detail and richness)?
42 (5)
Certainty of the review findings
As described in the Quality assessment strategy section, the CerQual approach to assess the certainty of
the review findings was applied. The CASP quality assessment finding, together with the number of
studies contributing to the finding, and an assessment of the consistency of study setting and population,
was assessed. Each finding could potentially be graded as being of high, moderate or low certainty. For
the evidence from patients, there were a total of 38 findings: 20 were assessed to be of moderate
certainty and 18 were assessed to be of low certainty. For the evidence from service providers, as only two
studies contributed to the evidence, there were a total of 25 findings: 19 were assessed to be of moderate
certainty and six were assessed to be of low certainty. Owing to the limited number of studies contributing
to each finding, together with the fact that the majority of the individual studies included in the review
were of low to moderate quality, no findings were assessed as being of high certainty.
Qualitative synthesis: evidence from patients
Table 22 shows the patient views regarding how art therapy helped (relative benefits).
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TABLE 22 Patient views regarding how art therapy helped (relative benefits)
Theme
Synthesised
finding – art
therapy is
effective when:
Evidence source(s)
[CASP assessment
of quality]
Certainty in
the evidence
Explanation of
certainty in the
evidence
assessment
Subtheme(s) and
explanation of
certainty in the
evidence assessment
(subtheme)
Relationships A relationship
with the art
therapist is
established
McCaffrey (2007)83
[low]
Moderate
certainty
The studies
overall were of
moderate quality.
The finding was
seen across
several studies,
settings and
populations
Forzoni (2010)79
[moderate]
Wood (2013)80
[moderate]
Relationships
with other group
members can be
established
McCaffrey (2007)83
[low]
Moderate
certainty
The studies
ranged in quality
from low to high.
The finding was
seen across
several studies, in
different settings
and populations
(cancer and
PTSD)
It provides support from
other group members73
This subtheme was seen
in only one study,
which was high quality,
in a breast cancer
population
Collie (2004);73
Collie (2006)75
[high]
It allows a shared
experience with other
group members77,82
This subtheme was seen
in two studies
of low to moderate
quality, and in different
settings and populations
Geue (2011)77
[low/moderate]
Lobban (2012)82
[low/moderate]
Wood (2013)80
[moderate]
It facilitates an
improved
relationship with
family, friends
and caregivers
Rhondali (2010)72
[high]
Moderate
certainty
The finding was
seen in only one
study of high
quality, specific
to the cancer
population
It counters
isolation
Turnbull (2002)81
[low]
Low certainty The finding was
seen in only one
study, which was
of low quality
Understanding It facilitates
increased
understanding
of self
McCaffrey (2007)83
[low]
Moderate In general the
studies were of
moderate quality.
The finding was
seen across
several studies,
settings and
populations
Forzoni (2010)79
[moderate]
Anzules (2007)84
[low]
Collie (2004);73
Collie (2006)75
[high]
Geue (2011)77
[low/moderate]
Lobban (2012)82
[low/moderate]
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TABLE 22 Patient views regarding how art therapy helped (relative benefits) (continued )
Theme
Synthesised
finding – art
therapy is
effective when:
Evidence source(s)
[CASP assessment
of quality]
Certainty in
the evidence
Explanation of
certainty in the
evidence
assessment
Subtheme(s) and
explanation of
certainty in the
evidence assessment
(subtheme)
It facilitates
understanding of
illness
Anzules (2007)84 [low] Low certainty This finding was
observed in only
two studies: one
of high quality
and one of low
quality, and in
different
populations
Collie (2004);73
Collie (2006)75 [high]
It promotes
future thinking
McCaffrey (2007)83
[low]
Moderate
certainty
In general, the
studies were of
moderate quality,
and the finding
was seen across
several studies,
settings and
populations
Rhondali (2010)72
[high]
Oster (2009)76
[moderate]
Collie (2004);73
Collie (2006)75 [high]
Geue (2011)77
[low/moderate]
Turnbull (2002)81
[low]
Perspective It give strength/
provides
perspective
McCaffrey (2007)83
[low]
Low certainty The studies were
of moderate
quality, but the
finding was seen
in only a small
number of
studies although
across different
settings, and
populations
(cancer vs.
depression)
Oster (2009)76
[moderate]
Distraction It provides
distraction from
pain
Rhondali (2010)72
[high]
Low certainty The finding was
seen in only one
high quality study
It provides
distraction from
the illness/
escapism
Rhondali (2010)72
[high]
Moderate
certainty
In general, the
studies were of
moderate quality,
although the
finding was seen
over a relatively
small number
of studies they
had similar
populations and
settings (e.g.
cancer, obesity)
Collie (2004);73
Collie (2006)75 [high]
Anzules (2007)84
[low]
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TABLE 22 Patient views regarding how art therapy helped (relative benefits) (continued )
Theme
Synthesised
finding – art
therapy is
effective when:
Evidence source(s)
[CASP assessment
of quality]
Certainty in
the evidence
Explanation of
certainty in the
evidence
assessment
Subtheme(s) and
explanation of
certainty in the
evidence assessment
(subtheme)
Personal
achievement
It provides
pleasure/
satisfaction/
accomplishment/
pride
Rhondali (2010)72
[high]
Moderate
certainty
In general, the
studies were of
moderate quality.
The finding was
seen across
several studies,
settings and
populations
Collie (2004);73
Collie (2006)75 [high]
Anzules (2007)84
[low]
Ferszt (2004)78 [low]
Forzoni (2010)79
[moderate]
It provides the
opportunity for
legacy
Rhondali (2010)72
[high]
Low certainty The finding was
seen in only one
study, although
this was of high
quality
Expression It allows
participants to
express their
feelings
Ferszt (2004)78 [low] Moderate
certainty
In general, the
studies were of
moderate quality
and the finding
was seen across
several studies,
settings and
populations
It provides a safe
place/to express fear
In general, the studies
were of moderate quality
and the subtheme was
seen across several
studies, settings and
populations
It provides an opportunity
to express anger73,75
The subtheme was seen
in only one study,
although this was high
quality
Oster (2009)76
[moderate]
Collie (2004);73
Collie (2006)75 [high]
Geue (2011)77
[low/moderate]
Lobban (2012)82
[low/moderate]
Turnbull (2002)81 [low]
Wood (2013)80
[moderate]
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TABLE 22 Patient views regarding how art therapy helped (relative benefits) (continued )
Theme
Synthesised
finding – art
therapy is
effective when:
Evidence source(s)
[CASP assessment
of quality]
Certainty in
the evidence
Explanation of
certainty in the
evidence
assessment
Subtheme(s) and
explanation of
certainty in the
evidence assessment
(subtheme)
Relaxation It provides a
healing
experience/
comfort
encouragement
and support/
relaxation
Ferszt (2004)78 [low] Moderate
certainty
In general, the
studies were of
moderate quality,
and the finding
was seen across
several studies,
settings and
populations
Collie (2004);73
Collie (2006)75 [high]
Geue (2011)77
[low/moderate]
Turnbull (2002)81
[low]
Wood (2013)80
[moderate]
Empowerment It promotes
empowerment
Oster (2009)76
[moderate]
Moderate
certainty
In general, the
studies were of
moderate quality.
Although the
finding was seen
across only a
relatively small
number of
studies, these
were in different
settings and
populations
It promotes control over
emotions
In general, the studies
were of moderate
quality. Although the
subtheme was seen
across only a relatively
small number of
studies, these were in
different settings and
populations
Collie (2004);73
Collie (2006)75 [high]
It promotes control over
real-life situations76
The subtheme was seen
in only one moderate
quality study
Turnbull (2002)81
[low]
Wood (2013)80
[moderate]
It raises
self-esteem
Ferszt (2004)78 [low] Low certainty The finding was
seen in only one
study, and this
was rated as low
quality
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Table 23 shows the patient views regarding how art therapy was unhelpful (relative harms).
Table 24 shows the patient views regarding the neutral effects of art therapy (neither nor
benefits)/acceptability.
Table 25 shows the service delivery recommendations from patients.
TABLE 23 Patient views regarding how art therapy was unhelpful (relative harms)
Patients reported
that art therapy was
unhelpful when:
Evidence source(s)
[CASP assessment
of quality]
Certainty
in the
evidence
Explanation of certainty in
the evidence assessment
Change to service
delivery implicated?
It caused anxiety Rhondali (2010)72
[high]
Moderate
certainty
Although each of these
findings was seen in a study
of high quality, it was
reported in only one study
and, therefore, cannot be
generalised to other settings
or populations
Analysis of suitable
patients for art therapy
It increased pain Rhondali (2010)72
[high]
Moderate
certainty
Analysis of assistance
needed or assessment of
suitability for patients
who are physically very ill
It resulted in the
activation of emotions
which were not
resolved
Collie (2004);73
Collie (2006)75 [high]
Moderate
certainty
Debriefing required or
ensuring competence of
the deliverer
The art therapist was
not skilled
Collie (2004);73
Collie (2006)75 [high]
Moderate
certainty
Ensuring competence of
the deliverer
Art therapy was
suddenly terminated
Collie (2004);73
Collie (2006)75 [high]
Moderate
certainty
Ensuring other support is
available if required
TABLE 24 Patient views regarding the neutral effects of art therapy (neither harms nor benefits)/acceptability
Neutral effects of art
therapy – themes
Evidence source(s)
[CASP assessment
of quality]
Certainty in
the evidence
Explanation of certainty in
the evidence assessment
Change to service
delivery implicated?
Superficial Forzoni (2003)79
[moderate]
Low certainty The finding was seen in only
one study of moderate quality
Analysis of suitable
patients for art therapy
Childish Forzoni (2003)79
[moderate]
Low certainty
Preference for other
therapies
Ferszt (2004)78 [low] Low certainty The finding was seen in only
one study of low quality
Self-indulgent Turnbull (2002)81 [low] Low certainty
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TABLE 25 Service delivery recommendations
Patient views identified
Evidence source(s) [CASP
assessment of quality]
Certainty in
the evidence
Explanation of certainty in
the evidence assessment
Important considerations for art therapy. Patients wanted:
Their privacy to be respected Oster (2009)76 [moderate] Low The finding was seen in only
one study of moderate quality
Emotional support Collie (2004);73
Collie (2006)75 [high]
Moderate The finding was seen in only
one study of high quality
A good relationship with the art
therapist
Collie (2004);73
Collie (2006)75 [high]
Moderate The finding was seen in only
two studies, of which one was
high quality
Turnbull (200281) [low]
The art therapist as a guide Collie (2004);73
Collie (2006)75 [high]
Moderate The finding was seen in only
one study of high quality
Barriers to participation in art therapy. Patients felt they could not participate in art therapy:
When they thought they were
too ill to do so
Rhondali (2010)72 [high] Moderate The finding was seen in only
one study of high quality
When art therapy was restricted
to certain medical conditions.
Wood (2013)80 [moderate] Low The finding was seen in only
one study of moderate quality.
When they lacked an
understanding of art therapy
Forzoni (2003)79 [moderate] Low The finding was seen in only
two studies of moderate quality
Wood (2013)80 [moderate]
When they feared not being
‘good at art’
Wood (2013)80 [moderate] Low The finding was seen in only
one study of moderate quality
Suggested improvements. Patients felt:
They needed further sessions of
art therapy
Ferszt (2004)78 [low] Low The finding was seen in only
one study of low quality
They need additional input from
other therapies (e.g. individual
counselling)
Ferszt (2004)78 [low] Low The finding was seen in only
one study of low quality
Benefits of art therapy
Relationships
A number of respondents across several studies72,73,77,79–83 talked about relationships as important in art
therapy. They suggested that art therapy was effective when a relationship with the art therapist was
established.79,80,83 One patient commented ‘I felt she [the art therapist] really understood what I am going
through’.79 A good relationship with the art therapist was seen as a requirement for an optimal art therapy
programme,73,81 and that the art therapist should act as a guide.73 However, it was also noted that art
therapy could be unhelpful if the art therapist was not skilled.73 One patient recounted, ‘I was getting very,
sort of out there in terms of the anxiety and that kind of thing, and it seemed to become evident she
couldn’t go there with me . . . She couldn’t deal with it, which was quite upsetting’.73
Respondents also discussed relationships with other group members and felt that art therapy was
beneficial when these relationships could be established.73,77,80,82,83 These findings were observed in studies
across a range of settings and in a range of populations.
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Respondents also felt that art therapy had the effect of facilitating improved relationships with family
members, friends and caregivers.72 This finding was observed in only one study, in which respondents
had cancer, and therefore this finding may not be generalisable to other populations. In one study,81
respondents with anxiety, depression and stress suggested that art therapy could serve to reduce isolation.
Understanding
Several studies included data concerning the importance of increased understanding as a beneficial result
of art therapy.72,73,76,77,79,81–84 More specifically, respondents talked about an increased understanding of
self73,77,79,81–84 and that art therapy promoted thinking about the future.72,73,76,77,81,83 These findings appeared
to be consistent across different populations. In two studies, one in patients with obesity84 and the other in
people with breast cancer,73 art therapy was felt to facilitate understanding of these illnesses; thus, this
finding may be specific to people with a diagnosis of a physical illness.
Perspective
A further beneficial effect of art therapy was the provision of strength and perspective.76,83 This was
illustrated by a participant in the McCaffrey et al. study:
These classes have put some perspective on my feelings and even though I am still sad and would give
the whole world to have my husband back, I realize I can go on and I can have a good life.
McCaffrey et al.83 (p. 83)
However, it should be noted that this finding was judged to be of low certainty because it occurred in only
two studies of overall low quality.
Distraction
Respondents highlighted distraction as a beneficial aspect of art therapy.72,73,84 More specifically,
respondents pointed to distraction from pain72 and distraction from the illness, or escapism.72,73,84 As might
be expected, these findings were restricted to cancer and obesity populations, and were, therefore, rated
as low to moderate certainty.
Personal achievement
Several studies included data reflecting that the provision of art therapy gave participants a sense of
personal achievement. In a number of studies,72,73,78,79,84 respondents commented that art therapy provided
pleasure, satisfaction, accomplishment and a sense of pride. A patient reported, ‘I underestimate myself
and didn’t think I was capable of doing what I did and of having any ideas. I am proud and I’ve rarely
been that in my life’.84 In one study of women with cancer,72 it was reported that art therapy provided an
opportunity to leave a legacy for loved ones.
Expression
Freedom of expression emerged as important across a range of studies.73,76,77,78,80–82 A patient commented,
‘It can touch the feelings that are buried . . . the art frees you up to touch deeper down that [sic] you
would verbally’.81 Specifically, art therapy was thought of as a safe place to express emotions, such as
fear73,76–78,81,82 and anger.73
Relaxation
A number of studies reported data suggesting art therapy provided a healing experience, comfort,
encouragement, support and relaxation.73,77,78,80,81 One participant reported, ‘it was really relaxing and
afterwards I felt good and encouraged’.77
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Empowerment
Recipients of art therapy expressed that it gave them a sense of empowerment. This came in the form of
control over emotions.73,76,80,81 In the Collie study,73 the author reports:
[The art therapist stated] ‘What art can do is it gives you . . . access to a larger part of who you are.’
She said art can take people away from their pain and show them that they are more than pain, and
therefore can give a sense of control.
Collie73 (p. 77)
Art therapy also promoted control over real-life situations76 and it was also cited as raising self-esteem.78
Acceptability and potential harms of art therapy
Although recipients in most of the studies indicated a high level of acceptability of art therapy, some
studies also described less positive attitudes.72,73,78,79,81 Some respondents made comments that indicated
that, although they did not feel art therapy would be harmful, they did not feel it would be beneficial. In
one study,79 a participant commented that art therapy was superficial; ‘I did not find anything particularly
useful in it: afterwards I felt as before [she makes a gesture of opening her hands]. It is a little chat with a
person who maybe can understand you, but in the end . . .’. Another patient felt it was childish. In another
study,81 a participant felt it was self-indulgent, and, in a final study,78 a participant simply had a preference
for other therapies. These findings were seen across only three studies of low to moderate quality.
More serious concerns included art therapy causing anxiety,72 increasing pain,72 and resulting in the
activation of emotions that were not resolved.73 In one study,73 a participant was also concerned that art
therapy may be harmful if the art therapist was not skilled. A final concern was that it may be harmful if
art therapy is suddenly terminated.73 These findings were seen across only two studies, both in patients
with cancer.
The provision of art therapy
Across several studies73,76,78,81 recommendations for art therapy were made. A participant in one study76
said that it was important that privacy be respected during art therapy. In addition, emotional support,73
a good relationship with the art therapist73,81 and that the art therapist should act as a guide73 were
suggested to be important aspects of art therapy. Suggested improvements for art therapy were made in
one study,78 including the need for further sessions of art therapy and for additional input from other
therapies, such as individual counselling.
Barriers to participation
Barriers to participation in art therapy were reported in three studies.72,79,80 Respondents commented that
they thought they were too ill to take part in the therapy,72 and in a further study respondents reported
that art therapy was restricted to people with certain medical conditions.80 Other barriers included a fear of
not being ‘good at art’80 and in two studies79,80 participants commented that a lack of understanding of art
therapy could be a barrier to participation. Figure 8 shows the overall synthesis of patients’ views regarding
the relative benefits, harm and acceptability of art therapy.
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Qualitative synthesis: evidence from service providers
Table 26 shows the service providers’ views regarding how art therapy was helpful (relative benefits).
Table 27 shows the service providers’ views regarding how art therapy was unhelpful (relative harms).
TABLE 26 Service providers’ views regarding how art therapy was helpful (relative benefits)
Synthesised finding – art therapy
is effective when:
Evidence source(s) [CASP
assessment of quality]
Certainty in
the evidence
Explanation of certainty in the
evidence assessment
Patients have time invested in them Turnbull (2002)81 [low] Low The finding was seen in only
one low-quality study
Patients like it/felt they benefited Turnbull (2002)81 [low] Moderate The finding was seen in only
two studies, of which one was
high qualitySharf (2004)
74 [high]
The therapist examines the effect of
art-making process on clients
Sharf (2004)74 [high] Moderate The finding was seen in only
one high-quality study
Clients can communicate through
artwork
Sharf (2004)74 [high] Moderate The finding was seen in only
one high-quality study
Art therapists help clients improve
their ability to manage anger
Sharf (2004)74 [high] Moderate The finding was seen in only
one high-quality study
It increases pride and self-esteem Sharf (2004)74 [high] Moderate The finding was seen in only
one high-quality study
Thoughts and feelings are expressed
more effectively
Sharf (2004)74 [high] Moderate The finding was seen in only
one high-quality study
Provides an opportunity for clients to
do something better with their time
Sharf (2004)74 [high] Moderate The finding was seen in only
one high-quality study
TABLE 27 Service providers’ views regarding how art therapy was unhelpful (relative harms)
Service providers reported that
art therapy was unhelpful when:
Evidence source(s) [CASP
assessment of quality]
Certainty in
the evidence
Explanation of certainty in the
evidence assessment
Administrative decisions led to poor
treatment outcomes
Sharf (2004)74 [high] Moderate These findings were seen in only
one high-quality study
The client lacks commitment or is
non-compliant
Sharf (2004)74 [high] Moderate
The client is resistant to art therapy Sharf (2004)74 [high] Moderate
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Table 28 shows the service providers’ views regarding the neutral effects of art therapy (neither harms nor
benefits)/acceptability.
Table 29 shows the service delivery recommendations from service providers.
TABLE 28 Service providers’ views regarding the neutral effects of art therapy (neither harms nor
benefits)/acceptability
Neutral effects of art therapy –
themes:
Evidence source(s) [CASP
assessment of quality]
Certainty in
the evidence
Explanation of certainty in
the evidence assessment
Lack of understanding of art therapy Turnbull (2002)81 [low] Low These findings were seen in
only one low-quality study
The art bit is irrelevant Turnbull (2002)81 [low] Low
Does not help everyone Turnbull (2002)81 [low] Low
Time back/pressure off Turnbull (2002)81 [low] Low
TABLE 29 Service delivery recommendations
Evidence source(s) [CASP
assessment of quality]
Certainty in
the evidence
Explanation of certainty in
the evidence assessment
Important considerations for art therapy:
A good relationship with the art
therapist/strong therapeutic
relationship
Turnbull (2002)81 [low] Moderate The finding was seen in only
two studies, of which one was
high qualitySharf (2004)
74 [high]
One-to-one contact Turnbull (2002)81 [low] Low The finding was seen in only
one low-quality study
Client commitment to recovery Sharf (2004)74 [high] Moderate The finding was seen in only
one high-quality study
Client to enjoy art therapy Sharf (2004)74 [high] Moderate The finding was seen in only
one high-quality study
Safe environment to express thoughts,
feelings and experiences
Sharf (2004)74 [high] Moderate The finding was seen in only
one high-quality study
Match techniques and materials
to clients
Sharf (2004)74 [high] Moderate The finding was seen in only
one high-quality study
To display artwork Sharf (2004)74 [high] Moderate The finding was seen in only
one high-quality study
Create art along with clients Sharf (2004)74 [high] Moderate The finding was seen in only
one high-quality study
Barriers to participation in art therapy. Service providers felt patients were not able to participate in art therapy
when:
Art therapists were not respected as
professionals by members of other
professional groups
Sharf (2004)74 [high] Moderate The finding was seen in only
one high-quality study
Suggested improvements. Service providers wanted:
Art therapist and other professionals
working together
Sharf (2004)74 [high] Moderate The finding was seen in only
one high-quality study
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Benefits of art therapy
In many ways the data from the two studies examining service provider views of art therapy mirrored those
of the patients. Service providers felt that art therapy was beneficial when patients have time invested in
them.81 One GP stated that ‘simply having the time to have somebody interested in them is therapeutic in
itself’.81 Service providers also felt that a good indicator of the benefit of art therapy was when the
patients say they like it or they felt they benefited.74,81 Art therapists felt that art therapy was most helpful
when the therapist examines the effect of art-making process with clients.74 Furthermore, it was seen as
beneficial when clients can communicate through artwork,74 when art therapists help clients improve their
ability to manage anger,74 when it increases pride and self-esteem,74 and when thoughts and feelings are
expressed more effectively.74 Finally, on a more practical level, art therapists felt that art therapy could be
beneficial when it provides an opportunity for clients to do something better with their time.74
Acceptability and potential harms of art therapy
Service providers made a number of observations about the acceptability and potential harms of art
therapy. According to the study that examined the perspectives of GPs referring patients to art therapy81
GPs, while not believing that art therapy could be harmful, do not regard it as beneficial either. In that
study, GPs referring patients to art therapy commented on a lack of understanding of art therapy,
reporting, ‘I don’t think I understood what the art bit was about’.81 They also suggested that the art part
of the therapy was irrelevant, stating ‘[I] thought it was about offering people an opportunity to discuss
things in therapy. If you or I went to a group we’d get something out of it’.81 They felt it was unlikely to
help everyone,81 and on a more practical note they felt that art therapy gave them with an opportunity
to take time back: ‘leaves me free for more medical care’.81 It should be noted that all of these neutral
findings were generated from only one study of low quality, which looked at the opinions of GPs referring
patients to art therapy and, therefore, cannot be generalised across other groups.
In terms of more serious detrimental effects of art therapy, Sharf74 reported findings from art therapists.
These potential harms included when administrative decisions lead to poor treatment outcomes, for
example when a client is not allowed to continue with art therapy; when the client lacks commitment or is
non-compliant; and when the client is resistant to art therapy.
The provision of art therapy (service delivery)
Both types of service providers (GPs and art therapists), like patients, felt that a good relationship with the
art therapist was important.74,81 GPs also reported that they felt the one-to-one contact was an important
aspect of the therapy.81 Art therapists also felt that client commitment to recover, the client’s enjoyment
of art therapy, providing a safe environment to express thoughts, feelings and experiences, matching
techniques and materials to clients, displaying artwork, and creating art along with clients were important
aspects of effective art therapy.74
Barriers to the provision of art therapy
Art therapists felt that their profession was not respected by members of other professional groups,74 and
that this created a barrier to patients being referred to art therapy. Art therapists went on to suggest that,
in situations where art therapists and other professionals were able to work together, improvements to
the service, patient outcomes and accessibility of art therapy were made. Figure 9 shows the overall
synthesis of service providers’ views regarding the relative benefits, harms and acceptability of art theraphy.
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Combining the quantitative and qualitative findings
Qualitative meta-synthesis was undertaken to provide added value to the quantitative analysis by indicating
patient issues around the acceptability of art therapy as a treatment for non-psychotic mental health
disorders. This section aims to synthesise the findings from the two reviews.
The findings from the quantitative review demonstrated that depression, anxiety, low mood, distress and
self-esteem were significantly reduced, and QoL and coping were significantly increased, relative to the
control group in one to six studies.48,52,58,59,61,62 Trauma was not significantly improved relative to the control
group despite an improvement from baseline in three studies.47–49 Cognition was not significantly improved
in the one study it was reported in.51 The findings of the qualitative review demonstrated that, overall, art
therapy was viewed as an acceptable treatment by patients and service providers, with relatively few
reports describing art therapy as unhelpful or unacceptable.
Some of the outcomes reported in the quantitative studies appear to map on to the qualitative findings
around the beneficial and, in a smaller number of cases, the harmful outcomes of taking part in art
therapy. Table 30 illustrates this mapping of outcomes from each review.
Findings from the qualitative review that appear to map on to the quantitative coping outcome include
both helpful and unhelpful qualitative findings. Self-esteem also mapped on to qualitative findings.
Quantitative outcome domains that mapped to a lesser extent to the qualitative findings were QoL,
distress, mood and anxiety (although in opposite directions). There was no qualitative evidence that
mapped specifically to the quantitative outcome domains of depression, trauma or cognition.
More in-depth synthesis of the findings of the two reviews was particularly challenging given that, despite
art therapy being defined as a complex intervention, the quantitative primary studies did not explore
the mechanisms of art therapy that may modify its effectiveness, such as therapist skill. However, the
qualitative review findings can help to elucidate the potential treatment effect modifiers identified in
the quantitative review, despite the fact that in most cases it was not possible to assess their effect on
outcomes. The potential treatment effect modifiers identified in the studies included, in the quantitative
review included, experience/qualification of the art therapist, individual versus group art therapy, age,
gender and pre-existing physical conditions.
Experience/qualification of the art therapist
The review of the quantitative evidence demonstrated that there was considerable variability in the
reporting of the accreditation of the therapist, although most studies were conducted by a person who
was seen be qualified as an art therapist. The findings of the qualitative review demonstrated that a good
relationship with the art therapist was reported as an important for art therapy to be helpful. Therefore,
it appears that the experience and skill of the art therapist may be an important mechanism of art therapy.
Individual versus group art therapy
The quantitative review reported that the majority of RCTs are of group art therapy, with only four of the
15 RCTs examining individual art therapy.49,55,56,62 Of the studies of individual art therapy, two49,62 did not
demonstrate an improvement on quantitative measures compared with the control group. Given that
the qualitative findings also pointed to the importance of relationships with other group members as a
particularly beneficial aspect of art therapy, with this finding seen in across several studies, an important
mechanism in art therapy may be the group setting.
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Pre-existing physical condition
The quantitative review highlighted that in nine studies patients had pre-existing physical
conditions.50,51,54–58,61,62 The remaining six studies were in people who were depressed,47,59 people with
PTSD,48,49 or older people.52,53 Neither the qualitative review nor the quantitative review found evidence
that the effectiveness or helpfulness of art therapy differed across patients with or without pre-existing
physical conditions. However, the qualitative review showed that a small number of themes appeared to
apply mainly to people with pre-existing physical conditions. These themes included the facilitation of an
improved relationship with family, friends and caregivers; facilitation of an understanding of the illness in
two studies,72,84 one of obesity and one of palliative care impatients; distraction from pain; distraction from
the illness/escapism; and providing the opportunity for legacy. These findings may have implications for
how art therapy is delivered to different populations to maximise beneficial effects.
Although age and gender were identified as potential treatment modifiers in the quantitative review,
neither review was able to demonstrate any evidence that these variables had an effect on quantitative
outcomes or patients’ perspectives and attitudes towards art therapy.
Discussion
Discussion of the qualitative review
The aim of the qualitative systematic review was to provide a detailed user perspective on the acceptability
and relative benefits and potential harms of art therapy. Overall, art therapy was viewed as an acceptable
treatment across the populations of participants studied.
A number of beneficial aspects of art therapy emerged, together with a relatively smaller number of
harmful aspects of art therapy, with relative harms being reported in only two studies.72,73 An important
theme emerging from the data was the relationship with the art therapist. This was raised as a positive
and beneficial aspect of art therapy but also as potentially harmful, and further as a recommendation for
service provision. A good relationship between the patient and art therapist was viewed as essential
for successful, effective art therapy. However, harm could be caused in situations in which a positive
relationship was not achieved, the therapist was viewed as unskilled, when emotions activated through
therapy could not be resolved or the therapist was suddenly unavailable through sudden termination of
the service. This finding was seen in evidence reported by patients and by service providers,74,81 who also
stressed the importance of a good therapeutic relationship.
Some themes, such as the importance of expression, the relationship with the art therapist and with
other group members and the facilitation of an increased understanding of self, were consistent across
populations, while a small number of themes appeared to apply to populations in which a diagnosis of
a pre-existing physical condition was present. These themes included the facilitation of an improved
relationship with family, friends and caregivers, identified in one study of a cancer population,72 facilitation
of an understanding of the illness in two studies (one of obesity84 and one of cancer73), distraction
from pain in one study of cancer,72 distraction from the illness/escapism in two studies of cancer
populations72,73 and one of an obesity population84 and providing the opportunity for legacy in a study
of a cancer population.72
Understanding and personal achievement were other important themes emerging from the evidence.
In addition, some barriers to participation were reported. A small number of participants also reported
that they did not want to take part in art therapy, which reiterates the importance of considering patient
preference in choice of treatment.14,15
The combination of the findings from the quantitative and qualitative reviews examined how outcomes
from the quantitative review mapped on to themes emerging from the qualitative review. This
demonstrated that a number of themes from the qualitative review appear to map on to the quantitative
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coping outcome. This included both helpful and unhelpful qualitative themes. Self-esteem also mapped on
to qualitative findings. Furthermore, the combining of the two reviews identified a number of mechanisms
within art therapy that may modify the effectiveness and acceptability of the treatment and should be
considered in further research and in the implementation of art therapy.
Limitations
Overall the evidence base was small (n= 12), with only two studies examining service provider views74,81
and, furthermore, only one of these74 examined art therapists’ views. The majority of the included studies
were of low or moderate quality. Limitations on word limits imposed by journals may have contributed to
this, as theses and grey literature provided better-quality evidence. Lack of rich data was the main limiting
factor relating to the qualitative evidence base.
Other significant limitations in the evidence base include the fact that the vast majority of studies reported
only positive findings. This may have been because of researcher bias, in that most of the authors of the
reports were art therapists,85 and the method of investigation in a number of studies appears to be biased
towards the reporting of positive findings.
There was a lack of evidence comparing art therapy with other treatment options; therefore, we are
unable to make comparisons regarding the acceptability of art therapy compared with other potential
treatments participants might be offered.
Combining the qualitative and quantitative data proved difficult because of the paucity of the evidence
base as a whole and the fact that meta-analysis was not possible. However, coping emerged as an
important factor across both reviews, and this is an outcome domain that is likely to be pertinent to people
with long-term health conditions. The small evidence base means it is not currently possible to make any
generalisations around age, gender or setting.
Conclusions
From the small number of qualitative studies identified, art therapy was reported to be an acceptable
treatment. The benefits associated with art therapy included the development of relationships with the
therapist and other group members, understanding the self/own illness/the future, gaining perspective,
distraction, personal achievement, expression, relaxation and empowerment. Small numbers of patients
reported varying reasons for not wanting to take part and therefore art therapy may not be a preferred
treatment option for everyone. A small number of cases highlighted potentially negative effects of art
therapy, which included the evoking of feelings that could not be resolved. Overall, there was low to
moderate certainty in the review findings.
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Chapter 4 Economic evaluation
This chapter addresses what the likely cost-effectiveness of art therapy in the treatment ofnon-psychotic mental health disorders is and will draw on the clinical effectiveness data presented
in Chapter 3.
Review methods
A systematic review was undertaken to identify existing economic analyses of the use of art therapy in the
treatment of non-psychotic mental health disorders specifically from the perspective of the NHS and
Personal Social Services. The purpose of this review was to identify, appraise and summarise published
models of cost-effectiveness and other evidence concerning the cost-effectiveness of art therapy in order
to inform our own modelling methodology.
Form of evaluation
The evaluation to be undertaken is that of a cost–utility analysis in order that the results presented can be
compared with interventions in other disease areas and be framed within the cost-effectiveness thresholds
[of £20,000–30,000 per quality-adjusted life-year (QALY)] reported by NICE.86 Ideally, RCTs would report
utility measures directly, but where this was not the case mappings from outcome measures reported to a
preference-based utility [such as the European Quality of Life-5-dimensions (EQ-5D) health instrument]
would be considered, as would using intermediate metrics to arrive at a utility value, such as mapping
from outcome A to outcome B, which could be mapped into a preference-based utility.
Comparators
The comparators are limited to those that have been included in a RCT and compared directly with art
therapy. This represents a limited selection of possible comparators, as any potential comparators that have
been trialled only against a control strategy would not be included. This decision has been taken for three
principal reasons: (1) the clinical profile of patients considered for art therapy is heterogeneous and thus
any estimated comparisons of effectiveness made indirectly through a common intervention could be
highly uncertain; (2) the position of art therapy may vary within packages of care which may affect the
observed efficacy; and, most importantly, (3) there are myriad treatments that could be considered which
would have resulted in a very large number of records identified in a literature search. The approach taken
was supported by the project steering group and resulted in the following potential set of comparators:
treatment as usual, wait-list control, CBT, verbal therapy, educational support, guided garden walking, art
and craft activities, regular programme activities, simple calculations and video tape on use of art therapy.
Search methods
The comprehensive searches from the quantitative and qualitative reviews of art therapy were designed to
capture relevant economic studies. Within these searches, synonyms relating to the condition were
combined with a search filter aimed at restricting results to economic and cost-related studies (used in the
searches of MEDLINE, CINAHL, EMBASE, and PsycINFO, with an amended version used for Web of Science;
see Appendix 2).
Screening and eligibility
All citations generated from the comprehensive searches (see Chapter 2) were reviewed by at least one
reviewer (LU or AS) and any studies reporting on costs or economics were flagged as potentially relevant
to the project health economic modellers. UK-specific citations were identified and the abstracts of these
were sifted to identify any potentially relevant economic evaluations for inclusion in the review. One
health economic modeller (AR) independently screened the relevant titles and abstracts. When there was
uncertainty in the decision, a second health economic modeller (MS) was consulted and a consensus
was obtained through discussion. Owing to the small number of papers identified from the title/abstract
DOI: 10.3310/hta19180 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 18
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Uttley et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
67
sift, a conservative strategy was employed that included papers for appraisal at full text if there were even
a small possibility that relevant data could be reported. Full papers of potentially relevant studies were
obtained and assessed by one modeller (AR), with discussion with a second modeller (MS) where
appropriate. In addition, the studies included in the review of clinical effectiveness were also appraised to
identify any potentially relevant economic information. A modified preferred reporting items for systematic
reviews and meta-analyses (PRISMA) diagram for the selection process is provided in Figure 10.
Inclusion and exclusion criteria
Studies were selected for inclusion according to predetermined eligibility criteria. Studies were included if
they reported the cost-effectiveness of art therapy using the definitions outlined in Chapter 1 of this
report. Owing to the dearth of evidence surrounding the cost-effectiveness of art therapy, studies were
also included if they investigated the costs incurred and health-related benefits accrued by the use of the
art therapy to treat patients with a diagnosed non-psychotic mental health illness and delivered by the NHS.
Studies that evaluated the cost-effectiveness of art therapy combined with any other therapy were
excluded, as were studies not published in the English language.
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FIGURE 10 Modified PRISMA flow diagram for the systematic review of cost-effectiveness.
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Results of the economic systematic review
Included studies: economic evaluation
Of the 10,270 total records, 192 records were identified by a systematic reviewer as potentially relevant to
the review of cost-effectiveness. Following a further title/abstract sift and subsequent full paper sift by
health economic modellers, only one study was considered as relevant that had not been included in the
clinical evidence base because it was not a RCT. A table of studies excluded at full text level is provided in
Appendix 5 along with the reason for exclusion. Although the identified study is not an economic
appraisal, it does investigate the costs incurred and health-related benefits accrued by the use of the
art therapy.87
Applying an economic checklist, such as that by Drummond et al.,88 was deemed inappropriate. A
considerable limitation of this case study is that it reports costs and outcomes over a 6-year period for only
a single patient, who had been receiving ‘other forms of psychological treatment for many years’. Six years
would be considered an extreme time period for receiving art therapy and it is unlikely that patients in the
NHS would receive treatment for this length of time. In addition, although 357 patients were recruited to
the full research study, the results for only one participant were reported, with no discussion of the impact
of selection bias on the results presented.
In total, the patient received 233 sessions of art therapy, each lasting 1.25 hours, over the 6-year period.
It was commented that the patient was receiving additional psychological therapy together with
pharmacological treatments at the time she started art therapy, but after 2 years of art therapy these
treatments were discontinued. Effectiveness was measured through two metrics, the Clinical Outcomes in
Routine Evaluation Outcome Measure89 and the BDI,90 both of which improved throughout the art therapy
and were maintained at 3 years’ follow-up.
The total cost of providing art therapy to this patient over the 6-year period was £7915 including salary
and trust overheads (assumed to be 2004 figures), which equates to approximately £34 per session or
£27 per hour. At the time of the study the authors state that the adult mental health cost per day was
£300 for an inpatient and thus the total cost of art therapy was equivalent to approximately 26 days’
hospital admission, although hospital admission data were not reported. In addition, the patient was
discharged from psychiatric outpatient therapy and stopped taking antidepressant medication, reducing
costs to the health service.
The conceptual model
As no existing models of art therapy were identified, a de novo model was constructed instead. The model
could be populated with data that had been identified in the clinical efficacy review but did not meet the
inclusion criteria for the cost-effectiveness review. Owing to the nature of the study question, it was
deemed that a complex model was not required and that a simple model would be sufficient and could
more clearly demonstrate the impact of key drivers within the cost-effectiveness ratio. As such, an area
under the curve model was developed to estimate the gain in utility with the following assumptions in the
base case:
1. the maximum treatment effect would be associated with the time at which treatment ended
2. there would be a linear increase in treatment effect, from zero at baseline to the maximum at the time
at which treatment ended
3. there would be a residual effect of treatment with a linear decline in benefit until there was zero
benefit at 52 weeks
4. given the short assumed duration of benefit, discounting was not necessary.
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The rationale for choosing 52 weeks as the base case duration of residual benefit was based on a number
of relevant references. Discussing data in Nicholson and Berman91 and in Lambert and Ogles,92 Cooper
wrote that ‘findings from the empirical research are fairly clear: clients, on average, do not tend to improve
once their therapy is over . . ., but equally they do not tend to deteriorate rapidly’.93 More recent data
provided in Sportel et al.94 (table 3) indicate that when Cognitive Bias Modification and Cognitive
Behavioural Group Training provided larger decreases in an outcome measure (the Spielberger Test Anxiety
Inventory95), the effect had not entirely waned at 12-month follow-up. This may be generalisable to other
forms of successful psychological therapy, and conservatively we elected to assume that all benefit
had dissipated at 52 weeks post treatment, although a longer period of 104 weeks was used in
sensitivity analyses.
The conceptual model used to calculate the utility gain across time is shown in graphical form in Figure 11.
In this figure it is assumed that there is a gain in utility of 0.0780 at week 8. The area under the curve
was then translated into QALYs assuming 52.18 weeks per year.
The estimate incremental costs of an intervention would be divided by the estimated incremental QALYs to
form a cost per QALY gained ratio.
Effectiveness data
The number of outcomes reported in the included RCTs was large but, given the aim of performing a
cost–utility analysis, few were deemed relevant. None of the RCTs identified included a preference-based
utility measure. To assess the applicability of the outcome measures, an online database (Health Economics
Research Centre database of mapping studies, Version 2, Health Economics Research Centre, Oxford.
Available at: www.herc.ox.ac.uk/downloads/mappingdatabase) reported by Dakin96 was used to identify
previously published mappings to the EQ-5D. Two outcome measures reported in the RCTs were shown to
be mapped on to EQ-5D: the SF-36, an outcome reported in Monti et al.,61 and the Barthel Index, an
outcome reported in Hattori et al.51 There were two published mappings from the SF-36: one by Ara and
Brazier97 and one by Rowen et al.98 Three mappings were found for the Barthel Index.99–101
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FIGURE 11 An illustration of the conceptual model of utility.
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However, in the Hattori et al.51 study, which was conducted in Japan, the Barthel index is reported for the
overall score only, and mapping to the EQ-5D would require the individual component scores. The authors
were contacted to enquire if the individual component data could be shared. However, the authors
declined owing to their intention to publish the data in a forthcoming publication (see Appendix 6).
The study that reported changes in SF-3661 was conducted in the USA and recruited 111 women. Included
patients had a breast cancer diagnosis (various stages) and were paired by age and randomised to either
an 8-week mindfulness-based art therapy group (n= 56) or a wait-list control group (n= 55). All
participants had a diagnosis of breast cancer and were recruited between 4 months and 2 years post
diagnosis. Women with a terminal diagnosis, or who had a current diagnosis of a major mood disorder,
psychotic disorder or significant cognitive deficit, were excluded. Those receiving any type of mental health
care could be included but had to obtain written permission from their treating health professional to
enter the study.
These data could be used to estimate a change in EQ-5D, albeit with the caveat that the patient group
may not be representative of those who are treated with art therapy in England and Wales. The changes in
the SF-36 scores are provided in Table 31. Only those variables that have been used in the mapping
algorithms have been reported. It is noted that the data for physical role and emotional roles at week 8 are
medians (and change in the median) as a result of the non-normality of the data. However, there appears
to be a discrepancy in the results for the physical role scale, as the values reported at weeks 0 and
8 indicate a change of 25 across the 8-week period [(50 – 0) – (25 – 0)]. For this report we have assumed
that the values of zero reported in change between art therapy and wait-list are correct, which would
appear unfavourable to art therapy. A further caveat regarding the reliability of these efficacy data is that
only women with values at baseline (week 0) and at end of treatment (week 8) were included in the
analysis, with no imputation for missing data. There were 11 dropouts in the art therapy arm and seven
dropouts in the control arm. If these reported dropouts were not random but related to lack of (perceived)
efficacy, then it is possible that the reported results favour art therapy.
Table 32 provides estimates of the utility gain associated with art therapy compared with control in the
Monti et al.61 study, assuming the deterministic values of change in each SF-36 scale provided in Table 31.
In the Ara and Brazier97 paper, the authors state that ‘we advocate model EQ(1) as the first choice for
predicting mean EQ-5D scores from mean dimension SF-36 scores when patient level data are not available.
TABLE 31 The medical outcomes SF-36 data reported by Monti et al.61
SF-36 scale
Wait-list control arm Art therapy arm
Change over the
8-week period Difference in change (art
therapy – wait-list control)
over an 8-week period
(95% confidence interval)Week 0 Week 8 Week 0 Week 8
Wait-list
control
Art
therapy
Physical
functioning
64.37 64.42 58.23 65.01 0.05 6.78 6.73 (–13.8 to 0.37)
Social
functioning
60.04 64.91 51.22 66.60 4.87 15.38 10.51 (–20.9 to –0.10)
Physical rolea 0.00 25.00 0.00 50.00 25.00 50.00 0.00
Emotional role 33.33 66.67 33.33 66.67 33.34 33.34 0.00
Mental health 64.91 67.07 56.90 69.95 2.16 13.05 10.89 (–16.8 to –4.96)
Vitality 42.63 42.91 40.26 50.06 0.28 9.80 9.52 (–16.7 to –2.37)
Bodily pain 58.14 58.74 54.23 60.14 0.60 5.91 5.31 (–14.1 to 3.50)
General health 55.78 55.19 47.13 55.09 –0.59 7.96 8.56 (–14.8 to –2.29)
a For discussion of the inconsistency in this scale see main text.
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Nevertheless, when comparing incremental differences between study arms or changes over time, model
EQ(4) is the preferred choice’. Ideally, we would therefore use EQ(4) from Ara and Brazier,97 which is a
linear regression, with the independent variables being the eight scales of the SF-36 (as shown in Table 31)
and the following additional variables: age, physical functioning,2 social function,2 mental health2 and
bodily pain.2
However, Monti et al.61 provide confidence intervals (CIs) only for the relative changes between art therapy
and wait-list control and not for individual components at 8 weeks, which meant that evaluation of the
uncertainty in the reported results could be undertaken only where the absolute values did not affect the
estimation. EQ(1) does not rely on the absolute values and was, therefore, chosen for use in this report.
The same logic was used to select generalised least squares model 1 from the Rowen et al.98 paper,
which was marginally inferior to models 2 and 3, in terms of R2, but did not rely on absolute values.
An additional reason for selecting a model with a parsimonious number of variables is because of the
uncertainty in the physical and emotional role data presented by Monti et al.,61 which could have a greater
influence on the estimated values when variables interact or have polynomial forms.
The coefficients associated with changes in SF-36 scores in Ara and Brazier97 and Rowen et al.98 are shown
in Table 32. To allow a comparison to be made more easily, the coefficients from Rowen et al.,98 which
were based on SF-36 scores that ranged from 0 to 100, have been divided by 100 to be concordant with
the results of Ara and Brazier, which were based on SF-36 scores ranging from 0 to 1.
The estimated gain in EQ-5D within the Monti et al.61 RCT is shown in Table 33. The Monti et al. paper
also reported change in the SCL-90-R and its summary score, the GSI.102 This was associated with a
positive effect on the GSI with a decrease of 0.16 (95% CI 0.08 to 0.24). Thus, an inference regarding the
impact of a changed GSI on utility can be calculated, which is also shown in Table 33.
TABLE 32 The coefficients mapped gain in EQ-5D associated with the Monti et al.61
SF-36 scale
Source of mapping equation and selected model
Ara and Brazier97 – EQ(1) Rowen et al.98 – GLS 1a
Physical functioning 0.00370 0.00332
Social functioning 0.00110 0.00115
Physical rolea 0.00024 –0.00060
Emotional role 0.00024 0.00010
Mental health 0.00256 0.00237
Vitality –0.00063 –0.00039
Bodily pain 0.00286 0.00303
General health 0.00052 0.00169
EQ, equation; GLS, general least squared.
a Divided by 100 to be appropriate for SF-36 scores ranging from 0 to 100, rather than 0 to 1.
TABLE 33 The estimated mapped gain in EQ-5D score associated with the Monti et al.61 RCT
Estimated utility gain
Source of mapping equation and selected model
Ara and Brazier97 – EQ(1) Rowen et al.98 – GLS 1
Associated with art therapy compared with wait-list 0.0780 0.0871
Associated with a unit decrease in GSI 0.4873 0.5422
EQ, equation; GLS, general least squared.
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Making such an inference allows RCTs that report the GSI from the SCL-90-R as an outcome measure to
be considered within the evidence base; however, this will increase the uncertainty within the results.
The only RCTs in which GSI data from the SCL-90-R were presented in an appropriate form were by
Thyme et al.47,62 The outcome measures recorded in these studies were also used to try and broaden the
evidence base, as inferences on the change in EQ-5D could be made for changes in the BDI-II, the
Hamilton Rating Scale of Depression, the Impact of Event scale and the Structural Analysis of Social
Behaviour. However, no further RCTs could be linked into the evidence network. This meant that a cost
per QALY estimate could be estimated only for art therapy compared with wait-list control and the
comparators in the Thyme et al.47 and Thyme et al.62 RCTs, which were psychodynamic art therapy and
control respectively.
The Thyme et al.47 study compared short-term psychodynamic art therapy and short-term psychodynamic
verbal therapy, henceforth shortened to art therapy and verbal therapy. The RCT was conducted in
Sweden and recruited 44 women. At recruitment, 28 (63.6%) study participants were diagnosed with
dysthymic disorder and 16 (36.4%) study participants had depressive symptoms and difficulties. One
participant withdrew before randomisation, resulting in a final study population at randomisation of
43 women (n= 21, art therapy; n= 22, verbal therapy). Of these, 39 women completed the study (n= 18,
art therapy; n= 21, verbal therapy).
The reported results are potentially confounded by concomitant treatment. Two participants in the verbal
therapy group ‘accepted body awareness as an additional treatment during psychotherapy’,47 compared
with none in the art therapy arm, and the mechanism by which these women were to be offered body
awareness is unclear. In addition, the use of antidepressants may differ between arms, as the text is
unclear: ‘In the [art therapy] group, one participant were [sic] prescribed antidepressants during therapy
(n= 1) and one between termination of therapy and the 3-month follow-up (n= 1), and in the [verbal
therapy] group three during therapy (n= 1) [sic] and two after (n= 2).’47 Data from women who dropped
out of the study (n= 2, art therapy; n= 1, verbal therapy) or who were referred to long-term art
psychotherapy (n= 1, art therapy; n= 0, verbal therapy) were not included in the analysis, which may add
uncertainty to the results. It is noted that as two active interventions were trialled no inference could be
made with respect to the relative efficacy compared with no treatment.
The Thyme et al.62 RCT comparing individual art therapy with control was conducted in Sweden and
recruited women with breast cancer (n= 20 in the art therapy group; n= 22 in the control group).
Candidates were excluded if they had a pre-existing physical or psychiatric illness. Additional treatments
were permitted and this, again, may confound the results. At baseline, four participants in the art therapy
arm and three participants in the control arm were using antidepressants. Two months later, only two
participants in the art therapy arm were using antidepressants, and at 4-month follow-up (6 months after
baseline) only one participant was taking antidepressants; in contrast, all three participants in the control
arm remained on antidepressants. The results presented were based on a total of 41 women, 20 from the
art therapy group and 21 from the control group. Data for one participant in the control arm were
incomplete and were discarded; this may bias the results against art therapy if the reason for the data
being incomplete was related to a worsening of the underlying condition.
The GSI data from Thyme et al.47 and Thyme et al.62 are provided in Table 34. It is noted that these will
have increased uncertainty owing to an assumed relationship between GSI and the utility mapped from
the SF-36 and may also be confounded by the use of adjunct treatments. It is seen that verbal therapy
appears better than art therapy, as the difference in GSI increased by 0.23, with a decline of 0.07 at
4-month follow-up. Such a pattern was not replicated in the Thyme et al.62 RCT where the gain
(a reduction in GSI) was slight, being an additional 0.04 at the end of therapy; however, this benefit
had increased 3 months later by an additional 0.07.
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Thyme et al.47 provided standard deviations for the GSI scores, which allow the CIs to be calculated for the
change in GSI score between verbal therapy and art therapy. These calculations are undertaken in Table 34,
with the conclusion being that there is significant uncertainty regarding which therapy is more effective.
Using the assumed relationship between GSI and utility detailed in Table 34, and using data from
Thyme et al.,62 it can be estimated that, at the end of treatment, art therapy compared with control
was associated with a utility gain of 0.019, using the Ara and Brazier97 mapping, or 0.022, using the
Rowen et al.98 mapping. These values are considerably lower than those calculated from Monti et al.61
A discussion of the possible reasons for this is provided later. The estimated utility gain of verbal therapy
over art therapy in Thyme et al.47 was larger: 0.112 using the Ara and Brazier97 mapping and 0.125 using
the Rowen et al.98 mapping.
The process described has allowed evidence from three RCTs to be considered, although there are
caveats regarding the mappings, the study population and the small sample sizes, all of which increase the
uncertainty in our results. At the project outset it was envisaged that there would be sufficient evidence to
be able to undertake a network meta-analysis; however, this was not facilitated by the evidence because
of the lack of comparable data from outcome measures used in the RCTs. A possible solution to the
problem of not all studies reporting the same outcome measure would be to perform a multivariate
network meta-analysis. This would allow strength to be borrowed about the effect on each outcome
measure, allowing for correlation within and between studies. Such an analysis would require each
outcome measure to have been reported alongside at least one other outcome measure and external
evidence with which to estimate the within study correlation. In the event, this was not possible because
the outcome measures were not collected as required. Nevertheless, such an analysis would still have been
beyond the scope of the project.
The three RCTs will be modelled distinctly rather than meta-analysed, with scenario analyses undertaken
where appropriate.
Given the modelling of the three RCTs individually, it is important that the costs accrued within the RCTs
are established, as these must be linked to the observed benefits. Assuming that the benefits would be
maintained with a different ratio of therapists to patients, different numbers or duration of sessions or a
different grade of therapist would be naive. Therefore, the anticipated costs assuming each regimen in the
RCT is delivered in the NHS needs to be estimated. These costs are detailed for each of the three RCTs.
Costs associated with the Monti et al.,61 Thyme et al.47 and Thyme et al.62
randomised controlled trials
Only the costs of art therapy have been included in the analyses. Any effect on other costs, for example
that of prescription medication hospitalisations or specialist care, has been excluded, owing to the lack of
robust data.
The costs presented are estimated on the assumption that those receiving group art therapy remain in the
group until the end of the sessions, even were there to be regular non-attendance. It was assumed that
TABLE 34 The global severity index values reported in Thyme et al.47 and Thyme et al.62
Baseline
At completion
of treatment At follow-upa
Reported difference in GSI score associated with art therapy compared
with verbal therapy (Thyme et al.47)
0.10 0.33 0.26
Reported difference in GSI score associated with art therapy compared
with control (Thyme et al.62)
–0.04 –0.08 –0.15
a Four months in Thyme et al.62 and 3 months in Thyme et al.47
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those receiving individual treatment who did not attend still incurred the cost of attendance, as the art
therapist would be required to be present. If these assumptions were relaxed, it is anticipated that the cost
per patient could decrease, although the impact on effectiveness in group therapy because of a higher
ratio of participants to therapists would be unknown.
Monti et al.61
The RCT ran for 16 months and resulted in seven intervention groups and seven control groups: those
allocated to wait-list control were offered art therapy 8 weeks later than those randomised to the art
therapy arm. This RCT design meant that comparative data were valid only for the period of 8 weeks
before the control group received art therapy.
As 56 patients received art therapy and there were seven groups, it can be calculated that the group size
was eight, although not all patients attended all eight sessions (median number of sessions attended
was six). The groups were led by a single study investigator who was a registered art therapist and each
lasted for 2.5 hours, resulting in 20 hours per treatment course.
Two estimates were made regarding the costs of replicating the Monti et al.61 art therapy treatment in
England and Wales. In addition to standard unit costs reported in Curtis,103 it was deemed worthwhile
exploring if any art therapy-specific costs were available. Our clinical advisors sought information from the
BAAT, which provided estimated figures which were used in addition to those reported by Curtis. The first
estimate from BAAT was £72 per hour (Val Huet, BAAT, 2014, personal communication), whereas the
second estimate used a cost of £99 reported by Curtis.103 The latter estimate is a cost for delivering CBT
and is likely to be an overestimate, as it assumes a clinical psychologist at band 8, at which grade few
art therapists are employed. However, the costs from Curtis103 were used in a sensitivity analysis. The
estimated costs of the art therapy course conducted in Monti et al.61 were £1440 using the BAAT estimate
and £1980 using the Curtis103 estimate. Assuming eight women per course, this would equate to cost per
woman of £180 (BAAT) or £247.50 (Curtis103).
Thyme et al.47
The art therapy intervention consisted of 10 sessions each lasting 60 minutes; these sessions were
delivered by two experienced art psychotherapists. The verbal therapy intervention consisted of 10 sessions
each lasting 45 minutes; these sessions were delivered by three experienced verbal psychotherapists,
although one withdrew from the study as a result of illness and was not replaced (the time at which this
occurred was not reported within the paper). For calculation of the costs of verbal therapy we have
assumed that the illness occurred midway through the intervention and have assumed 2.5 therapists.
Assuming a cost of £72 per hour per art therapist, it is estimated that the cost of the art therapy
intervention was £1440 (£72 × 2 × 10 × 1); if a value of £99 per hour was used instead, this cost rose to
£1980. Assuming that there were 18 women within the art therapy group, to align with the outcome
data, these would equate to costs of £80 or £110 per participant.
Assuming a cost of £72 per hour per verbal therapist, it is estimated that the cost of the verbal therapy
intervention was £1350 (£72 × 2.5 × 10 × 0.75); if a value of £99 per hour was used instead, this cost rose
to £1856. Assuming that there were 21 women within the verbal therapy group, to align with the
outcome data, these costs would equate to £64 or £88 per participant.
Thyme et al.62
The Thyme et al.62 RCT assessed the effectiveness of an individual brief (5-week) art therapy intervention
compared with a control group in women with breast cancer. The duration of the session was not
reported; therefore, a clear estimate of the cost could not be provided. As a lower bound, if the session
was assumed to be 1 hour in duration, this would result in the participant receiving 5 hours of an art
therapist’s time and would be costed at £360 per participant (assuming £72 per hour) or at £495 per
participant (assuming £99 per hour).
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Evaluation of the robustness of results reported in Monti et al.,61 Thyme et al.47
and Thyme et al.62
An assessment of the clinical methodology used within each of the three RCTs that provide an estimate
of utility differences has been undertaken in order to evaluate the robustness of the reported results. All of
the three studies had limitations, but the Thyme et al.47,62 RCTs were shown to have the most potential
confounding and uncertainty in the true effect size.
The report by Monti et al.61 does not offer a discursive description of the working art therapy definition
used for the trial, but it contains a table showing the linking of the mindfulness aspects with the art
therapy which provides a clear indication of what was being tested.
The comparison between verbal therapies and art therapy reported in Thyme et al.47 may be problematic.
The verbal psychotherapy treatment follows the long-established ideas of Mann104 on brief structured
psychotherapy. Mann is clear about structure and about significant aspects of brief therapy. In contrast,
the range of art therapy literature cited (Cane,105 Waller and Gilroy,106 Betensky107 and Schaverien108)
represent very different approaches to art therapy. One chapter in one of these four books contains some
speculative ideas about brief work,106 but brief work is not mentioned in the rest. The differences between
the art therapy approaches cited are evident in the apparently unconnected, somewhat prescriptive, tasks
the women in the group are asked to undertake. This is in contrast to the relative coherence of Mann’s
ideas for brief work,104 which are sometimes used, incidentally, by art therapists. In addition, the results
may be confounded by the imbalances between the trial arms in the numbers of patients with borderline
personality organisation (BPO), receiving adjunct antidepressants and receiving adjunct body awareness
treatment. It was seen that four (22%) participants receiving art therapy had BPO compared with three
(14%) receiving verbal therapy. A smaller proportion of participants were using antidepressants in the
art therapy group [11% (n= 2)] than in the verbal therapy group [14% (n= 3)]. Potentially of more
importance was the fact that 10% (n= 2) of participants in the verbal therapy group also received body
awareness treatment, compared with no participants in the art therapy group. These factors raise concerns
regarding whether or not the results are confounded, particularly as the sample size in the study is small.
However, the authors do state that ‘the results indicated that the variables did not distort the main results
of the study. Neither did the interviews that were performed after the psychotherapy and at 3-month
follow-up disclose any major changes in the participants’ life that could explain our results.’104
The art therapy intervention in the Thyme et al.62 RCT appeared more clearly structured and described
than the Thyme et al.47 RCT. It is believed that the structure of the treatment programme (individual and
for only five sessions) was because of logistical reasons; however, this may present limitations in the
generalisability of the results. It was observed, in contrast to Monti et al.61 and Thyme et al.,47 that
benefits increased after cessation of treatment. It is unclear whether or not this benefit is related to
the shorter duration of treatment. While the Thyme et al.47 RCT does provide data that can be used in the
cost-effectiveness analyses, it is believed that conclusions produced from these should be interpreted
with caution.
Methodology for producing results
Results were produced deterministically using the mean value for each parameter, with a number of
scenario analyses undertaken. These included use of the Rowen et al.98 and the Ara and Brazier97 mapping
functions, extending the duration of response to 2 years and using cost estimates from BAAT and
from Curtis.103
Probabilistic results were generated by sampling from appropriate distributions. These included the relative
effects reported by Monti et al.61 in the SF-36 dimensions used in the mapping, and the relative effect
of art therapy compared with verbal therapy in the Thyme et al.47 RCT. Scenario analyses were also
conducted for the probabilistic results.
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As no correlation parameters were reported in the RCTs, it was assumed that all parameters were
independent. This would not be the case between the measures of SF-36 and GSI recorded in Monti et al.,61
which are, it was assumed, likely to be highly correlated. However, for simplicity, we assumed that the GSI
effect was constant and recalculated the relationship of GSI and utility when the effects of art therapy on the
SF-36 dimensions were sampled.
To estimate the uncertainty in the Thyme et al.47 results, the width of the CI of the mean effect was
estimated using the number of participants and the reported standard deviations before therapy and on
completion of therapy through a t-test. There were an estimated 34 degrees of freedom for the art
therapy arm and 38 degrees of freedom for the verbal therapy arm. The CI of the mean was used to
estimate a standard error of the mean.
Probabilistic results were not undertaken for the Thyme et al.62 scenario, as there were no data to quantify
uncertainty about parameters.
Conducting probabilistic sensitivity analyses (PSAs) allows a quantification of uncertainty in the output:
1000 PSA samples were evaluated. This has been displayed in a number of ways. Initially, the range
in the mean cost per QALY gained was estimated using a percentile method. Then a cost-effectiveness
acceptability curve (CEAC) was generated.109 The CEAC provides the probability of each intervention being
optimal at different cost per QALY thresholds. Furthermore, a jackknifed estimate was performed to assess
whether sufficient probabilistic samples had been run to determine the mean cost per QALY.110 Finally, a
histogram of the estimated utility gain was constructed.
Table 35 provides summary statistics for the distributions within the model. For all parameters, a normal
distribution has been assumed, although it is acknowledged that at extreme samples, non-credible utility
gains greater than 1 could be generated. This limitation was deemed to have minimal impact on the
results given the predicted changes in utility provided in Table 34.
TABLE 35 Summary statistics for the distributions used in the probabilistic analyses
Parameter Mean value 2.5th percentile 97.5th percentile
Utility gain in the Monti et al.61 RCT of art therapy compared
with wait-list controla
0.078 0.034 0.119
Utility gain in the Monti et al.61 RCT of art therapy compared
with wait-list controlb
0.087 0.043 0.126
Relationship between one unit decrease in GSI and utility
gain (using Ara and Brazier97)
0.485 0.212 0.744
Relationship between one unit decrease in GSI and utility
gain (using Rowen et al.98)
0.542 0.271 0.790
GSI decrease of verbal therapy compared with art therapy in
the Thyme et al.47 RCT
0.235
(verbal therapy
more effective)
–0.270
(art therapy
more effective)
0.721
(verbal therapy
more effective)
Derived utility gain in the Thyme et al.47 RCT of verbal therapy
compared with art therapy (using Ara and Brazier97)
0.114 –0.145 0.386
Derived utility gain in the Thyme et al.47 RCT of verbal therapy
compared with art therapy (using Rowen et al.98)
0.127 –0.160 0.426
a Having sampled from the SF-36 dimensions and mapped to utility using the Ara and Brazier97 algorithm.
b Having sampled from the SF-36 dimensions and mapped to utility using the Rowen et al.98 algorithm.
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In addition, a threshold analysis has been conducted to ascertain the likely level of gain in utility that
would be required for art therapy, as typically used in England and Wales, to be deemed cost-effective
using thresholds of £20,000 and £30,000 per QALY gained. To undertake this analysis, assumptions
regarding the likely cost, and likely durations of treatment and residual benefit were required. While it is
acknowledged that there is a spectrum of needs and treatments, it was believed that the majority of
patients would be treated in either an art therapy outpatient group or a community recovery setting, with
only a small proportion needing more expensive treatment. Using data from the BAAT, it was assumed
that typical treatment would be of 42 sessions over a 52-week period and with a cost per patient of £750.
Analyses were run using an assumed residual benefit of either 52 or 104 weeks.
Results
The focus of this section is on the results generated using the data reported in the Monti et al.61 RCT.
Exploratory analyses using the data reported in Thyme et al.47 and Thyme et al.62 are reported, but these
should be viewed with caution given the limitations within these trials.
Primary results
The deterministic results from Monti et al.61 are shown in Table 36. It is seen that in all cases art therapy
had a cost per QALY gained of less than £6000, providing an indication that art therapy is highly cost-
effective compared with wait-list control using thresholds of either £20,000 or £30,000 per QALY gained.
Probabilistic results are provided in Table 37. These are very similar to the deterministic results, with the
discrepancy caused by Monte Carlo sampling error. The jackknifed mean costs per QALY values had small
CIs, indicating that 1000 PSA samples were sufficient. The CEAC for the scenario least favourable to art
therapy is provided in Figure 12, with a histogram of the utility gain in this scenario provided in Figure 13.
TABLE 36 Deterministic results from Monti et al.:61 art therapy versus wait-list control
Duration of
residual benefit
Costing
source
Using the Ara and Brazier97 mapping Using the Rowen et al.98 mapping
Incremental
costs (£)
Incremental
QALY
Cost per
QALY (£)
Incremental
costs (£)
Incremental
QALY
Cost per
QALY (£)
52 weeks BAAT 180 0.0448 4015 180 0.0501 3595
52 weeks Curtis 248 0.0448 5520 248 0.0501 4943
104 weeks BAAT 180 0.0837 2151 180 0.0935 1926
104 weeks Curtis 248 0.0837 2957 248 0.0935 2648
TABLE 37 Probabilistic results from Monti et al.:61 art therapy versus wait-list control
Duration
of residual
benefit
Costing
source
Using the Ara and Brazier97 mapping Using the Rowen et al.98 mapping
Incremental
costs (£)
Incremental
QALY
Cost per QALY
(£) (95% CI)
Incremental
costs (£)
Incremental
QALY
Cost per QALY
(£) (95% CI)
52 weeks BAAT 180 0.0447 4031
(2628–9202)
180 0.0499 3610
(2477 to 7229)
52 weeks Curtis 248 0.0447 5542
(3613–12,653)
248 0.0499 4963
(3405 to 9940)
104 weeks BAAT 180 0.0834 2159
(1408–4930)
180 0.0931 1934
(1327 to 3873)
104 weeks Curtis 248 0.0834 2969
(1936–6779)
248 0.0931 2659
(1824 to 5325)
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FIGURE 12 The cost-effectiveness acceptability curve for the Monti et al.61 RCT, mapping from Ara and Brazier97
and assuming 52 weeks’ residual benefit and costs per patient from Curtis.103
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FIGURE 13 A histogram of the utility gain of art therapy compared with wait-list estimated from the Monti et al.61
RCT, mapping from Ara and Brazier97 and assuming 52 weeks’ residual benefit and costs per patient from Curtis.103
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It is seen that even with the scenario least favourable to art therapy there is a high probability of art
therapy being optimal assuming a cost per QALY threshold of £10,000.
It is seen that, in the vast majority of cases, art therapy resulted in a QALY increase, although in one
sample (0.1% of all samples) it was estimated that art therapy could have a detrimental effect. This is
shown on the far left of the graph and is coloured black. Typically the gain in QALYs was between 0.035
and 0.050.
Estimating the utility gain required at 52 weeks in order for art therapy,
as employed in England and Wales, to be deemed cost-effective
The estimated utility gain required at 52 weeks in order for art therapy to be cost-effective is given
in Table 38.
It is estimated that the largest utility gain required would be below 0.04. This compares favourably with
the values reported in the Monti et al.61 RCT (reported in Table 33), which are estimated to be in excess of
0.075, although this value was generated in a group of women with breast cancer and the generalisability
to a population with non-psychotic mental health disorders is not known. Thus, it is plausible that art
therapy, as used in England and Wales, is a cost-effective use of resources compared with no treatment.
Exploratory results
Thyme et al.47
The deterministic results from Thyme et al.47 are shown in Table 39. It is seen that in all cases verbal
therapy was estimated to dominate art therapy, in that it is cheaper and more efficacious. However, as will
be detailed, there is considerable uncertainty in these results.
Probabilistic results are provided in Table 40. These are very similar to the deterministic results. The
jackknifed mean costs per QALY values had small CIs indicating 1000 PSA samples were sufficient.
Although the mean cost per QALY value looks considerably favourable to verbal therapy in all scenarios
the 95% CIs indicate that art therapy may have a cost per QALY gained compared with verbal therapy of
less than £300.
The CEAC for the scenario least favourable to verbal therapy is provided in Figure 14, with a histogram of
the utility gain in this scenario provided in Figure 15.
It is seen that there is considerable uncertainty in the optimal decision, with art therapy being optimal in
20% of the PSA evaluations. As there is little difference in the cost of these interventions, this uncertainty
is caused solely by uncertainty in which treatment is the most efficacious, as shown in Figure 14. In
addition, limitations within the Thyme et al.62 RCT would increase the uncertainty of the results.
It is seen that there is considerable uncertainty in the results regarding whether art therapy or verbal therapy
is more efficacious. The bars coloured black and white indicate where art therapy is estimated to be more
efficacious, with those in green indicating where verbal therapy is estimated to be more efficacious. The
analyses of uncertainty indicate that further research is required before a definitive statement could be
made, and it is commented that the data presented may be confounded (see Chapter 2).
Thyme et al.62
The deterministic results from Thyme et al.62 are shown in Table 41. It is seen that the cost per QALY is
much higher than in the Monti et al.61 RCT, reflecting both an increased cost (as would be expected in
individual therapy) and a reduced effectiveness. Only where the cost per patient was low and residual
benefit high was the cost per QALY below £20,000.
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TABLE 39 Deterministic results from Thyme et al.:47 verbal therapy versus art therapy
Duration
of residual
benefit
Costing
source
Using the Ara and Brazier97 mapping Using the Rowen et al.98 mapping
Incremental
costs (£)
Incremental
QALY
Cost per
QALY (£)
Incremental
costs (£)
Incremental
QALY
Cost per
QALY (£)
52 weeks BAAT –16 0.0666 Dominated –16 0.0744 Dominated
52 weeks Curtis –22 0.0666 Dominated –22 0.0744 Dominated
104 weeks BAAT –16 0.1224 Dominated –16 0.1367 Dominated
104 weeks Curtis –22 0.1224 Dominated –22 0.1367 Dominated
Dominated means both more expensive and less efficacious.
TABLE 40 Probabilistic results from Thyme et al.:47 verbal therapy versus art therapy
Duration of
residual
benefit
Costing
source
Using the Ara and Brazier97 mapping Using the Rowen et al.98 mapping
Incremental
costs (£)
Incremental
QALY
Cost per
QALY (£)
Incremental
costs (£)
Incremental
QALY
Cost per
QALY (£)
52 weeks BAAT –16 0.0675 Dominating
(dominating –
183a)
–16 0.0757 Dominating
(Dominating –
99a)
52 weeks Curtis –22 0.0675 Dominating
(dominating –
251a)
–22 0.0757 Dominating
(Dominating –
136a)
104 weeks BAAT –16 0.1241 Dominating
(dominating –
168a)
–16 0.1391 Dominating
(Dominating –
91a)
104 weeks Curtis –22 0.1241 Dominating
(dominating –
230a)
–22 0.1391 Dominating
(Dominating –
125a)
Dominated means both more expensive and less efficacious.
a These values represent cost per QALY lost and as such these upper bound values indicate art therapy is more
cost-effective than verbal therapy.
TABLE 38 Assumed utility gain required for art therapy, as delivered in England and Wales, to be deemed
cost-effective
Duration of residual benefit
Assumed cost per QALY threshold
£20,000 £30,000
52 weeks 0.038 0.026
104 weeks 0.026 0.017
DOI: 10.3310/hta19180 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 18
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Uttley et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
81
Art therapy
Verbal therapy
Cost per QALY gained threshold (£000)
Pr
o
b
ab
ili
ty
 o
f 
b
ei
n
g
 o
p
ti
m
al
1.0
0.8
0.6
0.4
0.2
0.0
0 5 10 15 20 25
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FIGURE 15 A histogram of the utility gain of verbal therapy compared with art therapy estimated from the
Thyme et al.47 RCT, mapping from Ara and Brazier97 and assuming 52 weeks’ residual benefit and costs per patient
from Curtis.103
TABLE 41 Deterministic results from Thyme et al.62 evaluating benefits at 5 weeks
Duration of
residual
benefit
Costing
source
Using the Ara and Brazier97 mapping Using the Rowen et al.98 mapping
Incremental
costs (£)
Incremental
QALY
Cost per
QALY (£)
Incremental
costs (£)
Incremental
QALY
Cost per
QALY (£)
52 weeks BAAT 360 0.0106 33,811 360 0.0119 30,275
52 weeks Curtis 495 0.0106 46,490 495 0.0119 41,628
104 weeks BAAT 360 0.0204 17,681 360 0.0227 15,832
104 weeks Curtis 495 0.0204 24,311 495 0.0227 21,769
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A further exploratory analysis was undertaken assessing the change in the cost per QALY should the
increased benefits shown at 4 months’ follow-up be included. In this scenario, a linear gain to 21 weeks
was assumed before the residual benefit was assumed. These results are shown in Table 42. In this
analysis, the cost per QALY values are markedly reduced and never rise above £15,000.
Owing to the method of data reporting, PSA was not performed on the analyses relating to the
Thyme et al.62 RCT.
Value of information analyses
Value of information analyses were not undertaken as these would be specific to the RCT being evaluated
and could easily be misleading. For example, in the analysis of the Monti et al.61 RCT there is little
uncertainty that art therapy appears more cost-effective than wait-list control. Undertaking expected value
of perfect information analysis111 would indicate that further research would not represent cost-effective
use of resources. However, there are significant differences, particularly in terms of duration between the
art therapy undertaken in the Monti et al.61 RCT and that which is employed in England and Wales.
The same is true of the art therapy techniques used in Thyme et al.47 and Thyme et al.62 Currently, there
are very few data, if any, on the cost-effectiveness of art therapy as used in England and Wales, and a
well-conducted RCT is required to establish the likely cost-effectiveness of art therapy in this setting. While
it may be possible to elicit values from experts, this is subject to limitations and was outside the scope of
the project.
Discussion
Discussion of the economic evaluation
The primary analyses indicate that art therapy as delivered in the Monti et al.61 RCT may be highly
cost-effective compared with wait-list but the generalisability of this study to patients in England and
Wales is unknown, as the population consisted of women with breast cancer and the percentage with a
non-psychotic mental health disorder was unknown. Confirmatory studies would be required to establish
this definitively. An analysis of the effectiveness, in terms of utility gain that would need to be produced
for art therapy as used in England and Wales, to be cost-effective was undertaken. This indicated that the
values reported in the 8-week Monti et al.61 RCT would be associated as a cost-effective intervention even
with the costs associated with a year of treatment.
Exploratory analyses using data from Thyme et al.47 indicate that, when using midpoint values, verbal
therapy appears more efficacious than art therapy. However, there is considerable uncertainty in this
estimation and a possibility that the results are confounded by concomitant treatments. Further research
is required before definitive conclusions can be made on the cost-effectiveness of art therapy against
verbal therapy.
TABLE 42 Deterministic results from Thyme et al.62 evaluating benefits at 21 weeks
Duration of
residual
benefit
Costing
source
Using the Ara and Brazier97 mapping Using the Rowen et al.98 mapping
Incremental
costs (£)
Incremental
QALY
Cost per
QALY (£)
Incremental
costs (£)
Incremental
QALY
Cost per
QALY (£)
52 weeks BAAT 360 0.0375 9600 360 0.0419 8596
52 weeks Curtis 495 0.0375 13,200 495 0.0419 11,820
104 weeks BAAT 360 0.0642 5606 360 0.0717 5020
104 weeks Curtis 495 0.0642 7709 495 0.0717 6893
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The results produced using the data from Thyme et al.62 change markedly based on the assumptions used.
Given this and the potential for the results to be confounded by concomitant treatment, further research is
required before any definitive conclusion can be made on the cost-effectiveness of individual art therapy
against control.
Limitations
The analyses undertaken have been simplistic, a decision necessitated by the dearth of RCT evidence
available; as such any conclusions reached should be treated with a degree of caution. The key RCT on
which our conclusions are based recruited women with breast cancer and the generalisability of data from
this group to those with non-psychotic mental health disorders is unclear. In addition, results generated
from Thyme et al.47 and Thyme et al.62 may be confounded. The Thyme et al. RCTs47,62 also required
mapping from GSI data from the SCL-90-R to the SF-36, and then from these data to the EQ-5D,
compared with a mapping of SF-36 to EQ-5D for Monti et al.61 The simplistic model did, however, allow
key variables that affect the cost-effectiveness ratio to be determined, and it is seen that the assumed
length of residual benefit, on which very few data are available, significantly impacts on the estimated
QALYs gained.
Conclusions
From the limited available evidence used to perform the economic evaluation it appears plausible that art
therapy is cost-effective compared with wait-list, although further research would be required to support
this conclusion and to establish if shorter durations of treatment are more cost-effective than the
current duration.
Exploratory analyses indicate that verbal therapy appears more efficacious than art therapy, but there is
considerable uncertainty in this estimation and further research is required before definitive conclusions
can be made on the cost-effectiveness of art therapy against verbal therapy. The results produced change
markedly, based on the assumptions used. Given this and the potential for the results to be confounded,
further research is required before any definitive conclusion can be made on the cost-effectiveness of
individual art therapy compared with control.
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Chapter 5 General discussion
Discussion of findings from the quantitative, qualitative and
cost-effectiveness reviews
On the basis of the evidence retrieved from the quantitative review, art therapy appears to have a
beneficial effect in improving mental health symptoms in a number of different clinical profiles and against
a variety of comparators. However, the data from the studies are of low quality, with small sample sizes,
and have substantial risk of bias; therefore, the results from the studies cannot be regarded as reliable.
With regards to the review question, there are insufficient data from RCTs which use the same outcome
measure to inform a robust analysis relating to the target population of people with non-psychotic mental
health disorders. There are limited data to be able to conclude about specific populations including
mental health disorders, age, gender or setting.
In estimating treatment effects, psychotherapies can be considered at greater risk of confounding variables
than pharmacological interventions. Art therapy is a complex intervention and, as such, it may be difficult
to attribute changes in mental health outcomes to be a direct result of the intervention unless more
high-quality RCTs are implemented. Figure 16 depicts the potential errors that can result at the various
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FIGURE 16 Potential error associated with RCTs of psychological therapy.
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stages of conducting a RCT of psychotherapy which can threaten the quality and validity of the trial if
good conduct is not implemented. Future research should ensure that trials have both internal and external
validity and should adhere to Consolidated Standards of Reporting Trials (CONSORT)40 guidelines in
conducting and reporting trials.
The qualitative review helped to elucidate some of the beneficial components from the small quantity of
evidence conducted in service users and service providers. The patient–therapist relationship appears to be
an important determinant in successful treatment. In addition, harm could be caused if the therapist was
viewed as unskilled and when they would be unable to help resolve emotions activated by the therapy.
The importance, therefore, of regulating and monitoring therapist competence is highlighted. In addition,
the importance of access to art therapy was emphasised as a concern should art therapy services suddenly
be terminated, and this was mirrored in the data from service providers. A small, low-quality study of
service providers also highlighted that some GPs may not understand the specific benefits of art therapy
per se but see it as a treatment option that alleviates their own time/capacity.
The cost-effectiveness review found that using the limited available data, art therapy may be cost-effective
compared with wait-list. There is a dearth of relevant economic evidence to inform whether or not
recommending art therapy versus an alternative psychological therapy or a pharmacological treatment
would be cost saving to the NHS. In addition, as art therapy is used in complex cases there is the potential
for its effects to impact on other health resources. As a consequence the full range of opportunity costs
may be difficult to identify, measure and value. There are likely to be regional variations in art therapy
service delivery and subsequently variations in relevant resource costs. As such it is important to identify
the broad range of costs and benefits of other interventions for non-psychotic mental health disorders.
Definitions of relevant comparators for evaluations may be subject to geographical heterogeneity as a
result of local provision and access to art therapy services and, moreover, this may differ according to the
particular clinical population under evaluation. Future research should ensure the interventions and
comparators assessed in trials are relevant from a policy perspective. Preference-based health-related QoL
instruments (e.g. the EQ-5D) should be used as a matter of course.
Limitations of this health technology assessment
Owing to the experience of the research team in systematic review methodology, the potential for bias in
the selection of evidence for this review is low. While two of the authors for this health technology
assessment are art therapists (ETB and CW) and one is an arts therapist (KDB), they were not responsible
for selection of studies into the quantitative, qualitative or economic reviews and therefore did not
influence the evidence selected for inclusion into the review. A project steering group consisting of
consultant psychiatrists and service users who were not directly affiliated with art therapy attended two
meetings to review and comment on the research design and main findings. In addition, the research
protocol has been available online via the NIHR and PROSPERO websites since commencement of the
project to facilitate public scrutiny of the proposed research methods.
The research design for this review could be considered as being led by the evidence as well as the
research question. The inclusion criteria were shaped to fit the research question and were influenced, to a
degree, by the initial scoping searches prior to project commencement. This resulted in the broadened
inclusion criteria for the study population. While this review can be considered as an evidence portfolio for
art therapy across several non-psychotic mental health disorder, it suffers from substantial heterogeneity
in the patient clinical profiles included, which is likely to be a treatment effect modifier. Focusing the
population of interest to specific health conditions or outcome domains in future systematic reviews will
increase the precision of any resulting pooled treatment effects.
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Chapter 6 Final report conclusions
Conclusions of the research
From the limited available evidence, the following conclusions can be drawn from this health
technology assessment:
l Art therapy appears to have statistically significant positive effects compared with controls in a number
of studies in patients with different clinical profiles. The most relevant symptoms which were effectively
targeted in these studies were depression, anxiety, low mood, trauma, distress, reduced QoL, low
coping skills and self-esteem. The small RCT evidence base indicated that art therapy was associated
with an improvement from baseline in all but one study and was a more effective treatment than
control groups in the majority of studies.
l Art therapy was reported to be an acceptable treatment and was associated with a number of benefits
from a small number of studies including the development of relationships with the therapist and
other group members, understanding the self/own illness/the future, gaining perspective, distraction,
personal achievement, expression, relaxation and empowerment. Small numbers of patients reported
varying reasons for not wanting to take part and, therefore, art therapy may not be a preferred
treatment option for everyone.
l Art therapy appears to be cost-effective versus wait-list but confirmatory studies are needed to confirm
this finding as well as evidence to inform future cost-effective analyses of art therapy versus
other treatments.
Recommendations for future research
1. More multiarm controlled trials. Future art therapy trials should consider the value of a non-active
treatment as usual/wait-list control arm, an attentional control (art and craft activities) and an active
psychological comparator to art therapy (e.g. CBT). The following need to be examined in future trials:
i. Whether or not simply doing anything works: the non-active arm is necessary to demonstrate
whether or not patients with non-psychotic mental health symptoms experience regression to the
mean even without receiving treatment. Within this category no treatment may be compared with
wait-list in the event that expectation of receiving the intervention is better than never being
offered it.
ii. Whether or not doing art therapy works: to mitigate potential performance bias through being
allocated to the active treatment group and assess the relative efficacy of art therapy, an attention
art-based placebo control will ensure that groups are treated equally. In turn this may inform on the
value of the qualified art therapist.
iii. Whether or not art therapy works better than anything else: using a gold standard active
psychological therapy comparator or proven effective treatment will inform on the benefits of art
therapy relative to other available packages of care. Consideration to geographical heterogeneity
and policy perspective should be given when selecting relevant comparators.
2. Pre-specified populations. Currently the evidence is sporadic across clinical profiles. Consideration
should be given to what the mental health symptoms of interest are and in which patient populations
these symptoms can be studied. Patients rarely occur in distinct clinical groups in practice such as
‘depressed’, and therefore studying patients with complex comorbid conditions for symptoms of
depression may be a more feasible approach to recruiting future research populations.
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3. Randomised selection of patients for recruitment as well as random allocation: undeniably psychiatrists
and other referrers select patients for art therapy who they believe may be likely to benefit from it.
But does this mean that we can generalise the results from people who are referred to those who are
not referred? Trials should adhere to CONSORT40 guidelines to ensure quality in the conduct and
reporting of future RCTs of art therapy.
4. Allocation concealment as well as randomisation: not only does proper randomisation need to be
conducted and reported but allocation to groups should be concealed. This is discrete from blinding
and refers to how patients are allocated to either the art therapy or the control group once recruited
into the study.
5. User-validated outcomes. Do the selected outcome measurements reflect a clinically meaningful
improvement to patients’ mental health? Do the patients being studied agree that the outcome
measures are externally valid? Preference-based health-related QoL instruments should be used, such as
the EQ-5D. Trials employing several outcome measures should state the primary outcome measure a
priori, as opposed to using several measurements, focusing on those with significant results.
6. Follow-up: measuring success at the end of the trial only is not adequate to capture residual benefits
of treatment. Long-term follow-up is required to establish the duration of effect and whether or not
re-treatment is an option for those who relapse. The duration of follow-up should also be sufficient to
capture all costs.
7. Considering the influence of the therapist: unlike pills in pharmacotherapy, no two therapists are alike
and subsequently the possibility of ‘therapist effects’112 should be considered. Art therapists may take
an approach informed by a particular therapeutic model (mindfulness, brief work; psychodynamic); a
service user-led recovery or collaborative approach; an approach based in guidelines about principles of
practice,24,25,27 or use evidence of what works for whom. Such differences should be documented and
explored in future trials. In addition, art therapists who are involved in research should be experienced
practitioners in the clinical area of interest to facilitate consensus on practice as usual.
8. Quantifying good practice: it is important to elucidate the beneficial factors in art therapy to inform
good practice protocols. Measures to ensure treatment fidelity should be employed by researchers in
future trials of art therapy. Moreover, instruments designed to describe the ideal regimen of
psychotherapy sessions should be explored for art therapy interventions.113,114 Standardisation of good
practice for specific patient clinical profiles rather than a ‘one-size-fits all’ approach will facilitate
quantitative comparison and analysis of interventions.
9. Robust qualitative evidence: qualitative evidence gathered using robust methods to provide rich data
should be nested in future RCTs of art therapy. This would facilitate further assessment of preference,
acceptability and harms and may help to identify treatment mechanisms which influence and modify
treatment outcomes with art therapy.
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Appendix 1 Patient and public involvement for
project 12/27/16
The project steering group
The NICE HTA programme has developed an evidence-based approach to involving service users in
research and development agenda-setting. In accordance with this, this research project developed a
project steering group for the purpose of allowing scrutiny of the research team’s proposed methods of
investigation and also to present main findings of the research.
The research team for this project, who are the listed co-authors for the manuscript, worked with two
service users and five external clinical experts in the project steering group to discuss the proposed
research design and preliminary findings. The patient representatives were people with non-psychotic
mental health disorders who had experience of taking part in art therapy and were recruited through
online advertisement on the ‘People in Research’ website upon advice from a patient and public
involvement (PPI) representative at the School of Health and Related Research (ScHARR), University of
Sheffield. The external clinical experts were consultant psychiatrists and were selected as key professionals
with an interest in treatment for non-psychotic mental health disorders.
Setting and context
The steering group met on two occasions for 2 hours over the 12-month research contract period.
Communications including meeting agendas, notes and directions were provided via e-mail prior to and
following meetings. The purpose of the first meeting was to describe and discuss the research team’s
proposed investigation for this health technology assessment. The protocol for the project was also
provided and lay summaries were presented by members of the research team to describe the intentions
and methods of the research.
The purpose of the second meeting was to present a lay summary of the preliminary findings from the
three systematic reviews and gather any further views on the research methodology used.
How the contributions of the steering group influenced
the project
Service users highlighted important considerations for patients in the provision of art therapy including the
element of patient choice, the potential adverse effects of art therapy when delivered by an untrained
individual and the potential appeal of art therapy compared with other treatments. These views aided the
project team in understanding the issues to service users and were reflected in the assessment report.
Clinical experts highlighted the complexities of assessing psychological therapies compared with
pharmacological interventions, the difficulties in defining the appropriate comparators to art therapy and
the complex nature of the populations that art therapy may be used in. These issues helped the project
team to frame the background context for art therapy usage and highlighted the relevant issues in
assessment of psychological therapies more generally.
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Reflections on the process
Travelling to an academic institution as a patient representative can be an intimidating experience and
requires confidence and trust in the research project. The patient representatives are a minority and so only
a few people could potentially fill the role. As the service users are people diagnosed with non-psychotic
mental health disorder, they could also be considered as vulnerable people. Accordingly, only a limited
number (four people) who were eligible to fill the role responded to the advert despite the offer of
expenses paid and an incentive reward.
Regardless of the amount recommended and granted by the funding body for reward payments for PPI,
the amount that can be paid to incentivise participation needs to be in line with the institution’s
(University of Sheffield) policy. This may result in PPI representatives being out of pocket for attending
and potentially creates an impression that contributions are not rewarded in line with other institutes’
patient committees (e.g. NICE). Furthermore, if expenses are paid and an incentive reward is issued, PPI
representatives are required to enrol on the institution’s bank worker system to ensure that National
Insurance contributions are made. This enrolment in itself can be perceived as a barrier to participation to
service users, who may be the relevant vulnerable population at the focus of the research.
The contributions of the service users and clinical experts in the steering group were valuable to the project.
The views were helpful and informative to the project team. However, there is theoretical incongruence
in the concept of integrating the views of a small number of individuals into a large scale project that is
endeavouring to be evidence based. Future projects should consider what input from the project steering
group should be fairly considered and incorporated by the research team in the absence of more
comprehensive and accessible public consultation on these issues that may be relevant to stakeholders.
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Appendix 2 Search strategies for quantitative,
qualitative and economic reviews
MEDLINE
1. Art Therapy/
2. art therap$.ti,ab.
3. art psychotherap$.ti,ab.
4. or/1–3
5. meta analysis.sh.
6. meta-anal$.tw.
7. metaanal$.tw.
8. meta analysis.id.
9. (systematic and (review or overview)).tw.
10. (critical and apprais$).tw.
11. (critical and review$).tw.
12. or/5–11
13. literature review.sh.
14. literature review.id.
15. 13 or 14
16. 12 or 15
17. case report.sh.
18. 16 not 17
19. limit 18 to human
20. 4 and 19 [to identify reviews]
21. treatment effectiveness evaluation.sh.
22. (random$ and trial$).tw.
23. (random$ and allocat$).tw.
24. double blind.tw.
25. single blind.tw.
26. clinical trial.id.
27. clinical trial$.tw.
28. ((singl$ or doubl$ or trebl$ or tripl$) adj5 blind).tw.
29. (clin$ adj25 trial$).ti,ab.
30. placebo$.tw.
31. placebo$.id.
32. placebo$.ti,ab.
33. random$.ti,ab.
34. methodology.sh.
35. experimental design.sh.
36. experimentation.sh.
37. experimental methods.sh.
38. or/21–37
39. limit 38 to human
40. 4 and 39 [to identify clinical trials]
41. ‘costs and cost analysis’/
42. ‘Cost Containment’/
43. (economic adj2 evaluation$).ti,ab.
44. (economic adj2 analy$).ti,ab.
45. (economic adj2 (study or studies)).ti,ab.
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46. (cost adj2 evaluation$).ti,ab.
47. (cost adj2 analy$).ti,ab.
48. (cost adj2 (study or studies)).ti,ab.
49. (cost adj2 effective$).ti,ab.
50. (cost adj2 benefit$).ti,ab.
51. (cost adj2 utili$).ti,ab.
52. (cost adj2 minimi$).ti,ab.
53. (cost adj2 consequence$).ti,ab.
54. (cost adj2 comparison$).ti,ab.
55. (cost adj2 identificat$).ti,ab.
56. (pharmacoeconomic$ or pharmaco-economic$).ti,ab.
57. or/41–56
58. (task adj2 cost$).ti,ab,id.
59. (switch$ adj2 cost$).ti,ab,id.
60. ((energy or oxygen) adj cost).ti,ab,id.
61. ((energy or oxygen) adj expenditure).ti,ab,id.
62. or/58–61
63. (animal or animals or rat or rats or mouse or mice or hamster or hamsters or dog or dogs or cat or
cats or bovine or sheep or ovine or pig or pigs).ab,ti,id,de.
64. editorial.dt.
65. letter.dt.
66. dissertation abstract.pt.
67. or/63–66
68. 57 not (62 or 67)
69. 4 and 68 [to identify economic evaluations]
70. experiences.tw.
71. interview$.tw.
72. qualitative.tw.
73. or/70–72
74. 4 and 73 [to identify qualitative research]
75. 20 or 40 or 69 or 74
76. 4 not 75 [to identify other study types]
EMBASE
1. art therapy/
2. art therap$.ti,ab.
3. art psychotherap$.ti,ab.
4. or/1–3
5. Meta analysis/
6. Metaanaly$.tw.
7. exp Literature review/
8. (systematic adj (review or overview)).tw.
9. Meta analys$.tw.
10. or/5–9
11. (letter or commentary or editorial).pt.
12. animals/
13. 11 or 12
14. 10 not 13
15. 14 and 14 [to identify reviews]
16. exp clinical trials/
17. Clinical trial.pt.
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18. (clinic$ adj trial$1).tw.
19. ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$3 or mask$3)).tw.
20. Randomi?ed control$ trial$.tw.
21. Random assignment/
22. Random$ allocat$.tw.
23. Placebo$.tw.
24. Placebos/
25. Quantitative studies/
26. Allocat$ random$.tw.
27. or/16–26
28. 4 and 27 [to identify clinical trials]
29. exp Financial Management/
30. exp *economics/
31. exp financial support/
32. exp financing organized/
33. exp business/
34. (cost or costs or economic$ or pharmacoeconomic$ or price$ or pricing$).tw.
35. Health resource allocation.sh.
36. Health resource utilization.sh.
37. (editorial or letter or news).pt.
38. (or/29–32 or/34–36) not (33 or 37)
39. 4 and 38 [to identify economic evaluations]
40. findings.tw.
41. interview.tw.
42. qualitative.tw.
43. or/40–42
44. 4 and 43 [to identify qualitative research]
45. 15 or 28 or 39 or 44
46. 44 not 45 [to identify other study types]
The Cochrane Library
#1. MeSH descriptor: [Art Therapy] explode all trees
#2. ‘art therap*’
#3. ‘art psychotherap*’
#4. #1 or #2 or #3
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Citation Indexes (Web of Science)
TABLE 43 Citation Indexes (Web of Science) search strategy
#1 TI= (art therap* or art psychotherap*)
DocType=All document types; Language=All languages;
#2 Topic= (meta-anal* or metaanal* or quantitativ* review* or quantitativ* overview or systematic* review* or
systematic* overview* or methodologic* review* or methodologic* overview* or integrative research review*
or research integration* or quantitativ* synthes*)
DocType=All document types; Language=All languages;
#3 #2 AND #1 – to identify reviews
DocType=All document types; Language=All languages;
#4 Topic= (random* or placebo* or single blind* or double blind* or triple blind*)
DocType=All document types; Language=All languages;
#5 Topic= (randomized or randomly)
DocType=All document types; Language=All languages;
#6 Topic= (clin* trial*)
DocType=All document types; Language=All languages;
#7 #6 OR #5 OR #4
DocType=All document types; Language=All languages;
#8 #7 AND #1 – to identify clinical trials
DocType=All document types; Language=All languages;
#9 Topic= (economic* or cost* or fiscal or funding or financial or finance or pharmacoeconomic* or price* or pricing)
DocType=All document types; Language=All languages;
#10 #9 AND #1 – to identify economic evaluations
DocType=All document types; Language=All languages;
#11 Topic= (findings or interview or qualitative)
DocType=All document types; Language=All languages;
#12 #11 AND #1 – to identify qualitative research
DocType=All document types; Language=All languages;
#13 #12 OR #10 OR #8 OR #3 – to identify other study types (these results were imported into Reference Manager and
duplicates were removed)
DocType=All document types; Language=All languages;
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Cumulative Index to Nursing and Allied Health
Literature (CINAHL)
TABLE 44 Cumulative Index to Nursing and Allied Health Literature search strategy
S1 (MH ‘Art Therapy’)
S2 TI art therap* OR AB art therap*
S3 TI art psychotherap* OR AB art psychotherap*
S4 or/S1–S3
S5 (MH ‘Meta Analysis’)
S6 TI meta analys* OR AB meta analys*
S7 TI metaanaly* OR AB metaanaly*
S8 (MH ‘Literature Review+’)
S9 TI ( (systematic n1 review) or (systematic n1 overview) ) OR AB ( (systematic n1 review) or (systematic n1 overview) )
S10 S5 OR S6 OR S7 OR S8 OR S9
S11 PT commentary
S12 PT letter
S13 PT editorial
S14 (MH ‘Animals’)
S15 S11 OR S12 OR S13 OR S14
S16 S10 NOT S15
S17 S4 AND S16 [to identify reviews]
S18 (MH ‘Economics+’)
S19 (MH ‘Financial Management+’)
S20 (MH ‘Financial Support+’)
S21 (MH ‘Financing, Organized+’)
S22 (MH ‘Business+’)
S23 S19 OR S20 OR S21 OR S22
S24 S18 NOT S23
S25 (MH ‘Health Resource Allocation’)
S26 (MH ‘Health Resource Utilization’)
S27 S25 OR S26
S28 S24 OR S27
S29 TI ( (cost or costs or economic* or pharmacoeconomic* or price* or pricing*) ) OR AB ( (cost or costs or economic*
or pharmacoeconomic* or price* or pricing*) )
S30 S28 OR S29
S31 PT editorial
S32 PT letter
S33 S31 OR S32
S34 S30 NOT S33
continued
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TABLE 44 Cumulative Index to Nursing and Allied Health Literature search strategy (continued )
S35 (MH ‘Animal Studies’)
S36 S34 NOT S35
S37 AU anonymous
S38 S36 NOT S37
S39 S4 AND S38 [to identify economic evaluations]
S40 TI findings OR AB findings
S41 TI interview OR AB interview
S42 TI qualitative OR AB qualitative
S43 S40 OR S41 OR S42
S44 S4 AND S43 [to identify qualitative research]
S45 (MH ‘Clinical Trials+’)
S46 PT Clinical trial
S47 TX clinic* n1 trial*
S48 TX ( (singl* n1 blind*) or (singl* n1 mask*) ) or TX ( (doubl* n1 blind*) or (doubl* n1 mask*) ) or TX ( (tripl* n1
blind*) or (tripl* n1 mask*) ) or TX ( (trebl* n1 blind*) or (trebl* n1 mask*) )
S49 TX randomi* control* trial*
S50 (MH ‘Random Assignment’)
S51 TX random* allocat*
S52 TX placebo*
S53 (MH ‘Placebos’)
S54 (MH ‘Quantitative Studies’)
S55 TX allocat* random*
S56 S45 OR S46 OR S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR S53 OR S54 OR S55
S57 S4 AND S56 [to identify clinical trials]
S58 S17 OR S39 OR S44 OR S57
S59 S4 NOT S58 [to identify other study types]
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PsycINFO
1. Art Therapy/
2. art therap$.ti,ab.
3. art psychotherap$.ti,ab.
4. or/1–3
5. meta analysis.sh.
6. meta-anal$.tw.
7. metaanal$.tw.
8. meta analysis.id.
9. (systematic and (review or overview)).tw.
10. (critical and apprais$).tw.
11. (critical and review$).tw.
12. or/5–11
13. literature review.sh.
14. literature review.id.
15. 13 or 14
16. 12 or 15
17. 17. case report.sh.
18. 16 not 17
19. limit 18 to human
20. 4 and 19 [to identify reviews]
21. treatment effectiveness evaluation.sh.
22. (random$ and trial$).tw.
23. (random$ and allocat$).tw.
24. double blind.tw.
25. single blind.tw.
26. clinical trial.id.
27. clinical trial$.tw.
28. ((singl$ or doubl$ or trebl$ or tripl$) adj5 blind).tw.
29. (clin$ adj25 trial$).ti,ab.
30. placebo$.tw.
31. placebo$.id.
32. placebo$.ti,ab.
33. random$.ti,ab.
34. methodology.sh.
35. experimental design.sh.
36. experimentation.sh.
37. experimental methods.sh.
38. or/21–37
39. limit 38 to human
40. 4 and 39 [to identify clinical trials]
41. ‘costs and cost analysis’/
42. ‘Cost Containment’/
43. (economic adj2 evaluation$).ti,ab.
44. (economic adj2 analy$).ti,ab.
45. (economic adj2 (study or studies)).ti,ab.
46. (cost adj2 evaluation$).ti,ab.
47. (cost adj2 analy$).ti,ab.
48. (cost adj2 (study or studies)).ti,ab.
49. (cost adj2 effective$).ti,ab.
50. (cost adj2 benefit$).ti,ab.
51. (cost adj2 utili$).ti,ab.
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52. (cost adj2 minimi$).ti,ab.
53. (cost adj2 consequence$).ti,ab.
54. (cost adj2 comparison$).ti,ab.
55. (cost adj2 identificat$).ti,ab.
56. (pharmacoeconomic$ or pharmaco-economic$).ti,ab.
57. or/41–56
58. (task adj2 cost$).ti,ab,id.
59. (switch$ adj2 cost$).ti,ab,id.
60. ((energy or oxygen) adj cost).ti,ab,id.
61. ((energy or oxygen) adj expenditure).ti,ab,id.
62. or/58–61
63. (animal or animals or rat or rats or mouse or mice or hamster or hamsters or dog or dogs or cat or
cats or bovine or sheep or ovine or pig or pigs).ab,ti,id,de.
64. editorial.dt.
65. letter.dt.
66. dissertation abstract.pt.
67. or/63–66
68. 57 not (62 or 67)
69. 4 and 68 – to identify economic evaluations
70. experiences.tw.
71. interview$.tw.
72. qualitative.tw.
73. or/70–72
74. 4 and 73 – to identify qualitative research
75. 20 or 40 or 69 or 74
76. 4 not 75 – to identify other study types
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Allied and Complementary Medicine Database (AMED)
1. art therapy/
2. art therap$.ti,ab.
3. art psychotherap$.ti,ab.
4. or/1–3
5. Meta analysis/
6. Metaanaly$.tw.
7. exp Literature review/
8. (systematic adj (review or overview)).tw.
9. Meta analys$.tw.
10. or/5–9
11. (letter or commentary or editorial).pt.
12. animals/
13. 11 or 12
14. 10 not 13
15. 4 and 14 [to identify reviews]
16. exp clinical trials/
17. Clinical trial.pt.
18. (clinic$ adj trial$1).tw.
19. ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$3 or mask$3)).tw.
20. Randomi?ed control$ trial$.tw.
21. Random assignment/
22. Random$ allocat$.tw.
23. Placebo$.tw.
24. Placebos/
25. Quantitative studies/
26. Allocat$ random$.tw.
27. or/16–26
28. 4 and 27 – to identify clinical trials
29. exp Financial Management/
30. exp *economics/
31. exp financial support/
32. exp financing organized/
33. exp business/
34. (cost or costs or economic$ or pharmacoeconomic$ or price$ or pricing$).tw.
35. Health resource allocation.sh.
36. Health resource utilization.sh.
37. (editorial or letter or news).pt.
38. (or/29–32 or/34–36) not (33 or 37)
39. 4 and 38 [to identify economic evaluations]
40. findings.tw.
41. interview.tw.
42. qualitative.tw.
43. or/40–42
44. 4 and 43 [to identify qualitative research]
45. 15 or 28 or 39 or 44
46. 44 not 45 [to identify other study types]
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Applied Social Sciences Index and Abstracts (ASSIA)
Search strategy
1. SU.EXACT(‘Art therapy’) OR (ti(art therap* OR art psychotherap*) OR ab(art therap* OR
art psychotherap*))
2. ti((meta-anal* OR metaanal* OR quantitativ* review* OR quantitativ* overview OR systematic*
review* OR systematic* overview* OR methodologic* review* OR methodologic* overview* OR
integrative research review* OR research integration* OR quantitativ* synthes*)) OR ab((meta-anal*
OR metaanal* OR quantitativ* review* OR quantitativ* overview OR systematic* review* OR
systematic* overview* OR methodologic* review* OR methodologic* overview* OR integrative
research review* OR research integration* OR quantitativ* synthes*))
3. 1 AND 2 [to identify reviews]
4. ti(random* OR placebo* OR single blind* OR double blind* OR triple blind* OR randomized OR
randomly OR clin* trial*) OR ab(random* OR placebo* OR single blind* OR double blind* OR triple
blind* OR randomized OR randomly OR clin* trial*)
5. 1 AND 4 [to identify clinical trials]
6. ti(economic* OR cost* OR fiscal OR funding OR financial OR finance OR pharmacoeconomic* OR
price* OR pricing) OR ab(economic* OR cost* OR fiscal OR funding OR financial OR finance OR
pharmacoeconomic* OR price* OR pricing)
7. 1 AND 6 [to identify economic evaluations]
8. ti(findings OR interview OR qualitative) OR ab(findings OR interview OR qualitative)
9. 1 AND 8 [to identify qualitative research]
10. 3 OR 5 OR 7 OR 9
11. 1 NOT 10 [to identify other study types]
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Appendix 3 Studies excluded at full text from the
quantitative review
TABLE 45 Studies excluded at full text from the quantitative review
No. Reference Reason for exclusion
1 Ando M, Imamura Y, Kira H, Nagasaka T. Feasibility and efficacy of art therapy for
Japanese cancer patients: A pilot study. Arts Psychother 2013;40:130–3
No control group
2 Ash-Lee S, Simoneau T, Talucci L. The use of an art therapy group in women with
cancer: A pilot study. Psycho-oncology Conference: 7th Annual Conference of the
American Psychosocial Oncology Society, 18–21 February 2010, New Orleans,
LA, USA. Conference Publication. 2010;19:S43
No control group
3 Baptista AS, Jones A, Cardoso FP, Schaffir BC, Coelho ERW, Orlandi A, et al.
Assessment of art therapy program for women with fibromyalgia: randomized
controlled blinded study. Arthritis and Rheumatism Conference: 12th Annual
Scientific Meeting of the American College of Rheumatology and Association of
Rheumatology Health Professionals, Washington, DC, USA, 9–14 November 2012.
Conference Publication. 2012;64:S794
Conference proceeding. No
study data – contacted author
(andreia.baptista@unifesp.br)
but no response
4 Bar-Sela G, Atid L, Danos S, Gabay N, Epelbaum R. Art therapy improved
depression and influenced fatigue levels in cancer patients on chemotherapy.
Psycho-Oncology 2007;16:980–4
No randomisation
5 Bell CE, Robbins SJ. Effect of art production on negative mood: a randomized
controlled trial. Art Ther 2007;24:71–5
Not art therapy intervention
6 Elbing U, Schulze C, Zillmann H, Raak CK, Ostermann T. Arthedata-An online
database of scientific references on art therapy. Eur J Integr Med 2009;1:39–42.
URL: http://cambase.dmz.uni-wh.de/CiXbase/kunthera/ (accessed 11 December 2014)
Not a reference, but a link to a
German art therapy database
7 Elkis-Abuhoff DL, Goldblatt RB, Gaydos M, Corrato S. Effects of clay manipulation
on somatic dysfunction and emotional distress in patients with Parkinson’s disease.
Art Therapy 2008;25:122–8
Not a RCT; parkinsons vs.
non-parkinsons groups
8 Freilich R, Shechtman Z. The contribution of art therapy to the social emotional
and academic adjustment of children with learning disabilities. The Arts in
Psychotherapy 2010;2:97–105
No randomisation
9 Gabriel B, Bromberg E, Vandenbovenkamp J, Walka P, Kornblith AB, Luzzato P.
Art therapy with adult bone marrow transplant patients in isolation: A pilot study.
Psycho-Oncology 2001;10:114–23
No control group
10 Goetze H, Geue K, Buttstaedt M, Braehler E. Art therapy for patients with
haematological cancer in the ambulatory aftercare. Psycho-oncology Conference:
11th World Congress of Psycho-Oncology of the International Psycho-Oncology
Society IPOS, Vienna, Austria, 2009. Conference Publication. 21–25 June
2009;18:S238–9
Not a RCT; no randomisation
to groups
11 Jones G. An art therapy group in palliative cancer care. Nurs Times 2000;96:42–3 Editorial; no study data
12 Madden J, Mowry-Rutter P, Foreman N. Results of randomized study of creative
arts therapy for pediatric brain tumor patients during outpatient chemotherapy.
Neurooncology 2008;10:459–60
Arts therapies combined
13 McCabe C, Roche D, Hegarty F, McCann S. ‘Open window’: A randomized trial of
the effect of new media art using a virtual window on quality of life in patients’
experiencing stem cell transplantation. Psycho-oncology 2013;2:330–7
Not art therapy intervention
14 Odell-Miller H, Hughes P, Westacott M. An investigation into the effectiveness of
the arts therapies for adults with continuing mental health problems. Psychother
Res 2006;1:122–39
Mostly psychotic with outcome
data not broken down by
condition
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TABLE 45 Studies excluded at full text from the quantitative review (continued )
No. Reference Reason for exclusion
15 Oster I. Art therapy with women with breast cancer-results from a randomized
study. Psycho-Oncology Conference: 11th World Congress of Psycho-Oncology of
the International Psycho-Oncology Society IPOS, Vienna, Austria, 21–25 June
2009. Conference Publication. 2009;18:S22–3
Conference proceeding of
the Oster Thyme Svensk
study – no data
16 Plecity DM, Danner-Weinberger A, Szkura L, von Wietersheim J. The effects of art
therapy on the somatic and emotional situation of the patients – A quantitative
and qualitative analysis. Psychothere Psychosomat Med Psychol 2008;59:364–9
Not a RCT; qualitative study
abstract no data
17 Richardson P, Jone K, Evans C, Stevens P, Rowe A. An exploratory randomised trial
of group based art therapy as an adjunctive treatment in severe mental illness.
Unpublished Report. 1994
Trial records of schizophrenia
study published 2007
18 Richardson P. Art therapy as an adjunctive treatment in severe mental illness:
a randomised controlled evaluation. Curr Control Trials 2004
Trial records of schizophrenia
study published 2007
19 Richardson P. Randomised controlled trial of group interactive art therapy as an
adjunctive treatment in severe mental illness. National Research Register 2001;1
Trial records of schizophrenia
study published 2007
20 Rodriguez J, Troll G. [Experiments in art therapy]. Soins – Psychiatrie 1990;34:118–19 Not a RCT
21 Rosal ML. Comparative group art therapy research to evaluate changes in locus of
control in behavior disordered children. Arts Psychother 1993;3:231–41
Pre-test/post-test design
22 Ryan BR. Effects of two group approaches on life satisfaction and mood of
older females in nursing homes. Dissertation Abstracts International: Section B:
The Sciences and Engineering 4347;72(7-B)
Dissertation ordered
(not a RCT)
23 Sela N, Baruch N, Assali A, Vaturi M, Battler A, Ben GT. [The influence of medical
art therapy on quality of life and compliance of medical treatment of patients with
advanced heart failure]. Harefuah 2009;150:79–83
Cannot locate corresponding
reference to citation
24 Sela N, Baruch N, Stein R, Yaari V, Pinchas A, Battler A, et al. Long term medical
art therapy: influence on quality of life functional capacity and compliance in
advanced heart failure patients. Supplement Conference Heart Failure 2010
Congress Berlin, Germany. 29 May–1 June 2010. Eur J Heart Fail 2010;9:S173
Not a RCT; no control group
25 Szawarski Z. Placebo and art therapy. Med Dypl 2003;12:21–6 Cannot locate corresponding
reference to citation
26 Valladares AC, Carvalho AM. [Art therapy and behavior development in the
context of hospitalization]. Revista Da Escola De Enfermagem Da Usp
2006;40:350–5
Not a RCT; no randomisation
to groups
27 van den Broek E, Keulen-de VM, Bernstein DP. Arts therapies and Schema Focused
therapy: A pilot study. Arts Psychother 2011;38
Arts not art therapy; does not
define art therapy intervention
28 Volker CA. Treatment of sexual assault survivors utilizing cognitive therapy and art
therapy. (self-esteem posttraumatic stress disorder victimization). San Francisco,
CA: California Institute of Integral Studies; 1999
Dissertation-insufficient data
reported and final sample
(n= 6)
29 Wallace J. Psychosocial changes associated with participation in art therapy
interventions for siblings of pediatric hematopoietic stem cell transplant patient.
Palo Alto, CA: Palo Alto University; 2012
Dissertation – not randomised
30 Zeltzer BB, Stanley S, Melo L, LaPorte KM. Arts therapies promote wellness in
elders. Behavioural Healthcare Tomorrow 2003;12:7–12
Not a RCT; no randomisation
to groups
31 Zimmerman ML, Wolbert WA, Burgess AW, Hartman CR. Art and group work:
interventions for multiple victims of child molestation (Part II). Arch Psychiatr Nurs
1987;1:40–6
Not a RCT; no randomisation
to groups
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Appendix 4 Studies excluded at full text from the
qualitative review
TABLE 46 Studies excluded at full text from the qualitative review
No. Reference Reason for exclusion
1 Agnese A, Lamparelli T, Bacigalupo A, Luzzatto P. Supportive care with art therapy for
patients in isolation during stem cell transplant. Palliat Support Care 2012;10:91–8
Case study
2 Allen KN, Wozniak DF. The language of healing: women’s voices in healing and
recovering from domestic violence. [References]. Soc Work Ment Health 2011;1:37–55
Not art therapy
3 Baumann M, Peck S, Collins C, Eades G. The meaning and value of taking part in a
person-centred arts programme to hospital-based stroke patients: findings from
a qualitative study. Disabil Rehabil 2013;35:244–56
Not art therapy
4 Beesley K, White JH, Alston MK, Sweetapple AL, Pollack M. Art after stroke: the
qualitative experience of community dwelling stroke survivors in a group art programme.
Disabil Rehabil 2011;33:2346–55
Not art therapy
5 Crone DM, O’Connell EE, Tyson PJ, Clark-Stone F, Opher S, James DVB. ‘It helps me
make sense of the world’: The role of an art intervention for promoting health and
wellbeing in primary care - Perspectives of patients health professionals and artists.
[References]. J Public Health 2012;5:519–24
Not art therapy
6 Dickson C. An evaluation study of art therapy provision in a residential Addiction
Treatment Programme (ATP). Int J Art Ther 2007;12:17–27
No qualitative data
7 Fulton J. Art therapy and chronic illness: An enquiry into aspects of service provision for
patients with atopic skin disease. Inscape 2002;7:2–15
No qualitative data
8 Geue K, Buttstadt M, Singer S, Kleinert E, Richter R, Gotze H, et al. (2011) [The impact of
an art therapy programme for cancer patients – an analysis from different points of view].
Forschende Komplementarmedizin 18:127–33
No qualitative data
9 Gussak D. Comparing the effectiveness of art therapy on depression and locus of control
of male and female inmates. [References]. Arts Psychother 2009;4:202–7
No qualitative data
10 Kwiatkowska G. [Reception and evaluation of art therapy by patients with neuroses.]
Psychiatria Polska 1990;24:136–40
No qualitative data
11 Makin S, Gask L. ‘Getting back to normal’: the added value of an art-based programme
in promoting ‘recovery’ for common but chronic mental health problems. Chronic Illn
2012;8:64–75
Not art therapy
12 Murphy J, Paisley D, Pardoe L. An art therapy group for impulsive children. Inscape
2004;9:59–68
Unobtainable
13 Oster I. Art therapy with women with breast cancer-results from a randomized study.
Psycho-Oncology Conference: 11th World Congress of Psycho-Oncology of the
International Psycho-oncology Society, IPOS Vienna, Austria, 21–25 June 2009.
[Conference Publication]. 2009;18:S22–3
Abstract superseded by
full paper
14 Pizarro JE-MA, Pizarro JJE. The efficacy of art and writing therapy: increasing positive
mental health outcomes and participant retention after exposure to traumatic
experience. [References]. Art Ther 2004;21
No qualitative data
15 Plecity D, Danner-Weinberger A, Szkura L, von Wietersheim J. Effects of art therapy on
the physical and emotional state of health of patients – a quantitative and qualitative
analysis. Psychother Psychosomat Med Psychol 2007;57:100
No qualitative data
16 Plecity DM, Danner-Weinberger A, Szkura L, von Wietersheim J. The effects of art
therapy on the somatic and emotional situation of the patients - A quantitative and
qualitative analysis. [German]. [References]. Psychother Psychosomat Med Psychol
2009;59:364–9
No qualitative data
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TABLE 46 Studies excluded at full text from the qualitative review (continued )
No. Reference Reason for exclusion
17 Reynolds F, Lim KH. Contribution of visual art-making to the subjective well-being of
women living with cancer: a qualitative study. Arts Psychother 2007;34:1–10
Not art therapy
18 Reynolds F, Prior S. Creative adventures and flow in art-making: a qualitative study of
women living with cancer. Br J Occup Ther 2006;69:255–62
Not art therapy
19 Rusted J, Sheppard L, Waller D. A Multi-centre randomized control group trial on the use
of art therapy for older people with dementia. Group Analysis 2006;4:517–36
Case study
20 Sainsbury S, Lee K. Art as therapeutic recreation following acquired brain injury (ABI) to
enhance emotional regulation. Brain Impairment Conference: 9th Annual Conference of
the Special Interest Group in Neuropsychological Rehabilitation of the World Federation
for NeuroRehabilitation WFNR. 2–3 July 2012, Bergen, Norway. Conference 13.
http://dx.doi.org/10.1017/BrImp.2012.11
Only abstract available
21 Sainsbury SA, Lee K. Art therapy in cases of acquired brain injury: helping participants
find social context through creative self-expression. Brain Impairment Conference: 2011
International Neuropsychological Society Mid-Year Meeting/ASSBI 4th Pacific Rim
Conference. 6–9 July 2011, Auckland, New Zealand. Conference Publication. 2011;12:33
Abstract only available
22 Singh BE-MA, Singh BBC. The therapeutic effects of art making in patients with cancer.
[References]. Arts Psychother 2011;38
Not art therapy
23 Smeijsters H, Cleven G. The treatment of aggression using arts therapies in forensic
psychiatry: results of a qualitative inquiry. [References]. The Arts in Psychotherapy
2006;1:37–58
Not about attitudes to
art therapy
24 Steward Aron. Art therapy intervention with “at-risk” adolescent boys: Effects on
self-image and perceptions of loss. [Database]. Dissertation Abstracts International:
Section B: The Sciences and Engineering [5-B]. 2007. US, State University New York
At Buffalo. Ref Type: Thesis/Dissertation
Not about attitudes to
art therapy
25 ter Maat MB. A group art therapy experience for immigrant adolescents. Am J Art Ther
1997;36:11–19
Case study
26 Webb-Ferebee Kelly Lea. Expressive arts therapy with bereaved families. [Database].
Dissertation Abstracts International: Section A: Humanities and Social Sciences [9-A],
3119. 2003. US, U North Texas. Ref Type: Thesis/Dissertation
Not art therapy
27 Wilson C. A time-limited model of art therapy in general practice. Inscape 2002;7:16–26 Case study
28 Wolf Bordonaro Gaelynn P. Art therapy with hospitalized pediatric patients. [Database].
Dissertation Abstracts International: Section A: Humanities and Social Sciences [5-A].
2005. US, The Florida State University. Ref Type: Thesis/Dissertation
Case study
29 Woolhiser J. Collage as a therapeutic modality for reminiscence in patients with
dementia. Art Therapy 2010;27:136–40
Not about attitudes to
art therapy
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Appendix 5 Studies excluded at full text from the
economic review
TABLE 47 Studies excluded at full text from the economic review
No. Reference Reason for exclusion
1 Karapostoli N, Polyzos N, Tsegos I. The cost of therapy services provided by a day
psychotherapy unit. Group Analysis 2012;45:515–35
Does not investigate art
therapy
2 Abbass A. Intensive short-term dynamic psychotherapy in a private psychiatric
office: clinical and cost effectiveness. Am J Psychother 2002;56:225–32
Does not investigate art
therapy
3 Berg M, Smit F, Vos T, Baal PH. Cost-effectiveness of opportunistic screening and
minimal contact psychotherapy to prevent depression in primary care patients.
PLOS ONE 2011;6
Does not investigate art
therapy
4 Berghout CC, Zevalkink J, Hakkaart-van RL. A cost–utility analysis of psychoanalysis
versus psychoanalytic psychotherapy. Int J Technol Assess Health Care 2010;26:3–10
Does not investigate art
therapy
5 Bosmans JE, Schaik DJ, Heymans MW, Marwijk HW, Hout HP, Bruijne MC.
Cost-effectiveness of interpersonal psychotherapy for elderly primary care patients
with major depression. Int J Technol Assess Health Care 2007;23:480–7
Does not investigate art
therapy
6 Browne G, Steiner M, Roberts J, Gafni A, Byrne C, Dunn E, et al. Sertraline and/or
interpersonal psychotherapy for patients with dysthymic disorder in primary care:
6-month comparison with longitudinal 2-year follow-up of effectiveness and costs.
J Affect Disord 2002;68:317–30
Does not investigate art
therapy
7 Frank B. The economics of preference change: The case of arts therapy – response.
J Econ Psychol 1997;18:465–8
Descriptive/qualitative paper
no economic data
8 Goldman W, McCulloch J, Cuffel B. A four-year study of enhancing outpatient
psychotherapy in managed care. Psychiatr Serv 2003;54:41–4
Does not investigate art
therapy
9 Marchand A, Germain V, Reinharz D, Mainguy N, Landry P. Analysis of the cost
and the effectiveness of a psychotherapy for panic disorder with agoraphobia
(PDA) versus a treatment combining pharmacotherapy and psychotherapy. Sante
Mentale Au Quebec 2004;29:201–20
Full paper in French
10 McCrone P, Weeramanthri T, Knapp M, Rushton A, Trowell J, Miles G, et al.
Cost-effectiveness of individual versus group psychotherapy for sexually abused girls.
Child Adolesc Ment Health 2005;10:26–31
Does not investigate art
therapy
11 Poinsier B, Laurin A.S. Economic evaluation of a simulated program of brief
psychotherapy for children with mild problems. Sante Mentale Au Quebec
1995;20:203–18
Full paper in French
12 Pulliam JC, Somerville P, Prebluda J, Warja-Danielsson M. Three heads are better
than one: the expressive arts group assessment. Arts Psychother 1988;1:71–7
Descriptive/qualitative paper
no economic data
13 Soeteman DI, Busschbach JJ, Verheul R, Hoomans T, Kim JJ. Cost-effective
psychotherapy for personality disorders in the Netherlands: the value of further
research and active implementation. Valuen Health 2011;14:229–39
Does not investigate art
therapy
14 Soeteman DI, Verheul R, Delimon J, Meerman AM, Eijnden E, Rossum BV, et al.
Cost-effectiveness of psychotherapy for cluster B personality disorders. Br J
Psychiatry 2010;196:396–403
Does not investigate art
therapy
15 Soeteman DI, Verheul R, Meerman AM, Ziegler U, Rossum BV, Delimon J, et al.
Cost-effectiveness of psychotherapy for cluster C personality disorders: a
decision-analytic model in the Netherlands. J Clin Psychiatry 2011;72:51–9
Does not investigate art
therapy
16 Teneycke T, Hoshino J, Sharpe D. The bridge drawing: an exploration of psychosis.
Arts Psychother 2009;5:297–303
Descriptive/qualitative paper
no economic data
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TABLE 47 Studies excluded at full text from the economic review (continued )
No. Reference Reason for exclusion
17 White M. Establishing common ground in community-based arts in health. J R Soc
Promot Health 2006;126
Descriptive/qualitative paper
no economic data
18 West C. Art therapy. Nurs Older People 2008;20:18–19 Overview no economic data
19 Asselt A.D, Dirksen C.D, Arntz A, Giesen-Bloo J.H, Dyck R, Spinhoven P, et al.
Out-patient psychotherapy for borderline personality disorder: cost-effectiveness
of schema-focused therapy v transference-focused psychotherapy. Br J Psychiatry
2008;192:450–7
Does not investigate art
therapy
20 Siskind D, Baingana F, Kim J. Cost-effectiveness of group psychotherapy for
depression in Uganda. J Ment Health Policy Econ 2008;11:127–33
Descriptive/qualitative paper
no economic data
21 Abbass A, Sheldon A, Gyra J, Kalpin A. Intensive short-term dynamic
psychotherapy for DSM-IV personality disorders: a randomized controlled trial.
J Nerv Ment Dis 2008;196:211–16
Descriptive/qualitative paper
no economic data
22 Maljanan T, Paltta P, Harkanen T, Virtala E, Lindfors O, Laaksonen M, et al.
The cost-effectiveness of short-term psychodynamic psychotherapy and
solution-focused therapy in the treatment of depressive and anxiety disorder
during a one-year follow-up. J Ment Health Policy Econ 2012;15:13–23
Descriptive/qualitative paper
no economic data
23 Park A, McDaid D, Wahlbeck K, Forsman A. What do we know about economic
evaluations of psychosocial interventions to promote mental health and wellness
in older people? Psychiatrische Praxis Conference: 9th International Conference of
the European Network for Mental Health Service Evaluation ENMESH, 23–25 June
2011, Ulm, Germany. [Conference Publication]. 2011;38
Full paper in German
24 Frisch M.J, Herzog D.B, Franko D.L. Residential treatment for eating disorders.
Int J Eat Disord 2006;39
Descriptive/qualitative paper
no economic data
25 Albrecht M, Krauth C, Rieger J, Lamprecht F, Kersting A, Schwartz FW.
[Extended psychosomatic rehabilitation programme for outpatients: Concept for health
economy evaluation of short-term and long-term cost and efficiency parameters.]
Gesundheitswesen 2000;62:2000
Full paper in German
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Appendix 6 Contact with authors
F rom: Lesley Uttley [mailto:l.uttley@sheffield.ac.uk]
Sent: Thursday, 19 December 2013 16:09 PM
To: hideyuki@ncgg.go.jp
Subject: Your study published in Geriatric Gerontology International 2010
Dear Hideyuki Hattori,
I would be very grateful for your help. Your study “Controlled study on the cognitive and psychological
effect of coloring and drawing in mild Alzheimer’s disease patients” has been included in a systematic
review of art therapy that I am conducting for the National Institute for Health Research, UK (http://www.
nets.nihr.ac.uk/projects/hta/122716). The review also includes a cost effectiveness analysis for which we
can map data from the Barthel index which is used in your study. You report the overall score for the
Barthel index but it would be very helpful if you could also provide us with the scores for the following
individual components:
1) Grooming;
2) Toilet;
3) Feeding;
4) Transfer;
5) Mobility;
6) Dressing;
7) Stairs;
8) Bathing;
9) Bladder;
10) Bowels.
Please let me know if it would be possible to provide us with this data? Many thanks in advance for your
help with this.
Best wishes
Lesley
–
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Dr Lesley Uttley
Systematic Reviewer
Health Economics and Decision Science (HEDS)
School of Health and Related Research (ScHARR)
On 19 December 2013 22:58, Hideyuki Hattori <hideyuki@ncgg.go.jp>wrote:
Dear Dr Lesley Attley
Thank you for emailing me. But I am afraid that I cannot disclose the data because we are going to
research more about art therapy for dementia patient and the data in the paper will be used or refered in
the future study.
I am sorry.
Dr Hideyuki Hattori
TEL:0562-46-2311
FAX:0562-44-8518
Email: hideyuki@ncgg.go.jp
On Friday, 20 December 2013 1:10, Lesley Uttley [l.uttley@sheffield.ac.uk] wrote:
Dear Hideyuki Hattori
Many thanks for your swift reply.
For your information we are able to include information that can remain “academic in confidence” in the
health technology assessment report so can guarantee that this information would be blacked out and
not published.
In any case, I thank you for your help so far and good luck with your forthcoming study and publication.
Best wishes
Lesley
–
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Dr Lesley Uttley
Systematic Reviewer
Health Economics and Decision Science (HEDS)
School of Health and Related Research (ScHARR)
On 29/07/2013 16:48, Mail Delivery System [MAILER-DAEMON@saira.epm.br] wrote:
This is the mail system at host saira.epm.br.
I’m sorry to have to inform you that your message could not be delivered to one or more recipients.
It’s attached below.
For further assistance, please send mail to postmaster.
If you do so, please include this problem report. You can delete your own text from the attached
returned message.
The mail system
<andreia.baptista@unifesp.br>: host harpia.epm.br[172.22.29.24] said: 550 5.1.1
<andreia.baptista@unifesp.br>: Recipient address rejected: User unknown in local recipient table (in reply
to RCPT TO command)
Final-Recipient: rfc822; andreia.baptista@unifesp.br
Original-Recipient: rfc822;andreia.baptista@unifesp.br
Action: failed
Status: 5.1.1
Remote-MTA: dns; harpia.epm.br
Diagnostic-Code: smtp; 550 5.1.1 <andreia.baptista@unifesp.br>: Recipient address rejected: User
unknown in local recipient table
From: Lesley Uttley <l.uttley@sheffield.ac.uk>
To: andreia.baptista@unifesp.br
Cc: Alison Scope <a.scope@sheffield.ac.uk>
Date: Mon, 29 Jul 2013 16:20:45 +0100
Subject: Art therapy for fibromyalgia study for inclusion in a systematic review
Dear Andreia Baptista
I am a systematic reviewer at the University of Sheffield, United Kingdom. We are undertaking a research
project for the UK National Institute for Health Research (NIHR) to examine the clinical and cost
effectiveness of art therapy.
Your abstract in Arthritis and Rheumatism (2012) Vol 64, has come up in our searches and I am assessing
the study for inclusion into our review. We would be interested to know when you will be publishing any
further results from this study? Currently we would need more data on the methods and results to be
included in the review.
More details about this project can be found here <http://www.hta.ac.uk/project/3030.asp>. Many thanks
in anticipation of your response.
Best wishes
Lesley Uttley
–
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Dr Lesley Uttley
Systematic Reviewer
Health Economics and Decision Science (HEDS)
School of Health and Related Research (ScHARR)
From: Lesley Uttley [l.uttley@sheffield.ac.uk]
Sent: 22 July 2013 15:39
To: Crawford, Mike J
Subject: CREATe trial status
Dear Mike Crawford
I’m currently conducting a systematic review of art therapy for the National Institute for Health Research
HTA programme. The CREATe trial (ISRCTN74217860) has come up in our searches and I wondered if
you’d be able to let me know the status of this trial and a rough idea of when you hope the data will
be published.
Many thanks in advance.
Best wishes
Lesley Uttley
–
Dr Lesley Uttley
Systematic Reviewer
Health Economics and Decision Science (HEDS)
School of Health and Related Research (ScHARR)
On 22/07/2013 16:09PM, Crawford, Mike J [m.crawford@imperial.ac.uk] wrote:
The study was abandoned due to poor recruitment – good luck with your review – mike
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